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A strong body of evidence suggests that environmental insults from the point of fertilisation 
to birth and neonatal life can shape the health of the individual for many years to come. 
Adverse exposures, such as maternal overnutrition, in the early life environment increase the 
risk of traditionally adult-onset diseases such as cardiovascular disease and type 2 diabetes 
adding greatly to the next generation’s burden of disease. Studies in animal models provide 
strong evidence that these effects are mediated by non-genetic programmed mechanisms. This 
is of particular concern, as recent studies in the UK suggest that over half of women are now 
overweight or obese during pregnancy. Current preventative strategies for adult 
cardiovascular disease have, thus far, focused on reducing an individual’s modifiable risk 
factors. However, given growing evidence that risk of cardiovascular disease is determined in 
utero, there is strong rationale that disease risk from mother to child could be reduced prior to 
birth, through targeted interventions in the mother before and during pregnancy.  
Using an established murine model of maternal diet-induced obesity during pregnancy, the 
first aim of this thesis was to characterise potential programming factors in the obese mother 
and identify those that were targeted by a treadmill exercise intervention. Through feeding of 
an obesogenic diet, dams became heavier, with increased fat mass, and showed insulin 
resistance at weaning. Previous work has shown the intervention improved maternal insulin 
sensitivity during pregnancy (E19) and data from this thesis revealed that this was not 
accompanied by any changes to body composition. 
Previous data using this model showed that male offspring born to obese dams have 
pathological cardiac hypertrophy and ex vivo cardiac dysfunction. A second aim of this thesis 
was to establish if exercise intervention in obese dams was protective to the cardiovascular 
health of the offspring. These studies revealed that maternal exercise intervention during 
obese pregnancy had a positive impact by preventing pathological left ventricular cardiac 
hypertrophy and in vivo dysfunction, but did not prevent programmed hypertension in the 
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male offspring. This demonstrates that offspring cardiac hypertrophy and dysfunction can be 
programmed independently of hypertension by maternal diet-induced obesity.  
The third aim of this thesis was to establish how female offspring were impacted by maternal 
obesity. The results demonstrated that female offspring born to obese dams were hypertensive 
and displayed right ventricular cardiac hypertrophy. However, there was no observable effect 
of maternal obesity on cardiac function in female offspring at this age. This highlights the 
potential sexually dimorphic effects of developmental programming by maternal obesity.  
A final aim of this thesis was to assess the immediate consequences of maternal obesity on the 
fetal heart and whether maternal exercise had any impact. This showed that in late gestation 
(E19), cardiac remodelling were already present in the male fetuses of obese dams, and the 
exercise intervention did not fully prevent this adverse finding. 
In conclusion, this thesis highlights that the cardiovascular health legacy of an individual is 
determined by maternal nutrition before birth and by the intrauterine environment. Just a 
small improvement in offspring risk could have important implications for the future 
prevalence of cardiovascular disease worldwide. Importantly this thesis highlights a potential 
need for combination intervention strategies to tackle the epidemic of obesity in pregnancy, as 
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1. General Introduction 
1.1 Cardiovascular Disease (CVD) 
The World Health Organisation (WHO) published a global action plan in 2008 to reduce the 
preventable and avoidable burden of morbidity, mortality and disability associated with non-
communicable diseases (NCDs). The target was to prioritise NCDs and their prevention by 
reducing modifiable risk factors through the creation of a health-promoting environment, 
while enabling research to focus on the prevention. An estimated 36 million deaths, equating 
to 63% of the 57 million deaths that occurred globally in 2008, were caused by NCDs, 
comprising mainly of cardiovascular diseases (CVDs) (48% of NCDs), cancers (21%), 
chronic respiratory diseases (12%) and diabetes (3.5%) (WHO, 2013). 
1.1.1 Incidence of CVD and risk factors 
In 2012, CVD was the most common cause of death in the UK for women (28% of all female 
deaths), but for men cancer is now the most common cause of death (32% of all male deaths) 
with CVD being the second most common (29% of all male deaths) (Bhatnagar et al., 2015). 
Furthermore, over one quarter of premature deaths (before the age of 75 years) in men and 
women were caused by CVD (WHO, 2013). Treatments and advances in surgical techniques 
mean that the chance of survival after a first CVD event have increased, but the patient is 
likely to live with the repercussions for the rest of their life (Bhatnagar et al., 2016). 
Employing prevention strategies before the progression into disease is critically important to 
help alleviate the disease burden.  
The major risk factors for CVD are age, diabetes, hypertension, hypercholesterolaemia, 
tobacco use, physical inactivity and an unhealthy diet, with the last two often leading to the 
onset of obesity. These are all modifiable risk factors, meaning that with lifestyle changes 
they can be eliminated, drastically decreasing the risk of CVD. It has been suggested that at 
least 80% of premature deaths from heart disease and stroke could be avoided through healthy 
diet, regular physical activity and avoiding tobacco smoke (WHO, 2017). These risk factors 
are still globally prevalent; obesity is a worrying problem with its growth now classified as an 
epidemic (see Section 1.2). Other diseases/disorders also increase the risk of CVD, for 
example hypertension and hypercholesterolemia, and so by successfully managing these 
conditions the CVD risk is lowered. Beta-blockers, angiotensin-converting enzyme inhibitors 
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(blood pressure-lowering drugs), and statins (cholesterol-lowering drugs) independently work 
to reduce the risk of recurrent vascular events by 75% when combined with cessation of 
smoking (WHO, 2017).  
Age is a non-modifiable risk factor for CVD, and with an ageing population due to increased 
life expectancy, this will become a challenge. Recently the influence of genetic risk factors in 
predisposing individuals to CVD has become more understood. Key polymorphisms have 
been linked with the onset of CVD, such as genetic differences in genes that cause high blood 
pressure (BP) (Wang and Staessen, 2000), severe hypercholesterolemia (Abifadel et al., 2003), 
hypertrophic cardiomyopathy (Olson et al., 2000), and atrial or ventricular septal defects 
(Garg et al., 2003). 
1.1.2 Economic burden of CVD 
The National Health Service (NHS) in England spent around £6.8 billion on CVD in 
2012/2013, the majority of which was spending on secondary care. There were over 1.6 
million episodes related to CVD in NHS hospitals, accounting for 10.1% of all inpatient 
episodes among men and 6.3% among women. It is clear that CVD remains a substantial 
health and economic burden despite the significant decline in incidence and mortality that has 
already been achieved (Bhatnagar et al., 2016). The decreased mortality rate of CVD means 
that more people are surviving and living with the implications of their disease, resulting in an 
increased demand in secondary care needed to manage their conditions. It has therefore been 
noted that the cost of inaction is far greater than the cost of taking action to prevent CVD and 
other NCDs (WHO, 2013). 
1.2 Obesity Epidemic: prevalence and impact 
Understanding the cause and consequence of obesity is essential for healthcare systems 
worldwide. Excess bodyweight is the sixth most important risk factor contributing to the 
overall burden of disease worldwide (Ezzati et al., 2002). This sits behind other risk factors 
that are often associated with obesity, such as high cholesterol levels (3rd) and low intake of 
fruit and vegetables (5th). The WHO describes obesity as a global epidemic and a highly 
prevalent but neglected public-health problem (WHO, 2000), and in fact worldwide obesity 
has more than doubled since 1980. In 2014, 39% of adults worldwide were overweight and of 
these, 13% of adults were obese (Figure 1.1). Body size can be assessed using a variety of 
measures, including weight, height, and waist circumference. A widely utilized tool is body 
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mass index (BMI) which defines normal weight as a BMI of 18.5–24.9 kg/m2, overweight as 
a BMI of 25–29.9 kg/m2, and obesity as a BMI of 30 kg/m2 or greater (WHO, 2015).  
 
FIGURE 1.1: Prevalence of obesity worldwide. Global heat map in 2014 of obesity 
prevalence in A) women and B) men. Adapted with permission [CC BY] (NCD Risk Factor 
Collaboration, 2016). 
 
Obesity is a chronic condition that is often progressive, despite it being preventable, and is 
multifactorial in its cause. Levels of obesity are thought to be rising, at least in part, due to 
increased saturated fat and simple carbohydrate intake, combined with physical inactivity. It 
has been suggested that if the trends in obesity prevalence continue, the global obesity target 
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(to halt the rise in obesity by 2025 to 2010 levels) will be almost impossible to achieve (NCD 
Risk Factor Collaboration, 2016).   
Studies assessing the genetic contribution to the obesity epidemic suggest that any identified 
loci have a fairly modest effect size so far. FTO has the largest impact in people from 
European descent but still only increases BMI by 0.26– 0.66 kg/m2 (Loos, 2009). This still 
leaves a large proportion of increases in bodyweight unexplained. Despite the large number of 
genome-wide association studies, the obesity-associated variants only represent 3% of 
predicted BMI heritability and cannot explain the rapid increase in obesity prevalence 
(Albuquerque et al., 2017).  
Obesity is a national health burden and in the US it now outranks both smoking and drinking 
in its deleterious effects on health and healthcare costs (Sturm, 2002). Many of the co-
morbidities of obesity relate to metabolic syndrome, defined by the WHO as obesity, 
hypertension and dyslipidemia with or without hyperglycemia (Alberti and Zimmet, 1998). 
Current calculations suggest that obesity at the age of 40 will decrease your life expectancy by 
seven years (Peeters et al., 2003). An analysis has been carried out to estimate the number of 
years of ill health and number of lives lost between ages 30-75yrs due to excess weight. The 
results showed that ischaemic heart disease causes the greatest number of years lost to 
disability, with diabetes a close second (Haslam and James, 2005). 
1.3 Developmental Origins of Health and Disease (DOHaD) 
The traditional risk factors of CVD, including the modifiable risk factors currently being 
targeted by the WHO, focus on the current environment or lifestyle that the individual is 
experiencing. It is now thought that our risk of CVD may actually be determined in utero 
through the maternal environment. This changes the traditionally held view in the clinic and 
highlights another key period of life where preventative strategies should be applied. Starting 
in the early 1990s, low birthweight and/or poor fetal growth have been associated with poor 
health in later life (e.g. abdominal fatness, CVD and increased blood pressure) (Barker, 
Osmond, et al., 1989; Barker, Winter, et al., 1989; Law et al., 1992; Barker et al., 1997). 
Alongside genetics and environmental/lifestyle factors, these studies introduced the idea of a 
third factor in the development of poor cardiometabolic health: the influence of the early life 
environment and in particular maternal/fetal nutrition. Both maternal malnutrition and 
maternal obesity are considered to be suboptimal intrauterine environments and act as large 
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influencers on the health and disease of their offspring. Their impact will be explored in the 
following sections of this introduction. 
The study of DOHaD aims to find the mechanisms by which the environment experienced 
during fetal development contributes to the risk of disease in postnatal life. Developmental 
periods are sensitive to environmental stimuli as the system has an element of plasticity; this 
mainly occurs in utero but can stretch into the postnatal period with the exact window and 
duration dependent on the species and tissue type. It is proposed that changes in response to 
the maternal environment during the critical period of fetal development will have long-
lasting effects on the future health of that individual, or in other words will ‘programme’ the 
individual to be predisposed to disease (Figure 1.2).  
1.3.1 Thrifty Phenotype hypothesis 
The original hypothesis, based on associations of low birthweight and type 2 diabetes 
(T2D)/CVD that started this field was the Thrifty Phenotype hypothesis, proposed in the 
1990s (Hales and Barker, 1992). The hypothesis describes the idea that maternal malnutrition 
causes changes that preferentially divert nutrients and/or oxygen supply to essential organs 
(e.g. brain) of the fetus at the expense of the non-key organs (e.g. adipose tissue and pancreas). 
These changes are likely beneficial in the short-term in continued conditions of poor postnatal 
nutrition, but the resulting altered birth phenotype may be maladaptive in later life, especially 
in conditions of postnatal overnutrition thus contributing to the adverse health outcomes. The 
fetus was proposed to adapt its metabolism to expect a similarly depleted environment 
postnatally through efficient storage of nutrients. Inappropriate control points are then 
established, such as decreased physiological tolerance to increased adiposity and a rich diet, 
thus disturbing the metabolic balance throughout the life of the individual in conditions of 
overnutrition (Rees, McNeil and Maloney, 2008) (Figure 1.2).  
The Thrifty Phenotype hypothesis was based on observations from a study of Hertfordshire 
males aged 64 whose birth records were available. There was an association between low 
birthweight and increased systolic blood pressure (SBP), increased prevalence of 
atherosclerosis (Barker, Osmond, et al., 1989; Barker, Winter, et al., 1989) and increased 
prevalence of T2D (Hales et al., 1991). This cohort was also used to draw associations of 
continued low bodyweight at one year with metabolic disease (including impaired glucose 
tolerance and increased incidence of T2D (Hales et al., 1991)). The strong association of low 
birthweight and poor health has been replicated in different populations worldwide. 
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1.3.2 Predictive Adaptive Response hypothesis 
The Predictive Adaptive Response hypothesis, which followed the Thrifty Phenotype 
hypothesis, proposed that changes will occur to promote fetal survival. These changes may 
not be immediately beneficial to the developing fetus, but if there is a correct prediction of 
postnatal environment it may become advantageous in later life. If the postnatal conditions do 
not match the prediction made in utero then this will result in a detrimental ‘mismatch’ and ill 
health will likely develop (Godfrey et al., 2007). This model goes beyond maternal 
undernutrition and extends to include maternal overnutrition. Rapid ‘catch up growth’ can 
occur in offspring who are born small for gestational age (SGA); this causes an increased risk 
of T2D and CVD morbidity and mortality, likely driven by the subsequent environmental 
mismatch (Barker, 2002; Barker et al., 2005). Since the rate of postnatal growth determines 
the risk of disease in the offspring, the impact of the programming time window could extend 
beyond birth. 
Early life programming is thought to play an important role in the aetiology of obesity, T2D, 
and CVD. The importance of tackling such NCDs has been recognised by the recent WHO 
global action plan (WHO, 2013), however the importance of a poor intrauterine environment 









FIGURE 1.2: Developmental Origins of Health and Disease. The multi-organ impact of an adverse intrauterine 
environment and the subsequent health burden on the offspring. NAFLD- Non-alcoholic fatty liver disease. 
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1.4 Maternal undernutrition: evidence from human cohorts 
1.4.1 Dutch Hunger Winter famine 
Famine is a problem that is confined more to the developing world, with less than 2% of the 
total number of people suffering from undernourishment coming from a developed country 
(FAO, 2015). Valuable data from a human cohort came from analysing data from births 
during the Dutch Hunger Winter famine, a period of five months of malnutrition in the 
western part of the Netherlands in the winter of 1944-45. During adulthood, children born to 
mothers who experienced the famine during early pregnancy had increased levels of CVD, 
increased BMI and were glucose intolerant (Ravelli et al., 1999; De Rooij et al., 2006). 
Children born to mothers who were pregnant before the famine and experienced famine in the 
later stages of pregnancy were also born with low birthweight and with an increased risk of 
obesity and T2D, but these individuals had a milder cardiovascular phenotype (Ravelli et al., 
1999). This important human cohort provided some of the first evidence that a suboptimal in 
utero environment for development has an impact on the health burden of the now adult 
offspring. It also highlights the importance of the timing of an insult during development, 
with malnutrition during early pregnancy causing the most harm.  
Similar outcomes has been shown in those exposed to other famines in utero, including 
famines in Austria following the two world wars (1918 and 1946-47) (Thurner et al., 2013). 
The Chinese famine (1959-1961) has shown that exposure to severe famine conditions in fetal 
life caused an increased risk of hyperglycemia and dyslipidemia in adulthood (Li et al., 2011; 
Z. Wang et al., 2017). Exposure to the famine specifically in the first trimester increased the 
risk of hypertension in adulthood (Wang et al., 2016).  
1.4.2 Twin Studies  
A critical tool in the field of developmental programming is using discordant siblings in 
studies to address and limit contributions by genetic and current environmental factors. The 
validity of using twin studies to make conclusions about singleton pregnancies has been 
questioned, due to the differences in the normal intrauterine growth profiles. However, studies 
between twins discordant for T2D showed that the twin with the lower birthweight is more 
glucose intolerant and has an increased risk of T2D. Low birthweight, due to inadequate 
energy and/or nutrient intake, prevents the developing fetus from reaching a healthy size and 
is associated with increased risk of disease (Ijzerman, Boomsma and Stehouwer, 2005). 
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1.5 Programming by maternal undernutrition in animal models 
Animal studies permit better control of variables while generating data in a shorter time frame. 
They also allow a greater investigative burden on mothers and offspring than tolerated by 
humans, and this allows causative associations to be made (Rabadan-Diehl and Nathanielsz, 
2013). Human epidemiology alone cannot easily dissect the cause-effect relationships, while 
animal studies can identify the specific mechanisms involved. Laboratory animals are kept in 
tightly controlled conditions, allowing any confounding factors identified by epidemiological 
studies to be removed, to adequately assess the alterations at the molecular and whole-body 
level. 
1.5.1 Maternal nutrient restriction 
Models of maternal undernutrition have been achieved by caloric restriction in a range of 
animal species. One study showed that rats calorically restricted by 50% during pregnancy 
had smaller pups that showed marked postnatal ‘catch up growth’, and the offspring had 
increased intra-abdominal fat at four months of age (Suzuki, Shibanuma and Kimura, 2010). 
This obesity-prone phenotype has been attributed to a premature leptin surge in neonatal life. 
The leptin surge is critically important for the formation of energy regulation circuits in the 
hypothalamus (Yura et al., 2005). In another study, rats received 30% of ad libitum intake 
throughout gestation with offspring displaying hyperphagia, hypertension, and markedly 
increased plasma insulin and leptin levels. These metabolic and cardiovascular abnormalities 
were amplified by postnatal hypercaloric nutrition, suggesting this is important in the 
aetiology of adult-onset disease (Vickers et al., 2000).  
Maternal undernutrition will typically result in fetal intrauterine growth restriction (IUGR), 
and this represents another model used to study maternal undernutrition. In a baboon model of 
IUGR, juvenile offspring displayed signs of hypertension, insulin resistance and metabolic 
syndrome (Choi et al., 2011). Cardiac dysfunction has also been detected in IUGR fetuses and 
neonates (Fouzas et al., 2014). Using cardiac magnetic resonance imaging, it was shown that 
IUGR caused young adult baboons to have systolic dysfunction and left ventricle remodelling 
that mimics accelerated ageing (Kuo et al., 2017).  
1.5.2 Low protein diet 
To determine the impact of maternal macronutrient deficiency, a maternal low protein model 
was established by Snoeck and colleagues (Snoeck et al., 1990). The model uses a control 
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20% protein diet compared to an isocaloric 8% protein diet in pregnancy that causes a 
significant reduction in birthweight (Chen et al., 2009). Endothelial dysfunction, hypertension, 
and increased cardiac sympathetic tone were seen in the offspring exposed to protein 
restriction in utero (Brawley et al., 2003; Torrens et al., 2009; Barros et al., 2015). ApoE 
mice fed an isocaloric 8% low protein diet during pregnancy and lactation demonstrated 
young adult offspring with accelerated development and increased progression of 
atherosclerotic lesions (Blackmore et al., 2012). 
Studying the effects of undernutrition in pregnancy is still relevant in teenage pregnancies and 
pregnancies in older mothers, where SGA still occurs, as well as in under-developed parts of 
the globe. Four decades ago the world’s underweight population was more than double that of 
the obese equivalent, however this is no longer true with global statistics showing that more 
people are obese than underweight (NCD Risk Factor Collaboration, 2016). With this in mind, 
the importance of studying maternal obesity has never been so important with an estimated 
50% of childbearing aged women (25-34 years old) being overweight or obese in the UK 
(Davies et al., 2014). As well as immediate detrimental consequences to mother and child, 
there is also now growing evidence to suggest that exposure to an obesogenic environment in 
utero programmes poor cardiometabolic health. 
1.6 Maternal obesity 
The global obesity epidemic is affecting all groups within the population, including women of 
childbearing age. A large retrospective study among maternity services in England showed 
the incidence of first trimester obesity (30 kg/m2) has increased from 7.5% to nearly 15.6% of 
the pregnant population over an 18 year period (Heslehurst et al., 2010). 
1.6.1 Risks to the mother 
Obesity during pregnancy increases immediate adverse pregnancy outcomes such as stillbirth, 
pre-eclampsia and caesarean delivery (Cedergren, 2004; Athukorala et al., 2010; Crane et al., 
2013). These increased risks are independent of partner status, smoking or maternal age. 
Incidence of fetal distress and a low APGAR score (score for physical condition of a 
newborn) increases with maternal obesity (Cedergren, 2004).  
Pre-eclampsia is characterised clinically by high maternal BP, proteinuria, and oedema and 
makes up 3-7% of all pregnancy hypertensive disorders (Pivarnik et al., 2006). Women with a 
history of pre-eclampsia are more likely to go on to develop essential hypertension in the 
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years that follow, creating a further health burden (Nisell et al., 1995). In fact, pre-eclamptic 
women often experience metabolic disturbances that mirror those of a non-pregnant CVD 
patient, such as hyperlipidemia, oxidative stress, and sympathetic over-activation, despite 
having no CVD diagnosis for themselves (Pivarnik et al., 2006). 
Caesareans due to ineffective intrauterine contractility are more common with increasing 
maternal BMI (Cedergren, 2009). Leptin, a hormone that increases with percentage body fat, 
has an inhibitory effect on myometrial contractions (Moynihan et al., 2006). Macrosomia (a 
newborn significantly larger than average) and the narrowing of the maternal pelvis due to 
increased soft tissue mass can cause cephalopelvic disproportion (failure of the fetus to travel 
through the birth canal). This is thought to be one explanation for the increased need for 
caesarean delivery in obese pregnancies (Ehrenberg, Huston-Presley and Catalano, 2003; 
Sherrard et al., 2007). The risks of maternal obesity to the mother are summarised in Figure 
1.3. 
Insulin resistance is a normal part of pregnancy and is very important in maintaining fuel 
supply to the growing fetus, however many obese women enter pregnancy with pre-existing 
insulin resistance which worsens throughout gestation (Catalano et al., 1999). The risk of 
developing gestational diabetes mellitus (GDM) is two times higher in women who are obese 
during their pregnancy compared to normal weight women (Athukorala et al., 2010). In 
addition, obese women diagnosed with GDM more often require insulin to control blood 
glucose level than normal weight women who can often successfully use diet to control the 
condition (Langer et al., 2005). Differences in metabolic profile, including dyslipidemia, are 
present in obese pregnant women at least ten weeks prior to diagnosis of GDM (White et al., 
2017). Both maternal obesity and GDM have adverse pregnancy outcomes, for example both 
independently increase the risk of the need for caesarean section (Ehrenberg et al., 2004).  
Studies have shown that pre-pregnancy BMI may have stronger influence on caesarean 
section, pregnancy-induced hypertension and large for gestational age (LGA) baby than GDM 
(Ricart et al., 2005), however the combination has a more severe outcome on maternal and 
neonatal outcomes then either alone (Catalano et al., 2012; Wahabi et al., 2014). 
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FIGURE 1.3: Summary of the wide-ranging consequences of maternal obesity. The 
consequences not only have an immediate impact on the mother and her pregnancy but also 
have programmed effects on the offspring’s health. 
 
1.7 Evidence from human cohorts for programming by maternal obesity 
1.7.1 Association studies 
The weight of a fetus is influenced by the parents’ weights and heights through a genetic link, 
but maternal weight has an additional programming influence through the intrauterine 
environment. Obesity during pregnancy has generally been assumed to be associated with 
offspring born LGA, however research now suggests obese mothers are just as likely to have 
offspring born SGA (Rajasingam et al., 2009), presumably in part related to effects of 
maternal obesity on placental function. In contemporary populations, where obesity 
prevalence is high, the relationship between risk of developing adulthood disease and 
birthweight is a U-shaped curve, with both low and high birthweight offspring at equal risk of 
cardiometabolic dysfunction (Pettitt and Jovanovic, 2001). These results show that exposure 
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to obesity during development can produce offspring in both birthweight groups with 
increased risk of disease, suggesting a growing threat to future generations. Maternal obesity 
is a heterogeneous condition and can be accompanied by metabolic syndrome alongside 
varying degrees of hypertension, insulin resistance, and dyslipidemia. It is, therefore, likely to 
present challenges in the study of its impact on fetal programming as the vulnerable fetus will 
be exposed to a myriad of different maternal “programming factors” that also may vary 
between individuals.  
1.7.2 Helsinki Birth Cohort  
The Helsinki Birth Cohort study was a unique undertaking, collecting extensive 
epidemiological data on 13,345 individuals throughout their lifespan, including prenatal life, 
childhood and later life. Maternal BMI correlated with many different offspring health 
outcomes including premature death, with the strongest effect on CVD and T2D (Eriksson et 
al., 2014). An association between maternal obesity and atrial fibrillation, a significant risk 
factor for future mortality from CVD, has also been demonstrated in this cohort (Odutayo et 
al., 2016; Johnson et al., 2017).  
1.7.3 Adoption studies 
Often it is difficult to show to what extent associations between parental and offspring 
adiposity is explained by shared postnatal environmental and lifestyle factors, but this can be 
studied in adoption studies. Despite adopted offspring being exposed to the shared 
environmental and lifestyle factors of their adoptive family, their BMI is still more strongly 
associated with that of their biological parents (Sorensen et al., 1992). This suggests that the 
mediator could be genetic and/or programmed.  
1.7.4 Sibling pair studies in Pima Indians  
Sibling studies are useful as you are able to control for genetics and lifestyle, as much as 
possible, by comparing siblings born to the same parents and raised in the same household. A 
population in central America known as the Pima Indians has one of the largest incidences of 
T2D and obesity; 50% of adults aged over 35 years have T2D (Knowler et al., 1981). Studies 
using siblings born before and after the mother was diagnosed with diabetes enabled 
researchers to separate the effects of programming by a diabetic pregnancy and the genetic 
influence. Siblings born from a diabetic pregnancy had increased prevalence of T2D and an 
increased BMI when compared to siblings born before the onset of maternal diabetes. 
Exposure to diabetes during pregnancy therefore delivers a high risk for the development of 
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diabetes and obesity in offspring which is in excess of risk attributed to transmission of 
genetic variants alone (Dabelea et al., 1998, 2000).  
1.7.5 Siblings studied before and after bariatric surgery 
One very powerful approach compares siblings born before and after the mother has 
undergone biliopancreatic bypass surgery, which causes weight loss and an improvement in 
maternal metabolic health (Umeda et al., 2011; Maggard-Gibbons et al., 2013). Offspring 
born after mothers underwent surgery are 52% less likely to become obese when compared to 
siblings born before surgery (Kral et al., 2006). Offspring born after weight-loss surgery also 
had improved fasting insulin and homeostatic model of insulin resistance (HOMA-IR) as well 
as lower BP (Guénard et al., 2013). In general, the sibling born before the weight loss surgery 
exhibited more indicators of cardiometabolic dysfunction than their sibling (Smith et al., 
2009). This study presents critical evidence that the effects are ‘programmed’ and are not 
simply genetic since environmental insults from the point of fertilisation to birth have 
impacted the future health of that individual.    
1.8 Risks to the offspring: Human studies 
1.8.1 Metabolic dysfunction  
There is growing evidence to suggest that pre-pregnancy BMI is a strong predictor of future 
offspring disease (Parsons, Power and Manor, 2001; Boney et al., 2005). Pre-pregnancy 
obesity causes an early tendency for offspring to be overweight which is perpetuated as the 
child grows (Salsberry and Reagan, 2005). Maternal obesity before pregnancy is associated 
with increased newborn fat mass, as calculated by skinfold thickness before one day of age 
(Pacce et al., 2016). Furthermore, maternal obesity is associated with an increased risk of 
obesity and metabolic dysfunction in the offspring and this effect is seen from childhood to 
adulthood (Boney et al., 2005; Cooper et al., 2010).  
A population-based prospective cohort revealed that pre-pregnancy BMI was positively 
associated with higher adolescent BMI, waist-to-hip ratios, and insulin, glucose and HOMA-
IR levels (Gaillard et al., 2016). Insulin resistance programmed at an early age will become 
more pronounced with age which could ultimately lead to metabolic disease (Rees, McNeil 
and Maloney, 2008). Maternal obesity is associated with increased BMI in children, and a 
retrospective study has shown that an increase of each BMI unit (z-score) at seven years old 
corresponded with 10% and 7% higher risk of CVD in males and females respectively. This 
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relative risk increased with age, in particular the risk doubled in both sexes by the age of 13 
(Baker, Olsen and Sorensen, 2007). 
Studies have shown that offspring from a GDM pregnancy have higher mean BMI, and this is 
independent of birthweight (Avgil Tsadok et al., 2011). When maternal pre-pregnancy BMI is 
included in the model this effect is markedly reduced, suggesting that the effect of maternal 
GDM is not independent of pre-pregnancy BMI. Some data suggests that maternal insulin 
resistance may be a more important predictor of infant adiposity then maternal BMI (Shapiro 
et al., 2015) as insulin resistance can divert excess fuel to fat accretion and fetal growth 
(Barbour et al., 2011). 
1.8.2 Cardiovascular risk factors  
Obese women are more likely to have children with congenital heart defects and the risk 
increases with advancing BMI (Mills et al., 2010). One study detected that fetuses (at 14 
weeks gestation) from obese women have reduced left and right ventricle global strain rate, 
indicating fetal myocardial dysfunction (Ingul et al., 2016).  
Some of the first evidence for an early life overnutrition environment and its influence on 
cardiovascular consequences comes from a Finnish study that showed a positive association 
between mother’s weight and CVD (Forsén et al., 1997). The Aberdeen cohort study also 
reported that maternal BMI positively correlates with increased risk of hospital admission and 
premature death from CVD (Reynolds et al., 2013). This cohort used a large database of 
pregnant women dating from the 1950s. Offspring were born between 1950 and 1976 and 
their birth records were linked to the general register of deaths and the Scottish morbidity 
record systems in order to assess all-cause mortality from CVD. The authors found an 
association between maternal overweight/obesity and increased cardiovascular events in 
offspring (maintained after adjustment for current socioeconomic status) (Reynolds et al., 
2013). This is concerning, given the increasing prevalence of obesity in child bearing women. 
Another study demonstrated a positive association between maternal BMI and early indicators 
of CVD risk factors in young children (Labayen et al., 2010). Higher maternal pre-pregnancy 
BMI was associated with an adverse cardiometabolic profile in adolescence (Gaillard et al., 
2016). These offspring also had increased adiposity and their BMI was closely associated 
with both maternal pre-pregnancy BMI and an adverse cardiometabolic profile. A prospective 
cohort of children called Project Viva assessed the relationship between pre-pregnancy BMI 
and cardiometabolic risk in school age offspring (age range six-ten years old). Children of 
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mothers with greater pre-pregnancy BMI had more overall as well as central fat, greater 
insulin resistance, dysregulated adipocytokines, elevated inflammatory markers and higher 
SBP (Perng et al., 2014).  
Offspring blood pressure  
The effect of maternal programming on offspring BP has been assessed as another 
cardiovascular risk factor. Higher maternal pre-pregnancy BMI was associated with elevated 
SBP in adolescents with a mean age of 17 (Gaillard et al., 2016). The authors also assessed 
how weight gain in early and mid (but not late) pregnancy had a positive association with a 
range of poor cardiometabolic parameters in offspring, including SBP (Gaillard, 2015)  
In 2009, the Institute of Medicine set guidelines for the appropriate weight gain during 
pregnancy, broken down by pre-pregnancy BMI (Rasmussen et al., 2009). Gestational weight 
gain (GWG) has been positively correlated with BP and BMI in exposed children at three 
years of age. SBP was an estimated to be 0.60 mmHg higher per 5 kg of GWG. This increase 
was reduced to 0.34 mm Hg per 5 kg weight gain after adjusting for child BMI, as the child’s 
size is a major determinant of BP (Oken et al., 2007). In a supporting study of adults at 21 
years, there was a positive association between GWG and offspring SBP that trended towards 
significant (Mamun et al., 2009). The relevance of higher average SBP in early adulthood is 
positively associated with future CVD (McCarron et al., 2000). The plethora of effects of 
maternal obesity on offspring health is summarised in Figure 1.3. 
1.9 Risks to the offspring: Animal studies 
Animal models from a wide range of species aid the study of maternal obesity and enable 
further understanding of maternal programming processes. Fetal programming research has 
commonly used rodents due to their placental similarities to humans, short gestation lengths, 
and their ability to generate large sample sizes. Most differences in using rodents to study 
fetal programming come from the fact that rodents are born to large litters with further 
development required postnatally, whereas humans, sheep, and non-human primates (NHP) 
are delivered in fewer numbers and born with a greater degree of intrauterine development. 
The critical windows of vulnerability during development therefore vary among species 
(Rabadan-Diehl and Nathanielsz, 2013). Due to the long-term nature of CVD it is often true 
that the data on such outcomes in humans will not be known for many years. Animal models 
are therefore critical to longitudinally determine the cardiometabolic effects on the offspring. 
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1.9.1 Large animal models 
Although less commonly studied, ovine models are used due to the similarities of placental 
structure and function in humans, and the ability to have repeated sampling of blood and 
tissue. Ewes are overfed (150% National research council recommendations) to induce 
obesity at conception, causing macrosomia, hyperglycemia, and hyperinsulinemia in fetuses 
at mid-gestation (Zhang et al., 2011). Fetuses from a maternal overnutrition model had altered 
heart stress signalling, including the activation of TGF-β, p38 and Smad pathways, leading to 
collagen accumulation and fibrosis (Huang et al., 2010). In the same model, fetal hearts from 
overfed ewes had impaired cardiac function in response to high workloads in an ex vivo 
perfusion set up (Wang et al., 2010). Adult offspring displayed altered growth, adiposity and 
glucose tolerance (Long, Ford and Nathanielsz, 2011).  
NHP models have supported the work in small animal and ovine models. Offspring of obese 
baboons had placental and fetal profiles that more closely resembled that of a LGA human 
fetus despite them being of normal weight (Farley et al., 2010). High fat diet feeding in the 
preconceptual period and throughout pregnancy resulted in smaller fetuses in the third 
trimester, but they underwent ‘catch up growth’ postnatally and showed increased adiposity. 
Irrespective of postnatal diet these offspring gained early-onset excess weight (Grayson et al., 
2010). 
1.9.2 Rodent models 
Rodent models are the most commonly used experimental animal model. High fat diets 
(HFD) vary in composition and can include diets that have 40% fat (% of kcal) and others that 
have 60% fat (% kcal). 
High fat diet feeding 
Offspring from HFD fed rats (45% kcal from fat) during pregnancy and lactation were 
significantly more obese than the control equivalents, and this was accompanied by 
hyperinsulinemia and hyperleptinemia in the offspring (Howie et al., 2009). The authors also 
had a group of females who were fed the HFD from weaning before continuing in pregnancy 
and lactation. It is of interest to note that a lifetime of high fat nutrition produced a similar 
offspring phenotype to simply high fat nutrition in pregnancy and lactation alone. This 
indicates that the preconception diet is independent of these offspring effects.  
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HFD maternal feeding (40% energy from fat) during pregnancy and lactation in a mouse 
model reduced offspring responsiveness to the beneficial effects of exercise (i.e. reduction of 
fat mass and improvement of insulin resistance) (Kasch et al., 2017). This suggests the 
offspring are not only more prone to becoming obese, but they also seem less able to combat 
the negative effects and get themselves out of this unhealthy state. 
HFD feeding (60% kcal from fat) from weaning in female mice programmes hypertension 
and adiposity in male offspring at six months of age (Guberman et al., 2013). The authors 
showed an associated activation of the adipose renin-angiotensin system (an endocrine system 
involved in BP homeostasis). Male offspring of mothers fed a HFD during pregnancy and 
lactation showed impaired nitric oxide (NO)-dependent endothelial and vascular function, and 
this likely mediated the offspring’s elevated BP (Gray et al., 2015). In a rat model of HFD 
feeding (45% kcal from fat) during pregnancy and lactation, offspring displayed endothelial 
dysfunction in response to acetylcholine (vasodilator) in both sexes, but an increased BP was 
only shown in the females at six months of age. HFD feeding (60% kcal) in mice for four 
weeks prior to breeding and during pregnancy also demonstrated increased BP (both systolic 
and diastolic) in the female offspring (Liang, Oest and Prater, 2009). 
Obesogenic diet feeding 
HFDs in rodents have been critical in understanding the effects of a HFD alone, however 
rodents do not generally find HFDs very palatable so it can often be difficult to cause 
significant bodyweight gain and such diets are not typical of a human western diet consumed 
in today’s society. In order to fully understand the current diet of the ‘western’ population, it 
is important to assess the long-term impact of exposure to a diet both high in fat and in simple 
sugars, which are very palatable, and this led to the development of obesogenic diets.   
Another rat model of overnutrition had cafeteria-style high fat feeding for five weeks before 
mating to induce obesity. The offspring had increased adiposity, insulin resistance, and 
hyperphagia (Morris and Chen, 2009). Mouse dams fed a high fat and sugar diet for six weeks 
before mating and continued on the diet for pregnancy and lactation had offspring that 
displayed hyperphagia, increased adiposity, and endothelial dysfunction at three months of 
age. A hypertensive phenotype was observed at six months of age (Samuelsson et al., 2008). 
Offspring of a rat model of maternal obesity had night-time elevations in mean arterial BP 
compared with control offspring, and this preceded the development of obesity and 
hyperleptinemia. The study suggested a sympathetic origin of the observed hypertension, and 
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this was supported by elevated noradrenaline and renin, and the inhibition of hypertension 
following β-adrenergic blockade (Samuelsson et al., 2010). This suggests the presence of 
sympathetic dominance and early cardiac dysfunction. Critically, this occurred before the 
onset of increased offspring adiposity or hyperleptinemia, indicating it arose as a direct 
consequence of in utero and postnatal maternal environments (Samuelsson et al., 2010). It has 
been suggested that neonatal hyperleptinemia as a result of maternal obesity causes permanent 
changes in the central melanocortin system which will contribute to the sympathetic mediated 
hypertension (Samuelsson et al., 2016). Consistent with this idea, experimental 
hyperleptinemia in neonatal rat pups from postnatal day 9 to 15 resulted in heightened BP in 
adulthood (Samuelsson et al., 2016).  
Our research group uses a model of maternal diet-induced obesity that attempts to mimic the 
western diet by feeding mice a diet high in fat and sugar (high fat pellet 20% w/w 
supplemented with sweetened condensed milk 55% sugar w/w). The female mice are fed this 
obesogenic diet from weaning and for at least six weeks before mating, so that by mating 
bodyweight was increased; using body composition analysis this increase can be explained by 
an increase in fat mass and not lean mass. Obesogenic diet-fed mice had an almost three-fold 
increase in relative fat mass compared to control lean females. This model enables assessment 
of the effect of obesity in the mother and its programmed effects, and not just the effect of 
feeding an obesogenic diet. Previous findings in our lab (described in the following section) 
provide the basis for all work undertaken in this PhD. 
Offspring from these obese mothers show pathological cardiac hypertrophy at an early age, as 
indicated histologically, and molecularly through the re-expression of fetal genes (Fernandez-
Twinn et al., 2012). This is followed by ex vivo cardiac dysfunction with both systolic and 
diastolic dysfunction at 12 weeks of age (reduced left ventricular developed pressure and 
increased left ventricular end diastolic pressure, respectively) as measured by isolated 
Langendorff heart perfusion. The advantage of the isolated heart set up is the ability to 
introduce drugs and therefore test the heart’s response to parasympathetic and sympathetic 
agents (e.g. carbachol and isoprenaline respectively). The ratios of sympathetic to 
parasympathetic chronotropic and inotropic responses were elevated, suggesting sympathetic 
dominance, which is often seen as an early hallmark for heart disease and failure (Blackmore 
et al., 2014). Importantly, this cardiac phenotype occurred in the absence of a change in 
bodyweight and despite the offspring eating a healthy diet from weaning.  
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The effect of a maternal and post-weaning obesogenic diet on cardiovascular function was 
assessed. The same model of maternal obesity was used as described above and then offspring 
from control and obese dams were weaned onto either a control diet or the same obesogenic 
diet. This study concluded that maternal obesity-exposure caused poor cardiac health and this 
was of comparable magnitude to current obesity. There was no additive effect of current 
obesogenic diet, suggesting that the cardiac dysfunction was programmed independently of 
offspring diet (Loche et al., 2018). This highlights the worrying finding that the impact of 
obesity during pregnancy on offspring cardiac dysfunction is of a similar magnitude to that 
due to current obesity. The opposite was true for offspring hyperinsulinemia, hyperleptinemia, 
increased fat mass, and hypertension; in utero and neonatal exposure to maternal obesity and 
offspring obesity acted synergistically (Loche et al., 2018). These additive effects could 
continue to develop over time and possible contribute to the worsening cardiac phenotype that 
would be expected to occur with age. This indicates the importance of an intervention during 
pregnancy to prevent the transmission of CVD to the offspring. 
1.10 Interventions to prevent adverse programming outcomes  
It is clear that interventions to tackle CVD and the associated health burden should start in 
utero and not in adulthood when disease pathology is already emerging. Targeting maternal 
wellbeing during pregnancy could ensure good cardiovascular health for future generations. 
An intervention to tackle maternal obesity is important since it not only predisposes offspring 
to developing CVD, but also offspring are more prone to becoming obese, which is an 
independent risk factor of developing CVD.  
A report from the Institute of Medicine (2010) indicates a need for evidence-based 
interventions that inform and motivate pregnant women to adopt a healthy lifestyle before and 
during pregnancy. Interventions to combat the unwanted impact of maternal obesity can be 
behavioural (dietary or lifestyle changes) or pharmacological. Pregnancy is a life event in 
which women may be more inclined to make behavioural changes (Oken et al., 2003). If 
appropriate management was provided before and during pregnancy, a behavioural 
intervention to promote a healthy lifestyle could be effective, and may even result in 
persistent positive behavioural changes concerning nutrition and physical exercise postpartum. 
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1.10.1 Maternal exercise interventions 
Exercise during pregnancy  
Physical activity makes up the cornerstone in the prevention and management of T2D as it is 
known to adjust the metabolic health of the patient by improving insulin action (Colberg et al., 
2010). This makes it an attractive method to improve the metabolic health of an expectant 
mother and therefore alleviate the adverse intrauterine environment the developing fetus is 
experiencing. During pregnancy, there are major physiological adaptations to sustain the 
continuous requirements of the fetus for nutrients and oxygen; this creates a pseudo-
diabetogenic state of progressive insulin resistance (Mottola and Artal, 2016; Musial et al., 
2016). Maternal glucose utilisation is spared in the peripheral tissues, with insulin action 
being altered in the liver, skeletal muscle and adipose tissue. This increases blood glucose and 
amino acid concentrations, allowing more to be available for placental transport. Exercise 
promotes insulin sensitivity, particularly in the skeletal muscle (Ren et al., 1994; Holloszy, 
2005) and evidence suggests vigorous physical activity in mid-pregnancy predicts improved 
glucose tolerance in normal, overweight and obese women (Medek et al., 2016). 
Some women are apprehensive about exercising during pregnancy due to the perceived ill 
effects that this will bring, however moderate aerobic exercise during a healthy pregnancy has 
been shown to have no detrimental effects on the mother’s health (Clapp, 1991; Platt et al., 
2013). It is well known that exercise improves cardiovascular function (Gielen, Schuler and 
Adams, 2010) and this is also true if the exercise is undertaken in gestation, where pregnancy-
induced increases in BP and the loss of parasympathetic tone were prevented (Stutzman et al., 
2010). A randomised control trial demonstrated that women who exercised during pregnancy 
from 12 weeks gestation, had improved aerobic fitness and muscle strength by 30-32 weeks 
of gestation (Price, Amini and Kappeler, 2012). The American College of Obstetrics and 
Gynecology (ACOG) released physical activity guidelines for pregnant women, with the 
recommendation that women with uncomplicated pregnancies engage in ≥20–30 minutes/day 
of exercise on most days/week (ACOG Committee opinion., 2015). The National Institute for 
Health and Care Excellence (NICE) guidelines similarly encourage continuing or starting 
moderate exercise during pregnancy (NICE, 2008) 
Exercise has been shown to reduce the risk of obstetric complications such as miscarriage 
(Latka, Kline and Hatch, 1999), GDM (Oken et al., 2007), and pre-eclampsia (Marcoux, 
Brisson and Fabia, 1989; Martin and Brunner Huber, 2010). It has also been shown to have a 
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beneficial impact on delivery by reducing both the risk of caesarean delivery (Melzer et al., 
2010) and premature delivery (Evenson et al., 2002; Magro-Malosso et al., 2017) as well as 
promoting a faster recovery postpartum (Price, Amini and Kappeler, 2012). Maternal and 
fetal health also benefited from exercise in these studies, with an improvement in maternal 
cardiovascular health through a decreased resting heart rate (HR) and BP (Lynch et al., 2003), 
improved fetal growth (Clapp et al., 2000), and lower fetal HR (May et al., 2010). The effect 
on postnatal health has been explored in some studies with activity during pregnancy related 
to improved neurodevelopment at 12 months (Domingues et al., 2014) and a reduction in 
overall chronic disease risk (Pivarnik et al., 2006; Moyer, Reoyo and May, 2016). 
Meta-analyses of randomized control trials showed that a supervised physical exercise 
program of low to moderate intensity that includes an aerobic component was able to reduce 
the risk of GDM by 28-31% and lower GWG by 1.1kg (Sanabria-Martínez et al., 2015). If the 
exercise was continued throughout pregnancy this reduction in risk increased to 36% 
(Sanabria-Martínez et al., 2015). 
Exercise as an intervention in an overweight/obese pregnancy 
Overweight/obese women are two times more likely to exceed the guidelines set for 
appropriate GWG, and excessive GWG is associated with negative obstetric outcomes 
(Cedergren, 2006). A study of supervised exercise sessions in overweight/obese pregnant 
women, called Exercise Training in Pregnancy (ETIP) trial, reduced incidence of GDM and 
lowered SBP (not diastolic pressure), but failed to reduce GWG (Garnæs et al., 2016). A 
behavioural intervention may be required to impact GWG, this was demonstrated in the UK 
Pregnancies Better Eating and Activity Trial (UPBEAT), where GWG was reduced (Poston et 
al., 2015) 
A supervised cycling exercise program was carried out in a randomized control trial of 
overweight/obese Chinese women. Women in the intervention group had lower incidence of 
GDM (with reduced insulin resistance at 25 weeks gestation), and less GWG by 25 weeks 
(Wang et al., 2017). An exercise-only intervention in overweight/obese women improved 
fitness but did not impact birthweight or maternal/fetal clinical outcomes. Compliance to the 
protocol was low and variable with only 35% of sessions completed, which decreased as 
pregnancy progressed (adherence monitored by HR monitors). Increased compliance 
correlated with improved postnatal adiposity (decreased total fat mass and BMI) of the 
mothers (Seneviratne et al., 2016). 
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It may be too premature to say these studies had a disappointing impact on the chosen primary 
maternal outcomes, as it may have encouraged a change in lifestyle that causes the mother to 
maintain a healthier BMI for her next pregnancy, and will have also lowered her own risk of 
cardiometabolic disease. Equally, the exercise may have minimized the adverse 
“programming factors” (not measured/detected in the study) which will have a positive 
impact on the baby and their future health. There are very few studies carried out in humans 
that follow up the mother and baby in order to study the long-term effects. When a study does 
undertake long-term follow up the results of this will not be elucidated for many years to 
come. Maternal obesity was associated with a 35% increased risk of premature all-cause 
offspring mortality by the age of 50 years, therefore even a modest reduction in this risk 
would have major health and economic benefits for society (Reynolds et al., 2013). Exercise 
and/or lifestyle intervention studies have had conflicting impacts on maternal outcomes, 
suggesting the type/intensity and compliance of the exercise protocol is important.  
Intervention studies in animal models 
A maternal exercise intervention has been shown to improve maternal glucose tolerance and 
prevent hyperinsulinemia in the obese mother both during pregnancy (Fernandez-Twinn et al., 
2017) and during lactation (Vega et al., 2016) without altering maternal bodyweight. These 
benefits are transmitted to the offspring by improving insulin and glucose homeostasis in 
adult mouse male offspring (Fernandez-Twinn et al., 2017). Equally, offspring metabolism 
could be improved by altering body composition, for example an increase in lean mass 
accompanied by a decrease in fat mass is seen in male offspring from a maternal obesity and 
exercise model in rats (Vega et al., 2016). In another study of voluntary wheel running in 
HFD fed mothers, changes in glucose tolerance were seen in the early life of male offspring 
from obese dams exercised during pregnancy, yet alterations in body composition were not 
present until offspring were 12 months old (Stanford et al., 2015). Offspring from swim-
trained mothers (before and during pregnancy) were protected against diet-induced obesity. 
Adult offspring were switched to a HFD for four months and in that time offspring from 
trained mothers gained less weight, which was attributed to decreased fat mass gain, and 
increased energy expenditure during the day (Wasinski et al., 2015).  
HFD-fed rats were provided access to a running wheel ten days before pregnancy; maternal 
exercise appeared to reduce the metabolic risk of the offspring caused by maternal obesity by 
improving insulin/glucose homeostasis. The impact on the offspring was sex-specific as males 
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appeared to benefit more from maternal exercise than females (Raipuria, Bahari and Morris, 
2015). A suggested mechanism for the amelioration in glucose metabolism is the reduction by 
maternal exercise in pro-inflammatory signalling in the hypothalamus of mice offspring, 
which could result in hypothalamic dysfunction (Bae-Gartz et al., 2015). 
1.10.2 Combined diet and exercise interventions  
A meta-analysis of 36 randomised controlled trials of diet and physical exercise interventions 
concluded that they were effective in reducing GWG and the likelihood of caesarean delivery 
(i-WIP Collaborative group, 2017). The LIMIT trial used lifestyle advice intervention that 
combined dietary and behaviour changes alongside physical activity in pregnant women with 
a BMI above 25 kg/m2. This lifestyle intervention lowered the risk of having a baby with a 
birthweight of more than 4 kg or having respiratory distress syndrome and was associated 
with a shorter hospital stay (Dodd et al., 2013, 2014). However, the authors showed no 
clinically relevant or statistical differences in the measured cardiometabolic and inflammatory 
markers in maternal and infant cord blood (Moran et al., 2017) which is probably why there 
was no observed effect in clinical pregnancy outcomes (Dodd et al., 2014). Long-term follow 
up of these offspring has not yet been completed and could still reveal differences and 
improvements.  
A randomized controlled trial called the UPBEAT used a complex behavioural intervention 
and addressed diet and exercise in obese pregnant women (Poston et al., 2015). The mean 
BMI of the pregnant women in the study was 36 kg/m2, with the inclusion criteria stating the 
BMI was above 30 kg/m2. Women in the intervention group had lower dietary glycemic load 
along with other favourable dietary changes (e.g. decreased intake of saturated fat) and 
increased physical activity. Behaviour of the mother was altered to a degree by the 
intervention, however this was not enough to improve glucose tolerance. The study did not 
achieve the set primary outcomes to reduce the incidence of GDM and LGA babies. GWG 
and the sum of skinfold thickness in the mother were decreased in the intervention group. 
Neonatal outcomes did not differ between groups (Poston et al., 2015). The intervention also 
did not alter cord blood metabolic profiles (Patel, Hellmuth et al., 2017), however a follow up 
in the offspring at six months revealed a reduction in subscapular skin fold thickness in the 
intervention arm, and causal analysis revealed this change was likely mediated by maternal 
antenatal diet (Patel, Godfrey et al., 2017).  
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Animal models should be used to determine the value of a dietary and physical activity 
interventions and guide future human intervention studies, due to their ability to enforce 
exercise and control diet completely. However very few animal models of combined 
behavioural interventions have been carried out. One study in obese rats performed a dietary 
intervention where one month before mating they were placed on a control diet which was 
continued throughout pregnancy and lactation. The dietary intervention was able to reverse 
some of the adverse metabolic effects of maternal obesity on offspring health (Zambrano et 
al., 2010). Improvements in offspring metabolic health was also demonstrated in a dietary 
intervention during pregnancy and lactation in obese mouse dams; further indicating its 
promise at preventing adverse long-term effects on offspring (Janoschek et al., 2016). 
1.10.3 Pharmacological Interventions 
Insulin sensitizer: Metformin 
Metformin has been given to women affected by polycystic ovarian syndrome with no 
evidence of causing birth defects (Cassina et al., 2014). The Metformin in GDM (MiG) trial 
recruited women with GDM at 20-23 weeks gestation. Metformin was started at 500 mg once 
or twice daily and then increased until the glycemic target was met. Women in the Metformin 
group had improved insulin sensitivity and reduced GWG (Rowan et al., 2008). 
Hyperglycemia and insulin resistance occurring with obesity (Jeevendra Martyn, Kaneki and 
Yasuhara, 2018) are thought to be strong influencers of the observed poor maternal and fetal 
outcomes (Smith et al., 2008). The Metformin in Obese non-diabetic Pregnant women (MOP) 
double blinded placebo trial was set up to test the effectiveness of Metformin (vs. placebo) in 
obese pregnant women. The median GWG and the incidence of pre-eclampsia were reduced 
in the Metformin group. There were no differences in reported adverse outcomes, however 
there was a significant increase in reported side effects causing 18% of women to stop taking 
Metformin, but despite this the overall adherence to the trial was considered good (Syngelaki 
et al., 2016). 
Increased reporting of side effects was also reported in the Effect of Metformin on maternal 
and fetal outcome in obese pregnant women (EMPOWaR) trial (another double blinded 
placebo controlled trial). This study did not show any differences in maternal outcomes or 
GWG with administration of Metformin, but the discordance between the two studies could 
be explained by the lower adherence to the metformin dose and decrease in successful 
recruitment/participation for the study (Chiswick et al., 2015). There was a reduction in 
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HOMA-IR and fasting glucose at 28 weeks gestation, however this was not present at 36 
weeks. Markers for inflammation CRP and IL6 maternal serum concentrations were also 
lowered in the Metformin group (Chiswick et al., 2015), and this may be beneficial as high 
levels have been associated with adverse pregnancy outcomes (Xu et al., 2014). 
The MiG trial has followed up the offspring to two years old and demonstrated increased 
measures of skinfold thickness with no overall change in total fat when measured by DEXA 
(Rowan et al., 2011). These children have increased subcutaneous fat and further follow up is 
required to determine if changes in their fat distribution has any consequences to their 
metabolic health later in life.  
Metformin administration in animal models of maternal obesity revealed positive impacts 
such as decreased inflammatory markers in fetal serum (Desai et al., 2013). If offspring were 
weaned onto a HFD, in utero metformin-exposed offspring gained less weight and adiposity, 
additionally the HFD-triggered impaired glucose tolerance was prevented (Salomäki et al., 
2014). Prenatal metformin administration prevents hypertension in HFD fed offspring 
exposed to a maternal high fructose diet during pregnancy (Tain et al., 2018).   
Antioxidants 
Oxidative stress is a well-recognized mechanism underlying developmental programming 
(Thompson and Al-Hasan, 2012). Elevated levels of oxidative stress have been shown in the 
placenta of obese women (Oliva et al., 2012) suggesting antioxidant treatment could be a 
relatively unexplored intervention. Oxidative stress can cause DNA damage, lead to cell death, 
and ultimately accelerate cellular ageing (Tarry-Adkins and Ozanne, 2017). Antioxidants 
protect against reactive oxidative species and are considered a therapeutic agent to prevent the 
subsequent damage. Oxidative stress has been shown to be present in pre-eclampsia (Burton 
et al., 2009) which often co-exists with other adverse pregnancy outcomes such as IUGR, 
placental previa, and fetal death (Turpin et al., 2015). Two large randomised controlled trials 
demonstrated a lack of an effect of an antioxidant regimen (Vitamin C + E) in preventing pre-
eclampsia in either high-risk (Villar et al., 2009) or low-risk pregnancies (Roberts et al., 
2010). The unexpected results of these studies could imply that there is no causative role of 
oxidative stress, despite it being present in the aetiology of pre-eclampsia, or that the 
supplementation regimen or the antioxidant used is inappropriate.  
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A high level of oxidative stress and inflammation has also been shown in the hearts of the 
offspring using a sheep model of maternal overnutrition. These hearts demonstrated impaired 
ex vivo cardiac function in response to high workload (Wang et al., 2010). An antioxidant 
(Quercetin) was used as an intervention in HFD-fed mouse dams during pregnancy. This 
supplementation prevented hyperinsulinemia, hypertension, and HFD-induced weight gain at 
12 months of age in the offspring (Liang, Oest and Prater, 2009).  
1.11 Thesis Aims and hypotheses 
The aims of this thesis were to develop an intervention that can override the unfavourable 
maternal legacy of obesity. If the increased risk, associated with maternal obesity, to the 
offspring is not addressed then it will strongly impact the disease risk of the next generation, 
causing an insurmountable healthcare burden across the world. It is therefore valuable to 
implement an intervention during development and before birth to improve that individual’s 
cardiovascular health. This should bridge the gap in current successful prevention strategies 
by employing a strategy that starts before the pathogenic progression of disease.  
Interventions during pregnancy could create a healthy environment in utero during a critical 
time during organ development. Women who adopt healthy lifestyle behaviours during 
pregnancy can positively impact postnatal health and decrease their child’s future risk of 
developing NCDs, such as obesity, T2D, and CVD. At the same time, mothers improve their 
own future health prospects, therefore such an approach targets more than one individual 
through a single intervention.  
Studying interventions that can normalise a defined maternal parameter can also help identify 
which critical programming factor is driving the effects in the offspring. Since obesity is a 
multifactorial disease, which involves many parameters that are known to affect fetal 
programming (e.g. insulin, glucose, cholesterol and free fatty acids), identifying key factors is 
important in the understanding behind fetal programming.  
The hypothesis of this thesis is that a maternal exercise intervention during pregnancy will 
prevent programmed offspring poor cardiovascular health. 
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This hypothesis was investigated through 4 specific objectives: 
1. To investigate the effect of an exercise intervention during pregnancy on the metabolic 
phenotype of obese mouse dams.   
2. To determine whether a maternal exercise intervention during an obese pregnancy 
improves the cardiovascular health of male offspring from obese dams.  
3. To assess, for the first time in this model, the impact of maternal obesity on the 
cardiovascular health of female offspring and then to determine the effect of the 
maternal exercise intervention. 
4. To study the immediate consequences of maternal obesity on the fetal heart and to 
then identify the impact of maternal exercise intervention. 
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2. General Methods 
2.1 Diet-induced obesity animal model 
All animal studies were conducted according to the UK Home Office Animals (Scientific 
Procedures) Act 1986 and following ethical review by the University of Cambridge Animal 
Welfare and Ethical Review Board (AWERB). This thesis capitalised on an established 
maternal diet induced-obesity model using C57BL/6J mice as previously described 
(Samuelsson et al., 2008; Fernandez-Twinn et al., 2012). From four weeks of age the diets 
were introduced ad libitum; females were either fed a standard control RM1 diet (Special 
Dietary Services) or a highly palatable energy-rich obesogenic diet (45% Atwater fuel energy 
(AFE) fat, custom made diet 824053, Special Dietary Services) supplemented with sweetened 
condensed milk (Nestlé) and fortified with mineral and vitamin mix (AIN93G, Special dietary 
Services) (diet composition in Tables 2.1+2.2). After three weeks on the respective diets, 
females were mated for a first pregnancy to ensure they were proven breeders and establish 
good maternal care. Time-Domain Nuclear Magnetic Resonance (TD-NMR) (Bruker 
minispec LF series, Bruker Optik GmbH, Germany) was used to determine body composition. 
Obesogenic diet-fed females were maintained on their diet until they achieved a fat mass ≥ 10 
g, when they were then considered obese and entered into the study for the experimental 
pregnancy. In keeping with this, control females who had a fat mass above 5 g were excluded 
from the study. This cut off was developed to ensure the reproducibility in the effects of 
maternal obesity. These two groups of females were rested for one week (to match for the 
training week undertaken by the obese-exercised group) before mating and weekly TD-NMR 
measurements were taken before mating and throughout pregnancy. The experimental 
schematic is shown in Figure 2.1. Females were mated with previously LAD1-fed males 
(diets were matched to the incoming female during the period of mating), they were left to 
mate for a maximum of five days and were removed upon a positive vaginal plug. Females 
were maintained on their respective experimental diets throughout pregnancy and lactation 
(Schematic shown in Figure 2.1). By the time females were mated for their second pregnancy 
they had been on the diet for approximately 15 weeks and were approximately 18 weeks old. 
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TABLE 2.1: Composition of maternal diets. Metabolisable energy for each diet component 
is shown in brackets. Composition is broken down by % (w/w). 
 Control dams Obese dams 
RM1 pellets HFD pellets Condensed milk 
(10.74 kJ/g) (28.43 kJ/g) (13.7 kJ/g) 
Simple sugars (w/w) 7% 10% 55% 
Fat (w/w) 3% 20% 8% 
Protein (w/w) 15% 23% 8% 
Polysaccharide (w/w) 50% 28% - 
 
TABLE 2.2: Detailed composition of custom-made high fat diet pellet. 
  % (w/w) 
Casein 26.5 
Cellulose 6.2 
Choline bitartrate 0.3 
L-cysteine 0.4 
Lard 18 
Mineral mix 4.3 
Rice starch 28.3 
Soya oil 4.3 
Sucrose 10.5 
Vitamin mix 1.2 
2.2 Maternal exercise intervention 
A third group of obese females (≥ 10 g fat mass) were randomly allocated to the intervention 
group and were trained to run on a treadmill. The protocol was started when obesogenic diet-
fed mice reached 10 g fat mass as measured by TD-NMR (one week before mating). For the 
first five days treadmill training was carried out, the speed and duration of treadmill running 
gradually increased incrementally to allow for familiarisation, so that by day five the full 
protocol was achieved. The full program was then carried out five days a week (Mon-Fri) for 
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20 minutes/day with a weekend of rest and this was continued from mating up to and 
including gestational day 17 (protocol shown in Table 2.3). These mice are referred to as 
obese-exercised (Ob-Ex) (schematic shown in Figure 2.1). 
TABLE 2.3: Exercise protocol with speed and durations. By training day 5, females were 
completing the full program and this was continued until gestational day 17.  
 
Litter size was standardized to six (in all groups) at postnatal day 2 (PND2) to ensure 
standardized milk supply and maternal attention. The n number for all experiments 
corresponds to the number of independent litters to eliminate confounding within-litter effects 
and only one male or female per litter was used for each outcome measure. The offspring 
were weaned at three weeks of age onto standard laboratory chow (RM1) and fed ad libitum. 
TD-NMR measurements were undertaken weekly in offspring from four to eight weeks of age. 
At eight weeks of age, mice were fasted overnight (16 hours). Tail blood glucose was 
measured (AlphaTRAK 2, Zoetis, USA) before the mice were then killed by a rising CO2 
concentration. At post mortem, blood was collected by cardiac puncture before tissue was 
collected, weighed and frozen at -80 ◦C. 
Speed 
(m/min) 









Training day 5 
(Full Program) 
5 1 1 1 0.5 0.5 
7.5 13 18 1 1.5 1.5 
10 - - 16 3 1 
12.5 - - - 10 14 
10 - - - 3 1 
7.5 - - 1 1.5 1.5 
5 1 1 1 0.5 0.5 
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FIGURE 2.1: Schematic of study design with exercise protocol of obese females. Small 
arrows below represent TD-NMR time points. Treadmill running was started 1 week before 
mating. Offspring were weaned at 21 days old. 
 
2.3 Serum analysis 
Blood was left to clot at room temperature for at least 30 minutes before it was centrifuged at 
900 g for five minutes, the supernatant serum was collected and snap frozen (-80°C).  Serum 
metabolites were measured by the MRC-MDU Mouse Biochemistry 
Laboratory (Addenbrooke’s Hospital, Cambridge, UK). Serum Leptin and Insulin were 
measured by Ultrasensitive Mouse Leptin ELISA kit (Crystal Chem INC, 90030) and 
Ultrasensitive Mouse Insulin ELISA kit (Crystal Chem INC, 90080) respectively, according 
to manufacturer’s instructions.  
2.4 Non-invasive tail cuff plethysmography 
BP was measured non-invasively by restraint tail cuff plethysmography using a BP-2000 
Series II machine (Visitech systems, USA) in offspring at seven weeks of age.  SBP can be 
determined by monitoring tail vessel dilation through the scattering of red light as the 
occlusion cuff inflates. Prior to being measured, animals had been handled frequently (due to 
weighing and TD-NMR measurements). This was important as it minimised stress the animal 
experienced during the BP measurement. Over three consecutive days there were two training 
days to enable familiarisation of the animal to restraint. On the third consecutive day, five 
pre-measurements were taken by the machine but were not used for the analysis. Following 
this, 10 measurements of SBP and pulse rate were recorded for each session. Only 
measurements recorded on the final (third) day were used for analysis to reduce variability in 
the results. On the third day, when the variability of the data was the lowest, all animals 
included in analysis had a co-efficient of variation of 10% or less. Measurements were taken 
   
33 
   
at the same time each day (16:00) to account for the natural circadian variation of BP over a 
24 hour period (Staessen et al., 1992). 
2.5 In vivo echocardiography  
Left ventricular (LV) transthoracic echocardiography was carried out using the Vevo770 
system and RC707B 30 MHz cardiac transducer (FUJIFILM, Visual Sonics, Canada). Mice 
were anaesthetised via inhalation of 2% isoflurane in O2 and anaesthesia was maintained 
through the use of a nose cone at 1.5% isoflurane. Mice were placed in a supine position on a 
heated platform and their limbs were taped over metal electrocardiogram (ECG) pads 
allowing for real time ECG monitoring. A rectal probe was used to monitor body temperature 
which was kept strictly in an appropriate range. HR was constantly monitored and kept >400 
beats per minute (bpm) by adjusting depth of anaesthesia if necessary. To gain an appropriate 
acoustic window, fur on the animals’ thorax was removed through the use of hair removal 
cream. Pre-warmed ultrasound gel was also utilized. The transducer was positioned to give 
parasternal long-axis view of the LV and focused at the level of the papillary muscle. In B-
mode the aorta was lined up with the apex of the heart. M-mode images and an EKVTM were 
captured in this view (Figure 2.2). Measurements were carried out on the M-mode software 
using Vevo770 software. Cardiac functional outcomes were calculated using the LV tracing 
function while lumen and wall dimensions were measured using the in-built measurement 
platform on M-mode images (for calculations used in software refer to Appendix AP1). This 
data was collected in partnership with Dr Denise Fernandez-Twinn and Dr Heather 
Blackmore, with two people there for all measurements as mandated by AWERB. 
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FIGURE 2.2: Representative image showing alignment of heart in B-mode and M-mode. 
B-mode was aligned in the parasternal long-axis view of the LV. Using the Vevo770 software 
an overlay was placed on the B-mode image equidistant between the apex and the start of the 
aorta opening. M-mode images were then captured from this position in the ventricle. IVS- 
Interventricular septum, LL- Left lumen and LVPW- LV posterior wall are labelled on the M-
mode image.  
2.6 RNA extraction and quantification 
Snap-frozen ventricular heart tissue stored at -80ºC was powdered over dry ice with a pre-
chilled pestle and mortar. 25 mg aliquots of powdered tissue were weighed for RNA 
extraction using a column based miRNeasy mini kit (Qiagen, Germany) following 
manufacturer instructions. Powdered tissue was lysed with a TissueRuptor homogeniser 
(Qiagen, Germany) in Qiazol. Chloroform was added and samples were incubated at room 
temperature. After a centrifugation step (12,000 g at 4ºC for 15 minutes) the upper aqueous 
layer was removed and placed in a fresh tube. 1.5 volumes of 100% ethanol was added and 
mixed. This was then pipetted into the columns provided and centrifuged for 15 seconds (> 
8,000 g at room temperature) to pull solution through column. A DNase digest was then 
performed (RNase-Free DNase set, Qiagen, Germany) to remove any contaminant DNA. The 
final RNA product was eluted in 30 µl of RNase free water.   
RNA concentration (ng/μl) was measured by Nanodrop (ThermoScientific, UK). Ratios of 
absorbances measured at 280 nm, 260 nm, 230 nm were measured alongside concentration to 
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assess the purity of the RNA. The 260/230 nm ratio indicates contamination of the sample 
with protein or phenols, a ratio of 2 is considered to be pure RNA. 280/260nm ratio indicates 
the presence of salts therefore an ideal ratio is between 1.8-2.2. The integrity of the extracted 
RNA was assessed by identifying the 28S and 18S ribosomal RNA bands following 
electrophoresis using a 1% agarose gel. The RNA sample was diluted to 100 ng/µl and the 
concentration was checked again using the Nanodrop (ThermoScientific, UK) and adjusted if 
necessary.   
2.6 Quantitative PCR 
10 µl of RNA (1 µg) was used for the reverse transcriptase (RT) reaction using a high 
capacity cDNA RT kit (ABI, USA), which was then added to 10 µl/reaction of mastermix 
(prepared as shown in Table 2.4). The RT reaction was performed using a Veriti 96 well 
thermal cycler (ABI, USA) as per manufacturer’s instructions (protocol shown in Figure 2.3). 
TABLE 2.4: Volumes of RT reaction for a single reaction. 
Provided in RT kit  1x reaction (µl) 
10 RT buffer  2.0 
25 dNTP mix  0.8 
10x RT primers  2.0 
Multiscribe RT  1.0 
RNase inhibitor 1.0 




FIGURE 2.3: Program of the thermocycler conditions.  
 
cDNA was diluted to a suitable dilution factor and stored at -20°C. 5 µl of each sample was 
added together to create a pooled sample. The 100% pooled sample was used to generate a 
pooled standard curve by serial diluting 1:2 to give six standards. This was achieved by 
adding nuclease free water to an equal volume of sample. Samples were then diluted 1:10 to 
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ensure that they lie in the middle of the newly generated pooled standard curve. The linear 
equation of the line of best fit was then used to calculate relative gene expression.  
2.6.1 Validation of primers 
Where possible, previously validated primers were used and when this was not possible 
primers were designed to be intron spanning using the Ensembl database. Target specificity 
was assessed using Primer-blast (National Center for Biotechnology Information, USA) and 
those with unintended targets were redesigned. Primers were also assessed for their 3’ self-
complementarity, with primers of the lowest value chosen. Running a melt curve was used to 
assess target specificity in validated primers. If there was more than one peak, the primer was 
not specific to the target and was also binding to an off-target region, such a primer would not 
be used and would be redesigned. Primer sequences are shown in the Chapter 4 and 5. 
Each primer was tested individually and in duplicate in samples and pooled standards using 
SYBRgreen technology. For each reaction the components were as follows: 5 µl cDNA 
dilution, 6 µl SYBR green mastermix and 1 µl Primer (1.6 µm). Real time PCR using 
SYBRgreen PCR mastermix (ABI, USA) was carried out using a 384 well 7900HT fast real-
time PCR system. Housekeepers were used to normalise gene expression and are defined in 
methods of the individual chapters.   
2.7 Protein extraction 
Powdered ventricular tissue (25 mg) was homogenised on ice in lysis buffer [50 mmol/L 
HEPES, pH 8; 150 mmol/L sodium chloride; 1% Triton X100; 1 mmol/L sodium 
orthovanadate; 30 mmol/L sodium fluoride; 10 mmol/L sodium pyrophosphate; 10 mmol/L 
EDTA with a protease inhibitor cocktail (set III), Calbiochem Novabiochem Biosciences, 
UK]. Homogenates were placed on a shaker at 4°C for 15 minutes before centrifuging for five 
minutes at 15700 g and removing supernatant to a new tube. Total protein concentration of 
homogenates was measured in duplicate by copper-bicinchoninic assay (Sigma-Aldrich, UK) 
in a 96 well plate. A standard curve was generated using a series of known protein 
concentration of bovine serum albumin (BSA). Absorbance at 562 nm were measured in a 
Tecan M1000 Pro plate reader (Tecan, Switzerland). The lysates were then diluted in lysis 
buffer to 1 mg/μl. 40 µl of 5x Sodium dodecyl sulphate (SDS) loading buffer (25mM Tris-
HCl (pH 6.8), 20% (v/v) glycerol, 10% (w/v) SDS, 500mM Dithiothreitol (DTT), 
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Bromophenol blue) was added to lysate dilutions (200 µl) in a 1:5 dilution. Protein lysates 
were stored at -20°C.  
2.8 Western blotting 
All buffers and compositions detailed in Table 2.5. 
2.8.1 SDS PAGE 
Resolving acrylamide gels (8-15%) were prepared depending on size of protein with the 
stacking gel containing 5% acrylamide. For Chapter 4, gels were set between glass plates with 
3 mm spacers and rubber tubing. For Chapter 5, gels were set between 1.5 mm spacers using 
the SE 600 Ruby Standard Dual Cooled Vertical Unit (GE healthcare, USA) system. An 
appropriate comb was used to set a maximum of 24 wells. After gels were set, they were 
placed in an electrophoresis tank with 1x SDS-PAGE running buffer. Protein samples were 
heated to 95ºC for five minutes before loading. 15 µg of protein/sample and 10 μl of protein 
ladder (10-250 kDa, PageRuler pre-stained protein markers, ThermoScientific, UK) were 
loaded into a polyacrylamide gel of appropriate percentage and separated electrophoretically 
in running buffer 40 V overnight (~16 hours) until the gel front reached the bottom of the gel 
and the band on interest was in the middle of the resolving gel.  
2.8.2 Coomassie stain: equal protein loading 
To confirm equal protein loading across all samples the first gel of the study was stained by 
Bio-safe Coomassie Brilliant blue stain (Bio-Rad Laboratories, UK). The gel was prefixed 
(50% Methanol, 10% Acetic acid and 40% H2O) for 30 minutes before the Coomassie stain 
was added for 2-4 hours at room temperature or until the gel was uniformly stained blue. A 
destaining solution was used until background was completely clear. The gel was imaged 
using Bio-Rad ChemiDoc Imager (USA), corresponding images are shown in Chapters 4 and 
5.  
2.8.3 Semi-dry transfer  
Proteins separated by SDS PAGE were then transferred onto a polyvinyl difluoride (PVDF) 
membrane (Immobilon-P; Millipore, USA) using a TE70XP Semi-Dry Transfer Unit. The 
membrane was first activated by immersing in 100% methanol for one minute, dH2O for one 
minute and then transfer buffer for five minutes.  Blotting paper (195 g/m2) was cut to gel size 
and pre-soaked in transfer buffer, three pieces of blotting paper were laid down onto the damp 
transfer surface, the pre-cut activated PVDF membrane was stacked on top followed by the 
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gel and a further three layers of pre-soaked blotting paper. Care was taken to ensure no 
bubbles are introduced in the stack that would impede effective transfer. Transfer was set at 
200 mA for one hour 30 minutes. Transfer efficiency was confirmed with Ponceau S staining.  
2.8.4 Blocking and antibody incubations 
Membranes were blocked with 5% skimmed milk protein (Marvel, Premier Foods, UK) in 1x 
Tris-buffered Saline (TBS) - 0.1% Tween 20 for at least one hour at room temperature. After 
which they were incubated in primary antibody (in 5% BSA (TBS-Tween) buffer) at 4ºC 
overnight. The following day they were washed in 1x TBS - 0.1% Tween 20 for 15 minutes, 
changing the solution every five minutes, before incubation with horseradish peroxidase-
conjugated anti-rabbit secondary antibody for one hour (1:10,000 for all antibodies) (Jackson 
ImmunoResearch, Stratech, UK). A second wash step of 15 minutes in 1x TBS - 0.1% Tween 
20 was undertaken after secondary antibody incubation. Antibody binding was detected using 
Luminata Forte Western HRP substrate (Millipore, USA) and chemiluminescent bands were 
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TABLE 2.5: Buffer components for western blotting. 
 
  Buffer Components of buffer 
Running buffer  25 mM Tris-Base  
200 mM Glycine  
0.1% SDS  
Transfer buffer  
 
50 mM Tris-Base  
40 mM Glycine  
0.15% (w/v) SDS  
20% (v/v) Methanol  
Resolving gel 
% acrylamide in the gel was chosen based on 
size of protein of interest; to allow for optimum 
separation of bands.  
8-12% Acrylamide (40%)  
0.05% Bisacrylamide (2%)  
37.5 mM Tris-HCl  
1% (w/v) 20% SDS  
0.05% Tetramethylethylenediamine 
(TEMED)  
0.005% Ammonium persulphate 
(APS) (10%)  
Stacking gel  5% Acrylamide (40%)  
0.05% Bisacrylamide (2%)  
12.5 mM Tris-HCl  
1% (w/v) 20% SDS  
0.05% TEMED  
0.005% APS (10%)  
Tris-Buffered Saline ((TBS) (10x) pH 7.6))  50 mM Tris-Base  
150 mM Sodium chloride  
TBS with 0.1% Tween (TBS/T)  1x TBS 
0.1% Tween-20  
Blocking buffer  
 
1x TBS, 0.1% Tween-20  
5% (w/v) non-fat dehydrated milk  
Antibody dilution buffer 1x TBS, 0.1% Tween-20  
5% (w/v) bovine serum albumin 
(BSA) 
1M Tris-HCl (pH 6.8)  121.14 g Tris-Base in 1 litre dH20  
3M Tris-HCl (pH 8.8)  363.42 g Tris-Base in 1 litre dH20  
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2.9 Statistical Analysis 
All data analysis was carried out using Prism 6.0 (GraphPad, USA). Prior to statistical 
analysis, data were tested for statistical outliers using the Grubbs test (GraphPad, USA). 
Statistical outliers (p< 0.05) were removed from the analysis. Data was analysed by one-way 
analysis of variance (ANOVA) to enable the comparison of three experimental groups and 
assess the effect of maternal lifestyle. Maternal lifestyle was used to describe the effect of 
maternal obesity with and without the exercise intervention. When the same measurement 
was carried out at multiple time points (e.g. TD-NMR) a two-way ANOVA was used to 
assess the effect of maternal lifestyle and time. Where possible, a repeated measures 
correction was utilised in this analysis.   
Post-hoc testing was carried out using the Bonferroni method. For all data, the mean and 
standard error of the mean (SEM) are presented and p< 0.05 was considered statistically 
significant. Sample sizes (n) are reported within each figure legend. For offspring data, the 
sample size represents the number of independent litters per experimental group, this avoids 
litter bias as only one male or female was used per litter. 
  
   
41 
   
3. Assessment of the maternal phenotype in a 
mouse model of diet-induced obesity 
3.1 Introduction 
3.1.1 Why study maternal obesity? 
As highlighted in Section 1.2, the world is experiencing an obesity epidemic that is affecting 
women of childbearing age. There is a large body of evidence supporting the impact of 
adverse early life exposures in utero and during early postnatal life on the programming of 
disease in adulthood. Subsequently, the rising levels of maternal obesity has the capacity to 
negatively impact on the health of future generations.  
Why generate an animal model of maternal obesity? 
The choice of the animal model is often a balance between the cost and practicality of the 
research, and the translatability to humans. Although NHPs are closest to human development 
their long gestation time leads to high research costs. In addition, their long lifespan makes 
longitudinal studies into adulthood a challenge. Ovine models can be used as, like humans, 
they usually have a singleton pregnancy, the lamb is born at a similar weight to a human baby 
and they are a good model for studying fetal physiology as they allow fetal catheterisation.  
Rodent models have been used extensively due to the short gestation time and relatively low 
costs compared to larger animals.        
In general, animal models of maternal overnutrition lead to outcomes in offspring that are 
similar to those seen in epidemiological studies. This is discussed in more detail in Section 
1.9. The ability to remove confounding factors and identify causal relationships has 
highlighted that subtle environmental changes can have important consequences for offspring 
health. Animal models are also able to uncouple maternal characteristics that would usually 
be interconnected in humans. This has helped in the identification of “programming factors” 
associated with maternal obesity that could mediate detrimental effects in the offspring.  
3.1.2 Contributing factors to adverse development 
During pregnancy there is an increased risk of hypertension, metabolic disturbances of 
nutrient metabolism, and inflammation; this is exaggerated when accompanied with obesity 
(Catalano, 2010). Any alterations from the normal responses to pregnancy that occurs in a 
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suboptimal intrauterine environment could represent “programming factors” in the mother 
that mediate the offspring outcomes.  
Insulin resistance  
Pregnancy is characterised by significant changes in physiology, endocrinology and 
metabolism that enable the mother to sustain fetal requirements for both oxygen and nutrients. 
This is achieved by creating a pseudo-diabetogenic state that results in progressive insulin 
resistance. By late pregnancy, insulin sensitivity is reduced by 50% in normal weight women 
compared to the non-pregnant state (Catalano et al., 1991). When the normal process of 
pregnancy-induced insulin resistance is exaggerated, and there are accompanying metabolic 
abnormalities in glucose metabolism, GDM can develop (Mottola and Artal, 2016). This is 
often the case in maternal obesity as obesity is usually accompanied by a pre-existing state of 
insulin resistance. GDM pregnancies are associated with increased obstetric complications 
(Section 1.5.1) and fetal macrosomia (Yessoufou and Moutairou, 2011). 
Maternal leptin 
Overweight or obese women have higher circulating levels of serum leptin (Misra, Straughen 
and Trudeau, 2013). The main determinant of serum leptin levels is thought to be adiposity 
(and BMI) and this is also true in the pregnant state (Misra and Trudeau, 2011). However this 
dogma becomes more complex during pregnancy, as leptin nearly doubles over the course of 
pregnancy with leptin production by the placenta thought to play a role in this substantial 
increase (Hauguel-de Mouzon, Lepercq and Catalano, 2006). This has implications for the 
fetus; maternal leptin correlates with cord blood leptin levels taken immediately after delivery 
and this is associated with altered anthropometric characteristics (Marino-Ortega et al., 2015). 
A postnatal leptin surge that occurs in the postnatal period in rodents is critically important 
for organogenesis, especially within the brain (Attig et al., 2011). Leptin remains elevated in a 
rat model of maternal obesity during the postnatal period, evidenced by an exaggerated leptin 
surge and an increase in leptin found in the pup’s stomach throughout lactation (as a proxy 
measure of leptin in the mother’s milk) (Kirk et al., 2009). This is thought to alter 
sympathetic tone through melanocortin signalling in the hypothalamus (Samuelsson et al., 
2016). The subsequent sympathetic hyper-stimulation in the developing renal-cardiovascular 
system could lead to hypertension and cardiovascular dysfunction in adulthood (Briffa et al., 
2015).  
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Oxidative stress 
An imbalance between reactive oxygen species (ROS) production and the cellular antioxidant 
defense system leads to oxidative stress. Obesity causes an increase in oxidative stress and 
inflammation, the resultant oxidative damage may contribute to the onset and development of 
many pathologies (Furukawa et al., 2004). In particular, maternal obesity results in 
dysregulation of the redox balance in the maternal-placental-fetal unit and this induces 
placental and fetal oxidative stress despite the high placental antioxidant defense (Malti et al., 
2014). 
Oxidative stress is associated with pregnancy complications such as pre-eclampsia (Atamer et 
al., 2005) and IUGR (Hracsko et al., 2008), which could contribute to the postnatal 
consequences for the offspring. Animal studies are starting to provide evidence that oxidative 
stress is important in the programming of CVD. Offspring of obese mouse dams have 
enhanced lipid peroxidation and impaired antioxidant capacity in their hearts, suggesting 
oxidative stress is a potential driving force for the development of CVD in the offspring 
(Fernandez-Twinn et al., 2012). Low protein diet-exposed rat offspring exhibited elevated 
arterial BP alongside exaggerated vasoconstrictor response to Angiotensin II; these alterations 
were prevented by the prenatal administration of the antioxidant, Lazaroid (Cambonie et al., 
2006).  
3.1.3 Why exercise as an intervention during pregnancy? 
Exercise could be an effective intervention as it is able to target some of the adverse 
programming factors outlined in Section 3.1.2. There are a growing number of pregnancy 
intervention studies that utilise exercise (reviewed in Section 1.10.1) to improve maternal and 
neonatal outcomes. Both NICE and ACOG recommend exercise during pregnancy for all 
women with uncomplicated pregnancies, as there is no evidence of harm and indeed evidence 
suggests improvements in pregnancy outcomes (NICE, 2008; ACOG Committee opinion., 
2015). Exercise, therefore, presents an attractive candidate for an intervention during a 
suboptimal pregnancy, such as maternal obesity.   
Ability to target insulin resistance 
In non-pregnant humans, a short bout of exercise has been shown to result in increased insulin 
sensitivity that persists for several hours after exercise (Maarbjerg, Sylow and Richter, 2011). 
A randomised control trial was undertaken in healthy pregnant women to assess the effect of a 
triweekly exercise protocol on glucose tolerance. Blood glucose level one hour after an oral 
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glucose challenge (50 g) was lower in the exercised group suggesting improved glucose 
tolerance (Barakat et al., 2012). Exercise can also be used to regulate glucose tolerance in 
women who are at high risk of developing GDM. Examples of risks include family history of 
diabetes, hormonal disorders such as polycystic ovarian syndrome, overweight/obesity and 
excessive GWG (Pons et al., 2015). Glycemic control is considered the cornerstone of GDM 
treatment, which can be achieved not only by control of diet (Hoffert Gilmartin, Ural and 
Repke, 2008) but could also be addressed by exercise. The development of GDM is an 
important complication to address as it has significant negative obstetric outcomes such as 
macrosomia, caesarean delivery, pre-eclampsia and other pregnancy induced-hypertension 
disorders; many of which will have important influences on the fetus (Ehrenberg et al., 2004; 
Yessoufou and Moutairou, 2011).  
Ability to attenuate oxidative stress 
Oxidative stress associated with obesity during pregnancy may be a contributing factor in the 
induction of programmed phenotypes (see Section 3.1.2). Exercise is able to attenuate 
oxidative stress and inflammation (Durrant et al., 2009; Peppler et al., 2016). Voluntary 
running in lean pregnant rats increases placental efficiency and antioxidant concentrations, 
which could attenuate oxidative stress (Gilbert et al., 2012). Wheel running in obese pregnant 
mice lowers markers of oxygen and nitrogen stress such as serum malondialdehyde and liver 
superoxide dismutase (Vega et al., 2016). Using the same model of diet-induced obesity used 
for this thesis, maternal obesity was associated with placental hypoxia and this was attenuated 
by a maternal exercise intervention (Fernandez-Twinn et al., 2017). Oxidative stress is an 
important mediator and being able to target this potentially harmful programming factor could, 
therefore, have significant implications for the offspring.  
3.1.4 Aims of the chapter 
The first aim of this chapter was to determine the impact of an obesogenic diet on maternal 
bodyweight and body composition during pregnancy and to then assess the effects of a 
maternal exercise intervention.  The second aim was to characterise how neonatal growth 
profiles were altered with maternal obesity and if this was modified by maternal exercise. The 
final aim was to assess whether the impaired glucose tolerance and hyperinsulinemia 
observed in obese dams during pregnancy was still present at the end of lactation. 
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3.2 Methods 
3.2.1 Body composition 
The detailed description of the experimental protocol is described in Section 2.1 and 2.2. 
Maternal body composition (fat and lean mass) was measured weekly by TD-NMR for four 
weeks starting one week before mating, during mating and for the first two weeks of 
pregnancy. For Obese and Ob-Ex groups the start of the study was when a minimum fat mass 
of 10 g fat was reached. The exercise protocol was started a week before mating and this first 
week was designated the training week. Female mice were placed with stud males for mating 
for a maximum of five days and then were removed to be singly housed when a vaginal plug 
was detected. Food intake was measured from the start of pregnancy (day of plug) until the 
dam gave birth. Dams were singly housed throughout this time. RM1 diet pellet, HFD pellet 
and condensed milk were weighed weekly to calculate intake. Food intake was not measured 
during lactation to avoid confounding factors of the pups also consuming the diet and the 
potential stress it may cause to the dams and pups.  
When dams littered, the dam and pups were not disturbed until PND2 when the litter size and 
sex was noted and the litter was weighed. Litter size was standardised to six pups to ensure 
equal nutritional access and maternal care. Fraction of male pups was calculated by dividing 
the number of male pups by the total number of pups in the litter. Whole litter weight was 
subsequently measured on PND7, PND14 and PND21. The average weight of each pup in the 
litter was then calculated by dividing the total litter weight by the number of pups in the litter. 
Fractional growth rate (FGR) was calculated by the following formula: 
𝐹𝐺𝑅 =  
(𝑃𝑁𝐷21 𝑤𝑒𝑖𝑔ℎ𝑡 − 𝑃𝑁𝐷2 𝑤𝑒𝑖𝑔ℎ𝑡)
(𝑃𝑁𝐷21 − 𝑃𝑁𝐷2)
/ 𝑃𝑁𝐷2 𝑤𝑒𝑖𝑔ℎ𝑡 
This gives the bodyweight gained per day during lactation as fraction of the weight on PND2. 
At three weeks of age mouse offspring were weighed individually, separated by sex and 
housed as a pair with a same sex littermate. All offspring were weaned onto a control (RM1) 
diet.  
3.2.2 Post weaning intraperitoneal glucose tolerance test (GTT) 
On the day of weaning, the dams were fasted overnight beginning at 16:30. Dams were placed 
individually into a clean cage with access to water. They were fasted for 16 hours and blood 
drawn from the tail for basal (0 minute) glucose measurements (AlphaTRAK2, Zoetis, USA). 
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Dams were then injected intraperitoneally (i.p.) with 1 g/kg glucose and further tail blood 
glucose measurements were made at timed intervals after injection (15 minutes, 30 minutes, 
45 minutes, 60 minutes, 90 minutes and 120 minutes). Tail blood was collected at 0 minutes, 
15 minutes and 30 minutes time points in haematocrit Na- heparin capillary tubes 
(Hirschmann- Laborgeräte, Germany). Plasma was isolated by spinning tubes in Haematospin 
(Hawksley, UK) for four minutes and plasma insulin was measured using a Mouse Insulin 
ELISA (CrystalChem, USA) following manufacturer’s instructions. Area under curve was 
calculated by summation of trapezoids (Prism, GraphPad, USA). Using the matched plasma 
insulin and glucose values HOMA-IR was calculated using the HOMA calculator (Diabetes 
Trial Unit, University of Oxford available here: https://www.dtu.ox.ac.uk/homacalculator/). 
3.2.3 Statistical analysis 
When the same measurement was taken at multiple time points (e.g. TD-NMR, food intake, 
lactation bodyweight and glucose curve) data was analysed by two-way ANOVA with 
repeated measures correction and a Bonferroni post-hoc test. The three groups were compared 
by one-way ANOVA and a post-hoc Bonferroni test. All data is presented as mean ± SEM. 
 
3.3 Results 
3.3.1 Maternal body composition and food intake 
There was a significant effect of maternal lifestyle (p< 0.001) and time (p< 0.001) on dam 
bodyweight from one week before and during mating and pregnancy (Figure 3.1A). Post-hoc 
testing demonstrated that obesogenic diet-fed dams had increased bodyweight throughout 
mating and pregnancy compared to control dams. There were no differences in bodyweight 
due to the exercise intervention (Obese vs. Ob-Ex dams) (Figure 3.1A).  
Over mating and pregnancy there was a significant effect of maternal lifestyle (p< 0.001) and 
time (p< 0.001) on dam fat mass, with post-hoc testing showing increased fat mass in 
obesogenic diet-fed dams at every time point measured compared to controls. This is not 
surprising as at the start of the study the fat mass was kept below 5 g for the control diet-fed 
dams and over 10 g for the obesogenic diet-fed dams. Maternal exercise did not alter fat mass 
over the intervention period. There was a significant interaction between the week of TD-
NMR measurement and maternal lifestyle, this means that the week of the TD-NMR 
measurements had a different effect on obesogenic diet-fed dams when compared to control 
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dams. This suggests that obesogenic diet feeding not only increases fat mass of the dam over 
mating and pregnancy but also that they gain more fat mass over this period (Figure 3.1B). 
There was a significant effect of time (p< 0.001) and maternal lifestyle (p< 0.05) in the lean 
mass of dams. Post-hoc testing detected differences in the second week of pregnancy; the 
obesogenic diet-fed dams had decreased lean mass compared to the control dams. There was 
also a significant interaction, suggesting the effect of the week of TD-NMR measurement on 
dam lean mass is different between the groups. This could highlight the smaller gain in lean 
mass in obesogenic diet-fed dams seen between the first and second week of pregnancy 
(Figure 3.1C). 
The TD-NMR measurements are equally spaced apart by one week and are not matched to the 
gestational day of pregnancy. This means, depending on how quickly the mice plug the TD-
NMR measurement may represent different time points in gestation which could vary by a 
maximum of four days. For example, post plug week two usually represents E12/13 but can 
also be any day between E10 and E14. There was, however, no significant difference between 
groups for the time taken to mate (Figure 3.1D) and there was no difference in the gestational 
day the final TD-NMR measurement was undertaken (Control, 13.1 ± 0.3; Obese, 12.6 ± 0.4; 
Ob-Ex, 12.3 ± 0.5; p= 0.356). 
GWG between mating and E14 was recorded and showed an overall effect of maternal diet by 
one-way ANOVA (Figure 3.1E). E14 was the last day in pregnancy when bodyweights were 
consistently recorded in the dams from all three groups. Bodyweight was not recorded later in 
pregnancy so as to not disturb the mice close to delivery.  
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FIGURE 3.1: Maternal body composition from one week before and during pregnancy. 
TD-NMR measurements were started one week before mating when Obese and Ob-Ex dams 
reached the required 10 g fat. Ob-Ex dams also started the training week of exercise on this 
day. TD-NMR measurements continued weekly. A) Bodyweight, B) Fat mass and C) Lean 
mass. Control n= 12, Obese n= 12 and Ob-Ex n= 11. Two-way repeated measures ANOVA 
with Bonferroni post-hoc test; ** p< 0.01 and *** p< 0.001. D) Number of days until positive 
vaginal plug (maximum 5 days with stud male). Control n= 12, Obese n= 12 and Ob-Ex n= 10. 
E) GWG (E1-E14) relative to bodyweight at mating (E1). Control n= 11, Obese n= 12 and 
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Obesogenic diet-fed dams had a higher caloric intake during pregnancy then control diet-fed 
dams. There was no impact of maternal exercise intervention on daily caloric intake (Figure 
3.2A). When the two components of the obesogenic diet (HFD pellet and condensed milk) 
were plotted separately, there was no difference in caloric intake during the intervention, 
between the non-exercised and exercise obese dams (Figure 3.2B).  When caloric intake was 
plotted by the week of pregnancy there was no effect of maternal exercise or day of gestation 
on the intake of HFD pellet (Figure 3.2C). There was an effect of gestational day on the 
intake of condensed milk, showing that the consumption of the milk was reduced at the end of 
pregnancy. Overall there was no impact of maternal exercise on dam food intake during the 
intervention period. 
FIGURE 3.2: Maternal food intake during pregnancy. A) Average total daily caloric 
intake (from day of mating until day of birth) Control n= 12, Obese n= 10 and Ob-Ex n= 7. 
One-way ANOVA with Bonferroni post-hoc test; *** p< 0.001. B) Daily caloric intake of 
obesogenic diet-fed dams split into HFD pellet and condensed milk. C) Daily caloric intake of 
HFD pellet over pregnancy. E1 is the day of mating and PND0 is the day the pups were born. 
D) Daily caloric intake of condensed milk over pregnancy. Obese n= 10 and Ob-Ex n= 8. 
Two-way repeated measures ANOVA with Bonferroni post-hoc test; ## Significant effect p< 
0.01 between E14-PND0 and other time points. 
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3.3.2 Litter and pup characteristics 
Obese dams had a reduced number of pups in the litter and the maternal exercise did not 
prevent this (Figure 3.3A). There were no significant differences in the sex ratio of the litter 
between the groups (Figure 3.3B). The weight of PND2 pups was reduced after exposure to 
maternal obesity, the exercise intervention did not avert this reduction in pup weight (Figure 
3.3C).  
 
FIGURE 3.3: Litter size and weight. A) Total litter size, B) Fraction of male pups C) 
Average bodyweight of pup at PND2. Control n= 12, Obese n= 12 and Ob-Ex n= 7. One-way 
ANOVA with Bonferroni post-hoc test; * p< 0.05 and ** p< 0.01.     
 
3.3.3 Lactation weights 
Offspring from obese dams were heavier on PND14 and PND21 than the offspring from both 
control (p< 0.001) and obese-exercised dams (p< 0.01) (Figure 3.4A). At PND14, the 
bodyweight of offspring from obese-exercised dams was similar to that of offspring from 
control dams but there was a significant difference compared to offspring from obese dams 
(p< 0.01) (Figure 3.4A). By PND21 the bodyweight of the offspring in the intervention group 
tracks between the two other groups, there was still a significant difference compared to the 
offspring from obese dams (p< 0.01) but there was also increased bodyweight compared to 
offspring from control dams (p< 0.01) (Figure 3.4A). There was a significant interaction 
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between postnatal day and maternal lifestyle suggesting that age had the same effect on 
offspring of obese and obese-exercised dams, but that they were different to offspring of 
control dams. When FGR across lactation was calculated offspring from obese dams showed 
a significant increase. This was not prevented by maternal exercise intervention (Figure 3.4B).  
Offspring of obese dams were heavier at three weeks of age compared to offspring from 
control dams; this was true for both male and female offspring. The offspring of obese-
exercised dams did not have increased bodyweight compared to offspring of control dams. 
Their bodyweight was also not different, however, when compared to offspring of obese dams 
(Figure 3.4C+D).  
 
FIGURE 3.4: Lactation and weaning bodyweights. A) Offspring bodyweight on PND2, 
PND7, PND14 and PND21 (day of weaning). Control n= 9, Obese n= 9 and Ob-Ex n= 6. 
Two-way repeated measures ANOVA with Bonferroni post-hoc test; A*** = significant 
effect of age p< 0.001, M*** = significant effect of maternal lifestyle p< 0.001 and I*** = 
significant interaction p< 0.001. B) Fractional growth rate during lactation. Control n= 9, 
Obese n= 9 and Ob-Ex n= 6 C) Bodyweight at three weeks old of male (D) and female 
offspring. Control n= 9, Obese n= 9 and Ob-Ex n= 6.  One-way ANOVA with Bonferroni 
post-hoc test; ** p< 0.01 and *** p< 0.001. 
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3.3.4 Maternal serological analysis at weaning 
At weaning, maternal bodyweight was increased in the obesogenic diet-fed dams and there 
was no effect of the intervention (Figure 3.5A). Serum leptin was measured in 16 hour fasted 
serum and showed an increase (corresponding to the increased bodyweight) in the obese and 
obese-exercised dams. Serum leptin in the mother at weaning was not altered by the exercise 
intervention (Figure 3.5B). 
 
FIGURE 3.5: Dam bodyweight at weaning and serum leptin. A) Dam bodyweight at 
weaning. B) Dam leptin levels in 16 hour fasted serum. Control n= 7, Obese n= 4 and Ob-Ex 




It has already been determined that obese dams are hyperinsulinemic during pregnancy 
accompanied by impaired glucose tolerance (Fernandez-Twinn et al., 2017). A GTT was 
performed on control and obese dams at weaning after a 16 hour overnight fast. There were 
no differences in glucose clearance after i.p. injection of 1 g/kg glucose (Figure 3.6A). This 
was reflected in the area under the curve analysis, as there was no difference between the 
groups (Figure 3.6B). Tail blood was collected at the 0 (baseline), 15 and 30 minutes. Plasma 
insulin was measured and was increased at all three time points. HOMA-IR was calculated 
after fasting, using the baseline sample (0 minute) taken before glucose injection and was 
increased in the obese dams (Figure 3.6C). This data was not available for exercised animals 
in this thesis. However, data provided by Dr Laura Kusinski and Dr Lisa Nicholas (Appendix 
AP2) shows that obese-exercised dams also do not have any further alteration in glucose 
tolerance at weaning.  
   
53 
   
FIGURE 3.6: Maternal GTT at weaning with matching plasma insulin. 0 minutes was at 
baseline following fasting and before i.p. injection. Control n= 5 and Obese n= 7. A) 16 hour 
fasted i.p. GTT. B) Area under curve analysis from GTT curve. C) Matching plasma insulin 
from the 0, 15 and 30 minute time points of the GTT and calculated HOMA-IR at fasting (0 
minute). P values shown in table calculated unpaired t-test between Control and Obese group.   
 
3.4 Discussion 
The aim of this chapter was to determine the impact of exercise during an obese pregnancy on 
the mother and neonate up until weaning. The exercise intervention did not alter bodyweight 
or body composition throughout pregnancy. Reduced litter size and birthweight were not 
corrected and the accelerated growth profile in the lactation period was still present, but 
delayed, by the intervention. The offspring from the intervention group, however, did not 
show increased bodyweight at three weeks of age which was seen after exposure to maternal 
obesity. It has been shown previously that maternal glucose tolerance and hyperinsulinemia is 
present in obese dams during pregnancy (Fernandez-Twinn et al., 2017). The data from this 
thesis has shown that this impaired glucose homeostasis was not maintained at weaning, and 
therefore the model has a gestational diabetic phenotype that is resolved when the dam is no 
longer pregnant.   
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3.4.1 Dam data 
By mating, dams had been fed the obesogenic diet for around 15 weeks and this was 
sufficient to induce obesity. Obesogenic diet-fed dams therefore had increased bodyweight 
and fat mass throughout pregnancy and lactation. The increased bodyweight resulted from 
increased fat mass. The moderate intensity of the exercise intervention and the fact the 
animals were fed ad libitum meant that the dam’s bodyweight and fat mass was not altered 
throughout the intervention. It is also important to note that during the week before mating the 
exercise protocol did not cause any significant weight loss, as periconceptional weight loss 
through maternal undernutrition has been shown to result in undesirable changes in fetal and 
neonatal measures (Matusiak et al., 2014). Alongside no changes in body composition, there 
was also no benefit of maternal exercise on GWG (E1-E14) in obesogenic diet-fed dams. 
Overall, this model resulted in dams fed the obesogenic diet being heavier, with an increase in 
adiposity and is therefore a successful model of maternal obesity. 
As the TD-NMR measurements were carried out weekly and were not matched to the day of 
gestation, the number of days to plug could have an impact on the last two TD-NMR 
measurements. The gestational day the TD-NMR measurement was carried out could vary by 
up to four days if the dam does not plug until the final day of mating (Note: Non-pregnant 
female mice were placed with stud males for a maximum of five days). To account for this 
possible confounding factor, the number of days to plug was plotted and there was no 
difference. This does not, therefore, account for the differences in the TD-NMR 
measurements between groups. During the second week of pregnancy, the lean mass of the 
obesogenic diet-fed dams was reduced and this was irrespective of if the dam was exercised. 
As TD-NMR measurements cannot distinguish between the body composition of the dam and 
her pups, this deficit could be accounted by the fact that both Obese and Ob-Ex groups had a 
reduced litter size at birth and a decreased PND2 pup weight.  
The intervention was not continued into lactation; at the end of lactation, bodyweight was still 
increased in the obesogenic diet-fed dams with no effect of the prior exercise intervention. 
Maternal exercise did not alter serum leptin levels in pregnancy, which was measured shortly 
after the exercise intervention (at E19); where data showed an increase in obesogenic diet-fed 
dams and this was not ameliorated by the exercise intervention (Fernandez-Twinn et al., 
2017). Serum leptin was increased in samples from 16 hour fasted dams and this is consistent 
with a corresponding increase in fat mass (Shimizu et al., 1997; Ruhl et al., 2007). Body 
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composition of dams at the end of lactation was not determined in this study, but it has been 
shown in previous cohorts that obese dams had increased total body fat both in absolute terms 
and as a percentage of bodyweight at the end of lactation (Blackmore et al., 2014; Fernandez-
Twinn et al., 2014). The lack of change in response to maternal exercise in these measured 
outcomes does not mean that the intervention had no impact on the dam. Previously published 
research from the lab has shown that maternal exercise prevented impaired glucose 
homeostasis and hyperinsulinemia during pregnancy (at E18) (Fernandez-Twinn et al., 2017). 
It is important to identify maternal factors altered by obesity during pregnancy, as well as 
factors that have been corrected by the maternal exercise intervention as this will allow the 
identification of potential “programming factors” that could mediate offspring outcomes 
(shown in the subsequent chapters). In this case, offspring outcomes that are reversed by 
maternal exercise cannot be mediated by a reduction in the mother’s adiposity but could 
instead be mediated by the improvement in glucose handling and insulin resistance during 
pregnancy. 
A GDM-like phenotype  
It has been shown by us (Fernandez-Twinn et al., 2017) and in a separate study that uses the 
same mouse model (Samuelsson et al., 2008), that there is impaired glucose tolerance and 
hyperinsulinemia in obese dams during pregnancy. This impairment in glucose tolerance 
appears to be confined to pregnancy, as by the end of lactation there was no longer any 
difference in glucose tolerance in the obese dams compared to controls.  This suggests a 
GDM-like phenotype where obesity in the dam is not enough to impair glucose tolerance 
alone and differences are only seen when paired with the demands of pregnancy. During 
pregnancy, adjustments in glucose homeostasis alongside other significant physiological and 
metabolic changes ensure the increasing demand of supplying nutrients to placenta and 
developing fetus are met (Di Cianni et al., 2003).  
Hyperinsulinemia is maintained at weaning in the obese dams (this was measured in 16 hour 
fasted plasma). Plasma samples collected during the glucose peak of the GTT (15 and 30 
minutes post i.p. glucose) also had elevated insulin levels in the obese dams. This could 
indicate that the obese dams require higher insulin levels to handle the glucose bolus given to 
maintain glycemia in the non-pregnant state. HOMA-IR index could be calculated as 
matching plasma glucose and insulin was available and this showed increased HOMA-IR 
following fasting, indicating increased insulin resistance. Insulin resistance is thought to 
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represent a starting point in the pathogenic progression of diabetes (Groop, 2000). Impaired 
glucose tolerance and diabetes won’t be present if the β-cells can produce enough insulin to 
maintain blood glucose within normal range. When this is no longer possible there will be 
disease progression. Therefore during pregnancy when further insulin resistance occurs, the 
obese dams had impaired glucose clearance possibly because their β-cells are now struggling 
to produce enough insulin to maintain glucose homeostasis.   
3.4.2 Neonatal offspring growth 
Pups from obese dams had decreased bodyweight at PND2 and were also born in smaller 
litters. Low birthweight in offspring of obese dams has previously been shown in both rats 
(Howie et al., 2009) and mice (Zheng et al., 2014). In human obese pregnancies women are 
just as likely to have offspring born SGA, as they are to have LGA babies (Rajasingam et al., 
2009). Maternal exercise of the obese dams did not cause any additional change in neonate 
weight or litter size. An epidemiology study of exercise during a lean pregnancy resulted in 
lower birthweight and BMI (Hopkins et al., 2010). In our obese dams, exercise did not appear 
to further reduce PND2 offspring weight as there was no difference between offspring of 
obese and obese-exercised dams; this suggests a difference in how fetal growth profiles are 
affected by exercise between a lean and obese pregnancy.  
Despite offspring from obese dams being smaller at PND2, they became heavier (vs. control) 
from PND14 onwards and had increased FGR during lactation, suggesting an alteration in 
their growth profile and possible postnatal ‘catch up growth’. Body composition analysis by 
TD-NMR is not possible during this period due to their small size, therefore it is not known if 
this increased weight in the postnatal period is due to changes in lean mass or fat mass. This 
resulted in an increased bodyweight at three weeks of age in male and female offspring from 
this group. The offspring of obese-exercised dams were also smaller at PND2 but did not 
show increased bodyweight during lactation until PND21 suggesting the accelerated growth 
occurs later in lactation. FGR was also increased in these offspring, again suggesting an 
accelerated growth rate; however when weights were plotted individually at three weeks of 
age, male and female offspring of obese-exercised dams had bodyweights that were similar to 
control. Alterations in the growth profile during lactation can be harmful, with studies 
showing that ‘catch up growth’ is associated with CVD and insulin resistance in adult life 
(Cianfarani, Germani and Branca, 1999; Eriksson et al., 1999). 
   
57 
   
3.4.3 Translatability of the intervention 
Adherence, in humans, to an intervention that involves a change in behaviour is a major 
limitation with the lowest adherence reported to be 16% (Russo et al., 2015). This still 
presents a challenge in implementing a successful intervention. Interventions during 
pregnancy can be complicated by the reported side effects of pregnancy such as nausea and 
fatigue. The exercise protocol was designed to be of moderate intensity for only 20 minutes a 
day, five days a week and should, therefore, be a realistic goal for obese pregnant women.  
Primary outcomes in the mother are not always met with exercise and dietary-based 
interventions, however differences in other outcomes are recorded and the potential benefit of 
the interventions on the infant and long-term health of the mother has yet to be assessed in 
most current human studies. For example, the UPBEAT trial demonstrated reduced infant 
adiposity at six months of age in the intervention group and a sustained improvement in the 
mother’s diet at six months postpartum (Patel, Godfrey et al., 2017). Increasing the intensity 
and duration of the intervention to maximize the impact is probably not going to be realistic in 
an obese population. Therefore, having an intervention that can have a positive impact 
without a change in maternal body composition or GWG is important. The impact of this 
intervention on offspring outcomes and its success will be assessed in the subsequent chapters.  
3.4.4 Conclusions 
Dams fed an obesogenic diet prior to conception can be considered obese at mating and 
throughout pregnancy and lactation; this increase in bodyweight was attributed to an increase 
in fat mass. Maternal exercise intervention did not alter bodyweight or body composition 
throughout pregnancy when compared to non-exercised obese dams. At the end of lactation, 
obesogenic diet-fed dams remained heavier and had increased serum leptin. Obese dams had 
normal glucose tolerance but showed hyperinsulinemia and insulin resistance at weaning. 
Alongside the previous published knowledge that there is impaired glucose tolerance during 
late pregnancy, this suggests the phenotype is similar to GDM. Pups born to obese dams were 
smaller at PND2 but then had accelerated postnatal growth and were heavier by weaning. The 
exercise intervention did not prevent pups being smaller at PND2 and these pups continued to 
have accelerated growth during lactation period.  
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3.4.5 Summary of key findings 
Results in this chapter have shown that: 
• Feeding of the obesogenic diet to the dams doubled the daily caloric intake and dams 
were fed respective diets for approximately 15 weeks before the start of the 
experimental protocol. 
• One week before pregnancy, when the Ob-Ex group started the exercise-training 
week, the obesogenic diet-fed dams were roughly 30% heavier and had over double 
the adiposity. The exercise intervention did not alter body composition of the dams. 
• At weaning, maternal obesity caused fasting hyperinsulinemia and insulin resistance 
as indicate by the increased HOMA-IR. 
• Maternal obesity decreased the pup weight on PND2 and this was not prevented by the 
exercise intervention. 
• Pups of obese dams, irrespective of if the obese dam was exercised, had increased 
FGR in the lactational period and were heavier at weaning, possibly indicating a 
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4. Cardiovascular phenotype in young adult 
male offspring 
4.1 Introduction 
4.1.1 Importance of CVD prevention 
The incidence of mortality from CVD fell by 68% between 1980 and 2013 (Bhatnagar et al., 
2016) however there are more people living with the effects and impact of CVD than ever 
before (Koch et al., 2015). This has been attributed to massive improvements in both 
prevention and treatment of cardiovascular events; for example improved control and 
management of hypertension through the use of beta blockers, the reduction in circulating 
cholesterol levels through administration of statins and the development and rapid use of 
thrombolysis or stents in an ischaemic event to limit tissue death (Mensah et al., 2017). With 
an ageing population, the incidence of CVD is expected to increase as people above 65 years 
of age have the highest prevalence for all CVD. This will have large implications for the 
healthcare services; a study predicting medical costs for CVD in the US suggest it will rise by 
200% by 2030 (Heidenreich et al., 2011).  
Prevention strategies have focused specifically on attenuating disease risk by reducing an 
individual’s modifiable risk factors, for example through an improvement in current lifestyle 
choices (U.S. Department of Health and Human Services, 2010; Holmes et al., 2014). 
However, this strategy does not target prevention of the risk of cardiometabolic disease that is 
established during fetal development through exposure to an adverse in utero environment 
such as maternal obesity. Maternal obesity impacts the offspring’s cardiovascular health 
through programmed mechanisms, this is described in human and animal studies in Section 
1.8-1.9. Instead current strategies target a window (adulthood) where disease pathologies may 
already be developed and does not take into account the disease risk already attributed to 
individuals at birth. Failing to address this particular risk could greatly increase the burden for 
CVD in the next generation. A prevention strategy is needed to target the in utero 
cardiovascular health of the unborn offspring. 
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4.1.2 Left ventricular cardiac hypertrophy 
LV hypertrophy occurs to normalise wall tension in the heart in response to pressure/volume 
overload. It is not a pre-requisite that this will result in cardiac dysfunction and is a common 
compensatory response to the physiological stressors of pregnancy and exercise (Nakamura 
and Sadoshima, 2018). This is known as physiological cardiac hypertrophy and it is 
characterised by increases in heart weight, cardiomyocyte cell size, protein synthesis and 
cardiac output. It is often reversible when the initial stressor is removed (Agrawal et al., 2010). 
However cardiac hypertrophy can also be pathological in nature and this is accompanied by 
adverse cardiovascular events such as arrhythmias, heart failure and death (Nakamura and 
Sadoshima, 2018). Risk factors for the development of LV hypertrophy include age, obesity, 
diabetes, hypercholesterolemia and prior myocardial infarction (Artham et al., 2009). Factors 
of the neurohumoral system have also been implicated including the renin-angiotensin and 
adrenergic systems, insulin, catecholamines and other growth factors (Heineke and Molkentin, 
2006).  
The Framingham study recruited residents aged 30-60 years old, from the town of 
Framingham, Massachusetts, USA for a landmark long-term study that aimed to identify 
common risk factors for the development of CVD. The study used echocardiographic 
determination of LV mass to offer prognostic implications (Levy et al., 1990). LV 
hypertrophy has been shown to hinder function through a reduction in stroke volume and 
rapid ventricular filling volume and time (Folkow, 1978; Smith et al., 1985).   
Increased LV mass and hypertrophy have been shown, in the Cardiovascular Health Study, to 
be a risk factor for depressed LV ejection fraction (Drazner et al., 2005). The mechanism by 
which this happens is not well understood (Artham et al., 2009). LV hypertrophy is also 
associated with interstitial fibrosis; another myocardial structural change that is known to 
impact function (Weber and Brilla, 1993). Specifically, hypertrophied tissue contains 
increased amounts of collagen and interstitial fibrosis and this has been shown to impact 
diastolic function (Artham et al., 2009). Other complications of LV hypertrophy are 
ventricular arrhythmias (McLenachan et al., 1989) and atrial fibrillation (Verdecchia et al., 
2003), both of which have been linked to sudden cardiac death. In another study, 
hypertrophied cells had altered ventricular physiology through a decrease in outward current 
caused by delayed rectifier channels (Kleiman and Houser, 1990).  
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LV hypertrophy and hypertension 
Although LV hypertrophy does occur in other rheumatic and coronary heart disease, 
hypertension is the chief precursor for the condition with elevated SBP, as opposed to 
diastolic, having the bigger impact. LV hypertrophy is a common consequence of 
hypertension as it acts as a fundamental adaptation to the pressure overload mechanism. This 
common adaptation allows the heart to maintain cardiac output during increases in afterload 
caused by increased arterial pressure (Dahlof, 2001). This may produce a stable period of 
compensation but eventually decompensation will occur leaving the ventricle unable to cope 
and leads to heart failure. The risk of death or fatal complications is increased 2-4 fold with 
LV hypertrophy (independent of age, sex and other risk factors) (Kannel, Dannenberg and 
Levy, 1987; Levy et al., 1990). 
Data from the Framingham study showed that 30% of those with echocardiography-detected 
LV hypertrophy would go on to have a cardiovascular event within five years. LV 
hypertrophy is a strong independent predictor of future cardiovascular events (Dunn et al., 
1990). Moreover, LV hypertrophy also increases the risk of coronary heart disease, 
myocardial infarction, stroke and heart failure independently of BP; the contribution of this 
risk is calculated to exceed the risk of the accompanying hypertension (Kannel, Dannenberg 
and Levy, 1987). These findings were supported in a study undertaken in a population of 
patients with hypertension that were more diverse racially and in socioeconomic background 
than the Framingham study. This study demonstrated that the increment in LV mass became 
an independent predictor of cardiovascular death including myocardial infarction and heart 
failure (Koren et al., 1991).   
Population based studies confirm that hypertension increases an individual’s risk of further 
cardiovascular complications by 2-3 times (Padwal, Straus and McAlister, 2001). 
Hypertension has been implicated in 39% of cases of heart failure in men and 59% in women 
suggesting its involvement in the aetiology of progressive cardiovascular disease (Levy et al., 
1996).  
Reversal of LV hypertrophy 
The use of anti-hypertensive therapy can regress LV hypertrophy and has been shown to 
reduce CVD risk, independent of BP lowering (Nagano et al., 1991). Contractility has also 
been shown to be improved even after anti-hypertensive therapies were stopped (Schmieder et 
al., 1989). Further studies demonstrated that blunting of the hypertrophic response is 
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associated with preserved cardiovascular function (Schmieder et al., 1989) and improved 
survival with a reduced morbidity and mortality (Prineas et al., 2001). The greater the 
reduction in LV hypertrophy the greater the reduction in major cardiovascular events (Okin et 
al., 2004). Since there is little understanding about the mechanism linking LV hypertrophy 
and poor cardiac function, the reason for a reduction in LV hypertrophy to improve clinical 
outcomes is similarly unknown. 
4.1.3 Pathological cardiac hypertrophy markers 
It is well described that during cardiac stress such as hemodynamic overload (Distefano and 
Sciacca, 2012) there is a re-expression of fetal genes. This alteration in gene expression is 
initially compensatory to maintain cardiac output, but decompensation can occur with 
persistent expression, and this may lead to heart failure (Distefano and Sciacca, 2012).  
Natriuretic peptides 
The Nppa gene encodes atrial natriuretic peptide (ANP) and Nppb encodes brain natriuretic 
peptide (BNP); both are circulating hormones that play a role in the regulation of 
intravascular blood volume and vascular tone. Nppa preferentially binds to the guanylyl 
cyclase-linked natriuretic peptide receptor-A (NPR-A) but can also bind to natriuretic peptide 
receptor-C which is not guanylyl linked and instead acts to clear the peptides from the 
circulation (Nishikimi, Maeda and Matsuoka, 2006). During embryonic development Nppa is 
expressed in both atria and ventricles, however after birth, expression is mainly confined to 
the atria within the mature myocardium (Chien et al., 2016). After induction of ventricular 
hypertrophy, Nppa is re-expressed in ventricular tissue. The induction of Nppa is a highly 
conserved feature of ventricular hypertrophy and this has been demonstrated in many animal 
models in response to a variety of stimuli such as hormone, pressure and volume overload and 
in genetic models (Chien et al., 2016). Mice lacking the NPR-A demonstrate an elevated 
ventricular mass and hypertension indicating this peptide may have a role in inhibiting cardiac 
hypertrophy (Oliver et al., 1997). This was then investigated in vitro, rat neonatal ventricular 
myocytes treated with endogenous ANP showed inhibition of hypertrophy (Horio et al., 
2000). These peptides cause effects that extend beyond the heart for example diuresis 
(increased urine production), natriuresis (increased sodium excretion), vasodilation and 
inhibition of the renin- secretion and aldosterone system (Nishikimi, Maeda and Matsuoka, 
2006).  
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Myosin heavy chain switch 
α and β myosin heavy chain (MYC) are two functionally distinct cardiac MYC isoforms; α-
MYC (Myh6) is the adult form and β-MYC (Myh7) the predominant fetal isoform 
(Holubarsch et al., 1985). Up-regulation of β-MYC is an early and sensitive marker of cardiac 
hypertrophy (Pandya and Smithies, 2011).  
β-MHC is characterised by lower adenosine triphosphatase activity and lower filament sliding 
velocity, but can generate cross-bridge force with a higher economy of energy consumption 
than α-MHC (Holubarsch et al., 1985). This suggests that a shift from α- to β-MHC might be 
an adaptive response to cardiac stress in order to preserve energy. It is therefore conceivable 
that the decrease in contractile function due to increased β-MHC might outweigh the benefits 
of improved economy and ultimately dictate clinical outcome (Krenz and Robbins, 2004). 
This shift in MYC ratio is common in hypothyroidism, triiodothyronine is able to bind to the 
thyroid hormone responsive element (TRE) of the Myh6 gene causing its upregulation. It can 
also bind to the TRE located in the Myh7 gene but this causes repression (Kuwahara, 
Nishikimi and Nakao, 2012). The subsequent increased β-MHC:α-MHC ratio resulted in 
impaired systolic cardiac dysfunction measured by magnetic resonance imaging (Chen et al., 
2001).  
4.1.4 Cardiac inotropic response to changes in workload 
Modulation of calcium pathways is critical for the heart to adapt to changing workloads 
(Chung et al., 2016; Eisner et al., 2017). Calcium (Ca2+) is at the centre of the excitation-
contraction coupling in the heart. The regulation of contraction of individual cardiomyocytes 
(the coordination of which is critical for effective pumping) is controlled by Ca2+ entry and 
release from a specialist organelle called the sarcoplasmic reticulum (SR). Ca2+  is stored in 
the SR of cardiomyocytes. The contraction cycle is triggered by the depolarisation of the 
sarcolemma, which activates the voltage gated L-type Ca2+ channels, and the subsequent Ca2+  
entry via these channels into the cardiomyocyte starts the release of Ca2+ from the SR via 
ryanodine receptors (Woodcock and Matkovich, 2005). 
The increase in intracellular Ca2+ then binds to Troponin C of the myofilament machinery and 
relieves the inhibition of the myosin and actin interaction. Tropomyosin is a specialised rod 
shaped protein that binds to the length of the actin filament to stabilise and stiffen it. Troponin 
T positions the myofilament machinery complex on the thin actin filament by binding to 
Tropomyosin. Troponin I is a polypeptide in the complex involved in Ca2+ regulation, it has 
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an inhibitory role while it is bound to actin. The increase in intracellular Ca2+ after Ca2+ entry 
allows Ca2+ to bind to Troponin C which releases the inhibitory interaction of Troponin I. 
This causes a shift in Tropomyosin to allow the binding of the myosin head to the actin 
filament which results in contraction (Bers, 2002). Ca2+ return to the SR is achieved in two 
ways, via the sarcoplasmic reticulum Ca2+ transporter (SERCA) (Bers, Eisner and Valdivia, 
2003) and through Na+/Ca2+ exchanger (Hilgemann, 2004).  
The force and/or rate of contraction has to be modifiable to allow the heart to increase the 
cardiac output in response to changes to workload. This is achieved by enhancing the Ca2+ 
mediated mechanisms described above and occurs through the activation of sympathetic 
nervous system. Phosphorylation of Troponin I, through sympathetic activation, decreases the 
Ca2+ sensitivity of Troponin C which causes an increased off-rate of Ca2+, to allow accelerated 
cardiac relaxation (Bodor et al., 1997; Zakhary et al., 1999). Phosphorylation occurs through 
increased β-adrenergic receptor activity leading to activation of protein kinase A/C.  
4.1.5 Exercise as an intervention  
Exercise is an effective intervention at improving one’s own metabolic health and therefore 
presents a promising candidate for intervening during an obese pregnancy, as it is known that 
improving the mother’s metabolism will also impact the future offspring. As shown in 
Section 1.10 many human intervention studies have used exercise in an attempt to improve 
mother’s health as well as fetal and neonatal outcomes. Most of these studies report only on 
immediate effects during pregnancy and at the point of delivery. Recent findings from the 
UPBEAT study have shown that increased physical activity and a reduction in glycemic load 
during pregnancy reduced offspring adiposity at six months of age (Patel, Godfrey et al., 
2017). However, due to the long-term nature of CVD and the relative infancy of such 
intervention studies, data on such outcomes in humans will not be known for many years. 
There is therefore a need to model such intervention strategies in animals to longitudinally 
determine the cardiometabolic effects on the offspring. 
4.1.6 Aim of the chapter 
The aim of this chapter was therefore to use a mouse model of maternal diet-induced obesity 
to test the effectiveness of an exercise intervention (treadmill running) during obese 
pregnancy at preventing programmed cardiovascular dysfunction in the adult male offspring 
and identifying underlying mechanisms. 
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4.2 Methods  
4.2.1 Animals 
Full details of the animal model with experimental schematic is in Sections 2.1 and 2.2. 
Weekly TD-NMR measurements were carried out on the male offspring from four weeks 
until eight weeks of age. At eight weeks of age tail blood glucose was measured after a 16 
hour fast (AlphaTRAK 2, Zoetis, USA). Mice were then killed by rising CO2 concentration. 
At post mortem, blood was collected by cardiac puncture before tissue was collected and 
weighed before being snap frozen on dry ice. All samples were stored at -80°C until analysis 
took place. Serum analysis is described in Section 2.3. 
4.2.2 Cardiomyocyte area analysis: WGA and CellD 
Immersion-fixed hearts were processed and sectioned at 10 µm. Using a previously published 
method (Blackmore et al., 2014), three mid-cardiac sections from each heart were selected for 
staining; six hearts (from six independent litters) were analysed per experimental group. The 
experimental group was blinded to the analyser. Wheat germ agglutinin [TexasRed-X 
conjugate, (Molecular Probes, Life Technologies, USA)] was used to stain cardiomyocyte cell 
borders. Sections were de-waxed using xylene and re-hydrated by immersing in decreasing 
strengths of ethanol. Sections were washed with phosphate buffered saline (PBS) before 
incubating with 10 µg/ml of agglutinin (in PBS) while gently rocking in darkness for 2 hours 
at room temperature. Slides were washed with PBS and air-dried before the addition of 
Vectashield mounting medium with 4’-6-Diamidino-2-phenylindole (Vector Laboratories, 
UK). Five images moving down the left ventricle were randomly taken using a Leica SP8 
confocal microscope (Leica, Germany) with the 40x oil immersion objective. Images were 
exported with a scale bar from the confocal microscope in a TIFF format. Images were 
analysed in CellD software (Olympus, Japan). After setting the scale, the polygon tool was 
used to manually circumscribe around the cell borders for all cells that were within cross 
section, complete and visible within image. Analysis was carried out on at least three images 
per heart section, and three heart sections were analysed per animal.  
4.2.3 PCR: primer sequences 
The PCR protocol including how primers were designed is described in Section 2.6. The 
primer sequences used in this chapter are shown in Table 4.1. 
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Forward primer (5’-3’) Reverse primer (5’-3’) 
Gapdh AGAGTGTTTCCTCGTCCCGT GCTGGGGAAGTAACTGGAG 
Nppa ATCGGAGCCTACGAAGATCCA  TTCGGTACCGGAAGCTGTT  
Nppb AGTCCTTCGGTCTCAAGGCA AACTTCAGTGCGTTACAGCC  
Myh6 CTGTTCCTCTCTCCGTCCAG  ATTCTGTCACTCAAACTCTGGTTA 
Myh7 GCCAACTATGCTGGAGCTGA GCAGACACGGTCTGAAAGGA  
Ehd2 GGTGCAAAAGAGAGAGTGAGC AGAGCAAGATGATGAGGTCCA 
Cat TCACTCAGGTGCGGACATTC TAGTCAGGGTGGACGTCAGGT 
Sod2 GGAGCAAGGTCGCTTACAGA GCGGAATAAGGCCTGTTGTT 
Gpx3 TTCTGAAGAACTCCTGCCCT CCAGAGGATGTAATGGATCT 
Nrf2 AGGTTGCCCACATTCCCAAA AGGGCAAGCGACTCATGG 
 
4.2.4 PicroSirius red stain: Fibrosis analysis  
Paraffin embedded mid-cardiac sections cut at 10 μm were de-waxed using the protocol 
previously mentioned (Section 4.2.2). Slides were submerged in PicroSirius red stain (Pioneer 
Research Chemicals Ltd, UK) for one hour with agitation. Slides were then plunged very 
briefly in and out of water and then allowed to dry face down over a downdraught bench to 
prevent pooling of stain at thicker edges of sections. Slides were placed in xylene for two 
minutes, this step was repeated before mounting with Pertex® mounting medium. After 
drying with mountant overnight slides were imaged using AxioscanZ1 slide scanner (Zeiss, 
Germany). The experimental group was blinded to the analyser. A 12 by 12 grid was 
superimposed onto the image. 10 grids per mid-cardiac section were selected randomly for 
analysis in ImageJ. RGB stack function was performed and an appropriate threshold was set 
to comprehensively allow the software to detect the positive stain. This threshold was then 
used in all further analysis. Area fraction of positive stain was then quantified for each of the 
10 randomly chosen grids. This was taken to represent a measure of % fibrosis in the mid-
cardiac section.  
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4.2.5 Non-invasive blood pressure measurement 
Full detailed methodology can be found in Section 2.4. 
4.2.6 Echocardiography: Aortic width analysis  
Full methodology is described in Section 2.5. Ascending aortic diameter was measured from 
captured EKVTM files and the width from wall to wall at mid-systole and diastole was 










FIGURE 4.1: EKVTM image of the LV 
showing measurements of ascending aorta 
width. Ascending aorta (Asc Ao) width was 
measured within 1 mm of the aortic valve 
(labelled on figure) at both end-systole 
(pictured) and end-diastole (not shown). 
 
4.2.7 Western Blotting 
Methodology for western blotting is described in Section 2.8. Coomassie stained gel shows 
equal protein loading (Figure 4.2). All primary antibodies were used at a 1:1,000 dilution and 
were obtained from Cell Signaling Technology (MA, USA): Tropomyosin (#3990S rabbit 
monoclonal), Troponin I (#4002S rabbit polyclonal), phosphorylated (Ser23/24) Troponin I 
(phos-Troponin I) (#4004S rabbit polyclonal) and ATP2A2/SERCA2 (#4388S rabbit 
polyclonal).  
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FIGURE 4.2: Coomassie stain of loaded gel to ensure protein loading. Control n= 9, 
Obese n= 8 and Ob-Ex n= 8.  
 
4.2.8 Statistical analysis 
TD-NMR measurements were analysed by two-way ANOVA with Bonferroni post-hoc test. 
When three groups were compared, one-way ANOVA with Bonferroni post-hoc test was used. 
Cell area data were analysed using a hierarchical linear model with random effects for 
individual animal, and an interactive effect between individual and section of origin (R 
statistical software package version 2.14.1 (R Foundation for Statistical Computing, Vienna, 
Austria). The model included maternal diet and maternal exercise as fixed effects. This 
structure accounted for the fact that multiple cell area measurements were obtained from 
multiple sections of the heart of each individual animal within the groups, and these data 
cannot be treated as fully independent. All data is presented as mean ± SEM. 
 
4.3 Results  
4.3.1 Body composition and organ weights 
Bodyweight and body composition were assessed longitudinally (weekly). TD-NMR (to 
measure body composition) was carried out weekly from four weeks of age up until eight 
weeks of age. Due to missing data a correction for repeated measures could not be carried out 
therefore a two-way ANOVA followed by Bonferroni post-hoc when necessary was used to 
assess statistical significance. Age had a significant effect on bodyweight, fat mass and lean 
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mass (Figure 4.3A-C). Maternal lifestyle (accounting for maternal diet and if the dam was 
exercised) only had a significant impact on fat mass. The offspring of obese dams had more 
fat mass compared to control, with the biggest differences observed at seven and eight weeks 
of age (Figure 4.3B).  
 
 
FIGURE 4.3: Longitudinal assessment of body composition. Body composition measured 
by TD-NMR from four weeks of age to eight weeks of age. TD-NMR measurements were 
carried out at the same time of the day each week (Morning) to account for different feeding 
behaviours in light/dark cycle. A) Bodyweight, B) Fat mass and C) Lean mass. Control n= 9, 
Obese n= 10 and Ob-Ex n= 6. Two-way ANOVA; A*** effect of age, p< 0.001 and M** 
effect of maternal lifestyle, p< 0.01.  
 
When body composition was assessed at eight weeks of age there was no difference in 
bodyweight, fat mass and lean mass between groups (Table 4.2). Male offspring were fasted 
for 16 hours (overnight) prior to post mortem at eight weeks of age. There were no differences 
in the fasted bodyweight or in the bodyweight lost during the fast (Table 4.2). Despite the 
effect of maternal lifestyle in TDNMR fat mass there were no difference in the weights of the 
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fat depot (epididymal and retroperitoneal) (Table 4.2). There were no differences in other 
measured organ weights (Table 4.2). 
TABLE 4.2: Body composition and organ weights in eight week old male offspring. TD-
NMR measured body composition in the fed state. Data is presented mean ± SEM. Males 
were fasted for 16 hour before post mortem where organs were dissected and the wet tissue 
weight was recorded. P values calculated from one-way ANOVA. 
 
 
Body composition + 
organ weights (g) 
Control n Obese n Ob-Ex n p value 
Fed bodyweight 25.5 ± 0.3 6 25.6 ± 0.3 6 25.6 ± 0.5 5 0.98 
Fat mass 2.3 ± 0.1 6 3.1 ± 0.3 6 2.6 ± 0.3 5 0.06 
Lean mass 18.5 ± 0.3 6 18.1 ± 0.3 6 18.1 ± 0.3 5 0.56 
Fasted bodyweight 22.8 ± 0.4 6 22.9 ± 0.4 8 22.7 ± 0.5 6 0.934 
Bodyweight lost with 
fast 
1.92 ± 0.19 6 2.24 ± 0.14 8 2.07 ± 0.12 6 0.696 
Epididymal fat  0.24 ± 0.02 8 0.30 ± 0.03 9 0.28 ± 0.02 5 0.192 
Retroperitoneal fat 0.05 ± 0.005 8 0.05 ± 0.003 9 0.06 ± 0.007 5 0.813 
Liver 0.97 ± 0.04 8 0.98 ± 0.04 9 0.97 ± 0.03 5 0.954 
Kidney; Left 0.17 ± 0.004 8 0.17 ± 0.004 9 0.17 ± 0.007 5 0.962 
Kidney; Right 0.14 ± 0.005 8 0.15 ± 0.004 9 0.15 ± 0.006 5 0.229 
Pancreas 0.12 ± 0.01 8 0.13 ± 0.006 9 0.13 ± 0.009 5 0.701 
Spleen 0.06 ± 0.002 8 0.06 ± 0.003 9 0.07 ±0.007 5 0.212 
Brain 0.45 ± 0.004 8 0.45 ± 0.005 9 0.44 ± 0.002 5 0.729 
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4.3.2 Serological analysis  
FIGURE 4.4: Serological analysis in 16 hour fasted serum. Methods for serum analysis is 
described in Section 2.3. Control n= 9, Obese n= 6 and Ob-Ex n= 9. Except for cholesterol (2 
outliers were detected by Grubbs test) Control n= 8, Obese n= 5, Ob-Ex n= 9 and Leptin (1 
outlier detected) Control n= 9, Obese n= 5 and Ob-Ex n= 9. Insulin ELISA was performed by 
Dr Denise Fernandez-Twinn and previously published (Fernandez-Twinn et al., 2017). One-
way ANOVA with Bonferroni post-hoc test; * p< 0.05. 
 
 
There were no significant differences in fasting plasma glucose when measured from tail 
blood before the post mortem (Figure 4.4A). Total cholesterol was decreased (p< 0.05) 
between the offspring of control and obese-exercised dams (Figure 4.4B). Serum triglycerides 
and free fatty acids were not different between the offspring groups (Figure 4.4C+D). Serum 
insulin was increased in offspring of obese dams (compared to control) and this increase was 
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prevented with a maternal exercise intervention (Figure 4.4E). Serum leptin was unchanged 
between groups (Figure 4.4F).  
4.3.3 Cardiac phenotype 
Pathological cardiac hypertrophy  
Offspring of obese dams had increased heart weight when expressed as an absolute weight 
(Figure 4.5A) and when expressed relative to bodyweight (Figure 4.5B) (as bodyweight was 
not different between the groups - see Table 4.2). This increase was prevented by the maternal 
exercise intervention. 
FIGURE 4.5: Heart weights at post mortem. Heart weight was measured by weighing wet 
tissue weight at post mortem post 16 hour fast. A) Heart weight B) Heart weight expressed 
relative to bodyweight. Hearts collected by Dr Sarah Carr. Control n= 11, Obese n= 9 and Ob-
Ex n= 10. One-way ANOVA with Bonferroni post-hoc test; * p< 0.05, ** p< 0.01 and *** p< 
0.001. 
 
Cardiac hypertrophy was further assessed by measurement of cardiomyocyte cell area in the 
mid-cardiac sections of the hearts (representative images in Figure 4.6A). A mean average 
was calculated by averaging all cell areas measured for each individual animal, then the six 
animals analysed were averaged to give an overall mean cardiomyocyte cell area of that group. 
Mean cardiomyocyte cell area was increased in offspring of obese dams (Figure 4.6B). 
Frequency distribution of cardiomyocyte cell areas showed a rightward shift, indicative of a 
higher proportion of larger cells in the offspring of obese dams, thereby confirming 
hypertrophy (Figure 4.6C). These parameters were normalized in offspring of obese-exercised 
dams. Hierarchical linear model analysis showed that the p value for the effect of maternal 
diet to increase cell size was p< 0.001, and for exercise to prevent this increase was p< 0.001. 
This specialised statistical analysis was kindly performed by Dr Catherine Aiken. 
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FIGURE 4.6: Pathological cardiac hypertrophy markers in male offspring at 8 weeks of 
age. Representative images of wheat germ agglutinin stained mid-cardiac sections (analysed 
manually by CellD). B) Mean cardiomyocyte cell area. C) Frequency distribution of 
cardiomyocyte cell area. n= 6 hearts per group with ~7000 cells analysed per group. Hearts 
for WGA analysis were collected by Dr Heather Blackmore. D) Ventricular fetal gene 
expression. Gapdh was the housekeeper and was unchanged between groups. Control n= 9, 
Obese n= 7 and Ob-Ex n= 9. One-way ANOVA with Bonferroni post-hoc test; * p< 0.05, ** 
p< 0.01 and *** p< 0.001. Nppa- atrial natriuretic peptide, Nppb- brain natriuretic peptide, 
Myh7- β-MHC and Myh6- α-MHC.  
 
Atrial natriuretic peptide (Nppa) expression was increased approximately three-fold in the 
hypertrophic hearts of the offspring of obese dams; this expression was normalized in the 
offspring of the intervention group (Figure 4.6D). Furthermore the Myh7: Myh6 ratio was 
increased in the hearts of offspring exposed to maternal obesity, which was driven by 
increased Myh7 rather than a change in Myh6 (Figure 4.6D). This was also normalized in the 
intervention group (Figure 4.6D). 
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Cardiac fibrosis 
 
FIGURE 4.7: Assessment of cardiac fibrosis and oxidative stress. A) Representative 
PicroSirius red stained heart sections. B) Images converted into RGB stack in ImageJ for 
analysis. C) % area of fibrosis (% area of red stain) was assessed in three groups. Hearts 
sections for staining provided by Dr Heather Blackmore and Dr Sarah Carr. Control n= 7, 
Obese n= 8 and Ob-Ex n= 5. One-way ANOVA with Bonferroni post-hoc test; * p< 0.05 and 
** p< 0.01. D) Expression of antioxidant defence genes: Cat- Catalase, Sod2- Superoxide 
dismutase 2, Gpx3- Glutathione peroxidase and Nrf2- Nuclear factor erythroid 2–related 
factor 2. Normalised to housekeeper Ehd2- EH Domain Containing 2. Control n= 8, Obese n= 
8 and Ob-Ex n= 6. 
 
Mid-cardiac heart sections were assessed for fibrosis using a PicroSirius red stain. 
Representative images from all three groups can be seen in Figure 4.7A. Total fibrosis (% 
area stained) was increased in the offspring of obese dams compared to both offspring of 
control and obese-exercised dams (Figure 4.7C). This was a modest increase of less than two-
fold and was not accompanied by any changes in the mRNA expression of key oxidative 
stress response genes such as Catalase (Cat) or Superoxide dismutase 2 (Sod2) (Figure 4.7D).  
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Offspring blood pressure 
BP was assessed in the offspring through non-invasive tail cuff plethysmography. Exposure to 
maternal obesity causes elevated SBP in the male offspring at eight weeks of age (Figure 
4.8A). This occurred without any change in pulse rate (Figure 4.8B). Maternal exercise 
intervention in an obese pregnancy did not prevent the increase in SBP. The width of 
ascending aorta was measured during in vivo echocardiographic analysis using EKVTM 
images. The diameter at systole was increased in offspring of obese dams (Figure 4.8C). The 
diameter at diastole was unaltered (data not shown), but the calculated difference in width 
between systole and diastole was increased in offspring from obese dams (Figure 4.8D). 
FIGURE 4.8: Offspring BP and aortic diameter. A) BP measurements were carried out at 
the start of dark (active cycle) at the same time (16:00) across three consecutive days. 
Measurements were taken from the 3rd day when variation between measurements was lowest. 
This is fully described in Section 2.4. B) Pulse rate (bpm). Control n= 16, Obese n= 14 and 
Ob-Ex n= 10. C) Asc Ao diameter measured 1 mm from aortic valve in EKVTM images at 
end-systole. Control n= 13, Obese n= 10 and Ob-Ex n= 6. D) Difference in Asc Ao diameter 
between end-systole and end-diastole. Control n= 10, Obese n= 9 and Ob-Ex n= 4. One-way 
ANOVA with Bonferroni post-hoc test; ** p< 0.01 and *** p< 0.001. 
 
Offspring of obese-exercised dams had increased SBP but no significant difference is seen in 
the aortic width diameters when compared to either the offspring from control or obese dams. 
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The measured values were in between the values for the two other groups. The lack of 
significance may reflect the fact that this group is relatively underpowered compared to other 
groups.  
In vivo cardiac function 
Left ventricular end-systolic volume (ESV) was elevated in male offspring of obese dams 
(Figure 4.9A) but there were no differences in the volume at diastole (Table 3). There was no 
significant effect on stroke volume (Figure 4.9B), however there was an accompanying 
reduction in ejection fraction (Figure 4.9C). This contributed to a significant overall effect of 
maternal obesity on reducing cardiac output in the offspring (Figure 4.9D) despite no 
differences in heart rate (Table 4.3). Furthermore, diameter of the ventricular lumen was 
increased at the end of systole in offspring of obese dams suggesting impaired cardiac 
contractility (Figure 4.9E). This was confirmed by a reduction in ventricular fractional 
shortening in the offspring of obese dams (Figure 4.9F).  
Offspring of the obese-exercised group did not have increased left ventricular ESV and end-
systolic diameter, and the functional parameters were restored to values matching offspring of 
control dams (Figure 4.9A-F). Structurally, the diameter of the IVS and LVPW at systole in 
the intervention group was increased compared to the offspring of non-exercised obese dams. 
This resulted in an increased systolic wall: lumen width ratio in the offspring of the obese-
exercised dams (Table 4.3).  
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FIGURE 4.9: Functional parameters assessed by in vivo echocardiography. A)-F) 
Systolic function and contractility measured by echocardiography. Parameters analysed by 
LV trace tool in M-mode. Control n= 16 and Obese n= 16 and Ob-Ex n= 7. One-way 
ANOVA where M*- overall effect of maternal lifestyle p< 0.05. Post-hoc Bonferroni testing; 
* p< 0.05 ** p< 0.01, *** p< 0.001. Echocardiography analysis was performed in 
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TABLE 4.3: In vivo echocardiographic parameters. Data is presented mean ± SEM. 
Control n= 16, Obese n= 16 and Ob-Ex n= 7. P values calculated by one-way ANOVA. 
Letters represent differences between specified groups by Bonferroni post-hoc test (p< 0.05); 
a Control vs. Obese and c Obese vs. Ob-Ex.  
† LV= Left ventricle, IVS= Interventricular septum, LVID= LV internal diameter and 
LVPW= LV posterior wall. 
The expression of contractile machinery proteins involved in Ca2+ handling pathways were 
assessed by western blot. Although maternal obesity did not have any effect on the levels of 
any of the key cardiac contractile machinery proteins (compared to the Control group), levels 
of Troponin I and Tropomyosin were increased over two-fold in the ventricular tissue from 
the offspring of obese-exercised dams compared to offspring of control and obese groups 
(Figure 4.10A+D). Levels of activated phos-Troponin I (Ser23/24) were also increased, which 
 Control Obese Ob-Ex p value 
End diastolic volume (mm3) 58.9 ± 3.9 68.4 ± 3.0 59.2 ± 3.0 0.097 
End diastolic diameter (mm) 3.70 ± 0.10 3.95 ± 0.08 3.72 ± 0.08 0.092 
Heart Rate (bpm) 443 ± 12 421 ± 11 446 ± 17 0.291 
IVS; diastole (mm) 0.924 ± 0.04 0.869 ± 0.05 0.957 ± 0.05 0.440 
LVID; diastole (mm) 3.65 ± 0.10 3.92 ± 0.07 3.71 ± 0.07 0.061 
LVPW; diastole (mm) 0.85 ± 0.04 0.82 ± 0.03 0.89 ± 0.07 0.620 
Wall:Lumen ratio; diastole 0.24 ± 0.01 0.21 ± 0.01 0.24 ± 0.02 0.279 
IVS; systole (mm) 1.37 ± 0.05 1.25 ± 0.05 1.51 ± 0.09
c 0.019 
LVID; systole (mm) 2.32 ± 0.12 2.82 ± 0.10
ac 2.24 ± 0.14 0.003 
LVPW; systole (mm) 1.34 ± 0.05 1.18 ± 0.05 1.42 ± 0.11
c 0.030 
Wall:Lumen ratio; systole 0.57 ± 0.04 0.43 ± 0.03 0.65 ± 0.08
c 0.007 
LV mass (mg) 90.2 ± 3.6 98.0 ± 3.9 97.6 ± 10.0 0.453 
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reflected an increase in the phos:total Troponin I ratio compared to the other two groups 
(Figure 4.10B+C). Furthermore, SERCA2, a protein involved in the recycling of Ca2+, was 
also increased in the adult male offspring of obese-exercised dams. (Figure 4.10E). 
FIGURE 4.10: Expression of key contractile machinery proteins. Expression level 
assessed by western blotting. Control n= 9, Obese n= 8 and Ob-Ex n= 8. One-way ANOVA 
with Bonferroni post-hoc test; * p< 0.05, ** p< 0.01 and *** p< 0.001.  
 
4.4 Discussion 
The aim of this chapter was to assess the cardiovascular outcomes of maternal obesity and 
then to assess the potential protective effects of the maternal exercise intervention. 
Pathological cardiac hypertrophy and ex vivo cardiac dysfunction has previously been 
demonstrated in male offspring from our model (Blackmore et al., 2014) and this 
cardiovascular phenotype has been further investigated in this chapter. In vivo cardiac 
dysfunction and pathological cardiac hypertrophy accompanied increased SBP in offspring of 
obese dams when compared to offspring of lean dams (Control diet-fed dams). The impact of 
maternal exercise on the poor cardiovascular health of the offspring of obese dams was also 
assessed and showed protective effects by the reversal of cardiac hypertrophy and dysfunction 
while failing to address offspring elevated SBP. This shows there has been a successful 
implementation of an intervention in the mother that has long-term impact on offspring 
cardiovascular outcomes. This information could be used to support the need for long-term 
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follow up in the offspring of already established human intervention studies. Just a small 
improvement in offspring risk could have important implications for the future burden of 
CVD worldwide. 
4.4.1 Offspring body composition and serum analysis 
It was a particular strength to be able to assess body composition longitudinally until eight 
weeks old. The significant effects of age on bodyweight and body composition track the male 
mouse as it matures from a juvenile to an adult. There was an effect of maternal exercise on 
offspring fat mass, with multiple comparison testing showing differences between offspring 
of control and obese dams at seven and eight weeks of age. This occurred with no 
accompanying changes in bodyweight or lean mass, despite the animals being fed the same 
control chow diet (RM1). When the TDNMR fat mass at eight weeks of age was considered 
separately, there were no statistical differences similarly there were no measurable differences 
in the weighed fat depots. This difference in fat mass was not great enough to cause any 
changes in serum leptin. 
An increase in serum insulin was observed in offspring of obese dams at eight weeks of age, 
this has been shown in previous cohorts (Fernandez-Twinn et al., 2012). This occurred 
without a difference in body composition between the offspring at eight weeks of age. Body 
fat percentage in adult males from Indonesia has been shown to be a good predictor of insulin 
resistance (Boy Kurniawan et al., 2018).  We have shown previously that there was an 
exercise-induced improvement in insulin sensitivity in the obese dams during pregnancy, this 
improvement is mirrored in the eight week old male offspring  (Fernandez-Twinn et al., 2017). 
Exercise improves insulin sensitivity (Gollisch et al., 2009), and despite the offspring not 
exercising themselves (intervention was in the mother only) they have a normalisation in their 
serum insulin. Normalisation of serum insulin by maternal exercise has also been shown in 
other studies both in offspring from obese (Bae-Gartz et al., 2015) and lean mouse dams 
(Carter et al., 2013). Through correlations an association has previously been shown between 
maternal and offspring serum insulin (Fernandez-Twinn et al., 2017). The data in this thesis 
showing that a maternal exercise intervention that prevents maternal hyperinsulinemia also 
prevents offspring hyperinsulinemia supports the hypothesis that this is a causal relationship. 
The mechanisms by which maternal hyperinsulinemia causes offspring insulin resistance and 
potentially cardiac dysfunction are outside of the thesis aims and are not currently known.  
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4.4.2 Maternal exercise prevented pathological cardiac hypertrophy 
Offspring of obese dams had pathological cardiac hypertrophy at eight weeks of age, in fact 
this has previously been shown to occur from as early as three weeks of age (Blackmore et al., 
2014). This increase in heart weight appears to be the result of cardiac remodelling, as 
indicated by previous cardiac stereology data that showed increases in LV volume at the same 
age (Blackmore et al., 2014). Cardiomyocyte cell area was assessed in the LV, and this 
demonstrated cell specific hypertrophy that could account for the increased heart weight and 
LV volume. A hierarchal linear model was also applied for a stringent assessment of changes 
in the frequency distribution of cardiomyocyte area. This is a powerful statistical analysis that 
takes into account the fact that cell measurements were obtained from multiple sections of the 
heart of each individual animal within the groups, and therefore cannot be treated as fully 
independent. Consequently, it can be concluded not only, that the mean cardiomyocyte area is 
increased in the offspring from obese dams, but that there was a significant rightward shift in 
the frequency distribution indicating a higher proportion of larger cells. 
In the heart during haemodynamic overload, there is re-expression of the fetal genes Nppa 
and Myh7, both of which are highly conserved markers of ventricular pathological 
hypertrophy (Pandya and Smithies, 2011; Chien et al., 2016). This re-expression can lead to 
decompensation and heart failure (Distefano and Sciacca, 2012). Myh6 (α-MHC, adult 
isoform) and Myh7 (β-MHC, fetal isoform) are two functionally distinct cardiac isoforms. In 
postnatal life, α-MHC completely replaces β-MHC in the ventricles, becoming the dominant 
isoform (>90%) in the adolescent mouse (Lyons et al., 1990). Myh7 has a lower sliding 
velocity, therefore an increased ratio of Myh7: Myh6 will negatively impact cardiac function 
(Holubarsch et al., 1985). This can be explained as the period of time available for ejection is 
finite, therefore any decrease in sliding velocity reduces the rate of volume ejection, leaving 
more blood behind at the end of systole (increased ESV) and decreasing stroke volume. 
Genetic alteration of MHC isoforms indicated that even a small shift in expression of β-MHC 
(12%) resulted in physiologically significant changes in cardiac contractility (Tardiff et al., 
2000). Maternal obesity caused the up-regulation of Nppa and Myh7 in cardiac tissue of adult 
male offspring, concurrent with other markers of pathological cardiac hypertrophy.  
It is striking that the maternal exercise intervention was able to reverse all measured 
parameters of pathological cardiac hypertrophy in the offspring of obese dams; including 
heart weight, cardiomyocyte cell area and the re-expression of fetal genes.  Reversal of LV 
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hypertrophy will have important implications for that individual’s future cardiovascular health, 
as reversal has been associated with a reduction in arrhythmias, improved diastolic function, 
preserved systolic function and increased coronary reserve (Dahlof, 1992). Many studies have 
shown that it is possible to reverse hypertrophy through the use of anti-hypertensive therapies, 
and that this improves cardiac performance, lowers CVD morbidity and mortality risk 
independent of the reduction in BP. Therefore, the prevention of cardiac hypertrophy in the 
offspring of obese dams with the maternal exercise intervention is a very important outcome 
that has improved their cardiovascular health.  
Cardiac hypertrophy was accompanied by increased interstitial fibrosis in the mid-cardiac 
section of the heart and is an indication of cardiac remodelling, in particular in the form of 
alterations in the extracellular matrix. The measured increase in fibrosis was mild and was not 
accompanied with changes in mRNA expression of genes critical for the oxidative stress 
response. There is a need, in the future, to measure these antioxidant defence genes at the 
protein level to fully assess if there are any changes in the oxidative stress response.  However, 
fibrosis can disrupt myocardial architecture, cause cardiac dysfunction and promote the 
progression of heart disease (Segura, Frazier and Buja, 2014). There was no difference in 
fibrosis between the hearts from offspring of control dams and offspring of obese-exercised 
dams, this is a positive finding as therapies that reduce the severity of fibrosis were effective 
at improving outcomes in heart disease (Schelbert et al., 2014). 
One focus of this thesis was to address the cause of the observed cardiac hypertrophy. One 
potential mechanism that we addressed was the possibility that the offspring were 
hypertensive, as this has been seen in a similar rodent model of maternal overnutrition at an 
older age (Samuelsson et al., 2010). We measured BP non-invasively in the offspring and 
there was an increase after exposure to maternal obesity, however this was maintained with 
maternal exercise whereas hypertrophy was not. This mismatch in these offspring outcomes 
in the intervention group indicates that offspring hypertension cannot be the only driver in the 
development of cardiac hypertrophy. A study in hypertensive children showed that the 
relationship between LV hypertrophy and BP explains only 25–30% of the variation in LV 
mass (Sorof et al., 2002), therefore suggesting another mechanism is at play. One of these 
could be the growth effect of insulin which is described in the next section. 
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4.4.3 Possible mechanisms for the reversal of cardiac hypertrophy by maternal exercise 
Previous work in our laboratory has shown that offspring hyperinsulinemia is associated with 
the programming of cardiac hypertrophy in offspring of obese dams (Fernandez-Twinn et al., 
2012). Data from this thesis supports this conclusion, as offspring of obese-exercised dams 
did not have cardiac hypertrophy and serum analysis showed no hyperinsulinemia, unlike 
offspring of obese dams who have both parameters. This previous study showed an 
association with increased serum insulin and an increase in PI3K and MAPK signalling 
pathways in the offspring heart tissue. PI3K signalling has commonly been associated with 
physiological cardiac hypertrophy (Ma et al., 2013), however constitutive activation seen in a 
transgenic mouse with AKT overexpression (a protein critical in PI3K pathway) can be 
damaging and led to cardiac hypertrophy accompanied by interstitial fibrosis and cardiac 
dysfunction (Shiojima et al., 2005).  
Chronic hyperinsulinemia experimentally induced in rats for seven weeks increased LV mass 
and wall thickness while also reducing stroke volume and cardiac output (Samuelsson et al., 
2006). Similarly, the reduction of plasma insulin ameliorates systolic dysfunction induced by 
a TAC model of pressure overload, with insulin treatment having the opposite effect of 
enhancing cardiac hypertrophy and decreasing systolic function (Shimizu, Ippei, Komuro, 
2010). In hypertensive patients the increased LV mass is associated with increased fasting 
plasma insulin levels and decreased whole body glucose disposal (Paolisso et al., 1995).  
Oxidative stress could also be a cause of the observed cardiac hypertrophy and accompanying 
interstitial fibrosis, with other models of developmental programming implicating oxidative 
stress as critical in the development of CVD (Wang et al., 2010; Giussani et al., 2012). 
Offspring of obese mothers who showed increased PI3K and MAPK signalling (as previously 
described), also had enhanced lipid peroxidation and impaired antioxidant capacity 
(Fernandez-Twinn et al., 2012). In this thesis the mRNA expression of key players in 
antioxidant defence was assessed but did not show any differences, however changes in 
expression of these genes can often occur at the post-transcriptional level and protein 
expression of these loci has not been explored. Elevated gene expression of oxidative stress 
markers is known to occur in E19 hearts (see Appendix AP3) although this does not result in 
changes in lipid peroxidation (see Section 6.3.6).  
Since offspring from obese-exercised dams were hypertensive without hypertrophy, the 
mechanism of pressure overload triggering cardiac hypertrophy has been placed in doubt. The 
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cardiac hypertrophy cannot be a consequence of hypertension but must instead be 
programmed through a discordant mechanism that is modifiable through the maternal exercise 
intervention. The fact that hypertension was not corrected in the offspring exposed to 
maternal exercise intervention leads us to assess maternal factors not corrected by the 
intervention as a potential mechanism.  
4.4.4 Possible programming factors for offspring hypertension  
Increased fetal exposure to glucocorticoids is thought to be one mechanism that is responsible 
for programming hypertension (Wintour et al., 2003; Dagan et al., 2007), however little 
information is available on other potential mediators; such as maternal-to-fetal hormones and 
growth factors. One factor which has gained more interest recently is maternal leptin, which 
we (Fernandez-Twinn et al., 2017), and others (Vega et al., 2016), have shown is not 
corrected by a maternal exercise intervention. 
Leptin has a neurotrophic role in the development of critical neuronal projections in key 
hypothalamic nuclei such as the arcuate nucleus of the hypothalamus (ARC) (Bouret, Draper 
and Simerly, 2004). Rodents have a characteristic neonatal leptin surge during the first two 
weeks of postnatal life which is also a critical developmental window for neurocircuits in the 
ARC to be established (Ahima, Prabakaran and Flier, 1998).  An elevated leptin surge has 
been shown in neonates exposed to gestational hypoxia (12% E15-E19) resulting in 
hyperphagia, this could be caused by increased basal ARC activation and altered ARC 
projections to the paraventricular nucleus, however the authors of this study do not assess 
effects on BP (Vargas et al., 2017). It has been shown that inducing experimental 
hyperleptinemia in neonatal rat pups from postnatal day 9 to 15 causes increased BP in 
adulthood (Samuelsson et al., 2016) and programs long-term renal structural and functional 
damage, through renal sympathetic nerve activation (Oosterhuis et al., 2017). It has also been 
suggested that an exaggerated neonatal leptin surge stimulates hypothalamic melanocortin 
signalling leading to altered sympathetic tone (Samuelsson et al., 2010). The lack of 
effectiveness of the exercise intervention to prevent offspring hypertension therefore may be 
related to the maintained hyperleptinemia in the obese-exercised dams. 
The critical window of prenatal exposure for the programming of adult hypertension has been 
identified in the rat. Maternal calorie restriction programmes hypertension in male and female 
offspring when imposed throughout the whole of gestation, or only during the second half of 
gestation, but has no effect on offspring adult BP when imposed during only the first half of 
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pregnancy (Vehaskari, Aviles and Manning, 2001). Since our exercise protocol continues to 
E17 and their ability to run declines during gestation; the greatest impact of our intervention 
may be in the early part of pregnancy and this may explain why we have not been able to 
prevent the programming of hypertension in our offspring. This highlights the importance of 
using an intervention at different critical time windows to dissect out the different 
mechanisms that ultimately control the complex changes to environmental cues that the 
offspring experiences during development. 
What is striking is that the critical window of susceptibility to altering BP coincides with 
kidney development in the late stages of pregnancy, and it is therefore likely that altered renal 
morphology could be responsible. Decreased glomerular density results in changes in tubule 
formation and this will impact on the development of ion transporters. Models of maternal 
diabetes and maternal low protein diet have shown offspring have increased tubular ion 
channel expression and ion transport, these offspring also have increased BP suggesting the 
subsequent reduced salt excretion could be the cause of the increased BP (Manning et al., 
2002; Nehiri et al., 2008). Decreased nephron number was also demonstrated in offspring 
exposed to antenatal protein restriction and this resulted in reduced glomerular filtration rate 
(Vehaskari and Woods, 2005). Equally, it could be that morphological changes in the kidney 
could be a consequence and not a cause of the accompanying hypertension. In the same model 
used in this thesis, eight week old offspring have glomerular hypertrophy (Pinnock 2018, 
personal communication), this is indicative of increased glomerular pressure possibly caused 
by the increased BP (D’Agati et al., 2016).  
In humans, persistent hypertension can cause significant enlargement of the aortic root width, 
compared to age and sex-matched populations of similar body size (Kim et al., 1996). The 
ascending aorta widens upon contraction, as it stretches to accommodate the blood ejected out 
from the LV. We observed a greater increase in aortic width following ventricular contraction, 
consistent with our functional data that shows adult offspring of obese dams experiencing 
increased haemodynamic stress and resulting in cardiac dysfunction caused by an increased 
SBP. The difference in width at systole and at diastole is also greater, consistent with 
increased stretch, as a greater force is needed to eject blood out of the LV against the 
increased BP. 
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Limitations with tail cuff plethysmography method 
Tail cuff was chosen over telemetry for technical and scientific reasons. Firstly, telemetry is 
recommended in mice heavier than 25 g (Kurtz et al., 2005; Huetteman and Bogie, 2009), and 
our experimental animals had not reached this weight by the time of BP measurement. 
Telemetry probe implantation requires specific technical expertise and the weight of the probe 
can often compromise animal welfare. Insertion of the probe involves permanent ligation of 
an artery which can cause circulation perturbations, and also requires the animal to be singly 
housed which is considered a stressful experience in rodents due to the social isolation 
(Bartolomucci et al., 2003; Polycarpou et al., 2016). Secondly, as echocardiography and BP 
were performed on the same mouse, we wanted to avoid the animal having to be 
anaesthetized on more than one occasion.  
Many publications have assessed the differences between the tail cuff and telemetry methods, 
including the effect of stress. The physiology of the stress response encompasses the whole 
body and therefore is an important consideration in data interpretation and experimental 
design. One study showed a slight underestimation of tail cuff BP measurements during 
restraint compared to telemetry. However, when compared to non-disturbed telemetry mice 
the readings were very comparable. A study using the same maternal diet-induced obesity 
model has previously shown hypertension in older offspring (12 weeks of age) using a 
telemetry method (Samuelsson et al., 2008); with tail cuff we were able to recapitulate this 
outcome in a younger males. We have adapted our interpretation of the data with a sensitivity 
and awareness of the limitations of the technique. Tail cuff measurements are not well suited 
for measuring diastolic measurements (Reddy et al., 2003), therefore we have not included 
this data for analysis. We also endeavoured to minimise stress to the animal by conditioning 
the animal to restraint over three days, keeping the experimenter the same and performing it at 
start of their active cycle so as not to abruptly awaken them from sleep.  
4.4.5 Mechanisms underlying the improved offspring cardiac function by maternal 
exercise intervention 
In the previous section we have shown that the hearts of offspring of obese dams are under 
increased afterload (force against the heart contracts) caused by the increased SBP. They will 
have to overcome a greater pressure to successfully eject blood out of the ventricle. If preload 
and inotropy remain constant, this change will result in impaired cardiac function. Increased 
afterload can result in an increase in ESV with a subsequent reduction in stroke volume. The 
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force-velocity relationship states that increased afterload will reduce the velocity of muscle 
fibre shortening; thereby reducing the velocity the ventricle can eject the blood. Less blood is 
able to be ejected from the heart and with more left behind, the ESV increases (Tarazi and 
Levy, 1982). The afterload in the offspring of obese dams was great enough to adversely 
impact on LV systolic function and myocardial contractility, as ESV was increased, and 
fractional shortening and ejection fraction were reduced. This suggests that adult offspring of 
obese mothers cannot maintain cardiac output under this haemodynamic stress, a pre-eminent 
feature of heart failure (Weber, Janicki and Maskin, 1985).  
As demonstrated, offspring of obese dams were hypertensive irrespective of the exercise 
intervention, therefore the increased afterload should also be present in the offspring of obese-
exercised dams, and yet their functional parameters were normalised. Restored ejection 
fraction, cardiac output and fractional shortening were seen with maternal exercise 
intervention. It is possible that there has been a compensatory increase in contractility to this 
haemodynamic stress. Increased wall contractility is indicated through the increased ratio of 
wall: lumen widths at systole compared to offspring of lean dams. This is a compensatory 
response that the offspring of obese dams perhaps could not mount or maintain, and this 
suggests a lower adaptive ability to high workload conditions. After a high workload 
challenge it was shown that there was a failure to maintain adequate cardiac workload in the 
ex vivo fetal sheep hearts of offspring exposed to maternal overnutrition (Wang et al., 2010). 
The pathological cardiac hypertrophy present in these animals could be the cause of their lack 
of ability to respond. Alternatively, hypertrophy could be a consequence and represent the 
failed adaptive response to lower wall tension and enhance contractility. This uncertainty for 
the ability of the heart to adapt to changing workloads is a concern in a young animal; as this 
diminished cardiac reserve could mean these animals could go on to develop more significant 
cardiac dysfunction with age.  
Modulation of Ca2+ pathways is critical for the heart to adapt to changing workloads (Chung 
et al., 2016). Key proteins in these pathways were elevated in ventricular tissue from 
offspring of obese-exercised mothers compared to offspring of both control and non-exercised 
obese mothers, this supports a role for increased inotropy as a potential driver of their 
improved cardiac function. Sympathetic activation occurs through the β1-adrenergic receptor 
which activates Protein Kinase A and the phosphorylation of Troponin I, which decreases the 
Ca2+ sensitivity of Troponin C causing an increased off-rate of Ca2+, allowing accelerated 
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cardiac relaxation (Bodor et al., 1997). An up-regulation of proteins in this pathway is 
indicative of an enhanced sympathetic response. Furthermore, elevated SERCA2 expression 
would allow Ca2+ to be recycled back to the sarcoplasmic reticulum facilitating efficient 
future cardiac contractions. Total Troponin I and Tropomyosin in the myocardium were also 
increased and could further explain the improved cardiac function.  
Although we have shown that cardiac dysfunction is normalized in offspring of obese-
exercised dams, it is not yet clear if these changes are beneficial to cardiac health long-term 
and whether the necessary adaptation to combat increased afterload can be 
maintained. Therefore, future studies should address this and consider an ageing component, 
it will be equally important to determine if there is further deterioration in the offspring of 
obese dams without intervention.  
4.4.6 Discordant programming pathways  
These findings highlight discordance between the mechanisms through which maternal 
obesity during pregnancy mediates the programming effects on offspring cardiac dysfunction, 
compared to those leading to hypertension. Our data suggest that cardiac hypertrophy 
measured in offspring of obese dams is not a consequence of hypertension but is heavily 
associated with the observed cardiac dysfunction. These outcomes could be programmed by 
maternal insulin, as we have successfully targeted maternal hyperinsulinemia in the exercise 
intervention. The fact that hypertension was not corrected in the offspring exposed to 
maternal exercise intervention leads us to consider maternal factors not corrected by the 
intervention, with maternal leptin discussed as a potential mechanism. 
4.4.7 Conclusions 
An intervention that is able to make a significant impact while only being implemented during 
pregnancy is important from a translational perspective. Pregnancy marks a useful point of 
contact, where women have regular medical appointments, allowing information and support 
to be provided. Our model is an excellent candidate for studying what impact a pregnancy 
treadmill exercise program may have on the future risk of cardiac disease development in the 
offspring. Whilst not all exercise and lifestyle intervention strategies during pregnancy have 
proved to have immediate measured benefit to the mother’s lifestyle behaviour or clinical 
outcomes (see Section 1.10), our study demonstrates that it is still critical that follow up is 
undertaken to assess if exercise could reduce the long-term risks of CVD in the offspring. 
Even a small improvement in offspring risk could have important benefits for the future 
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burden of CVD worldwide (Norman and Reynolds, 2016). It is well documented that exercise 
intervention in an individual is sufficient to reduce their own risk of CVD (Adamu, Sani and 
Abdu, 2006). However, data from our study highlights that risk of CVD can be influenced as 
early as the developing fetus and therefore interventions to prevent CVD should start very 
early in life, and not only when the disease manifests later in life. The potential benefits of 
exercise intervention strategies during an obese pregnancy are not limited to effects on 
maternal health, but also improving the cardiovascular and metabolic health of the next 
generation.  
4.4.8 Summary of key findings 
Results of this chapter have shown: 
• Maternal obesity caused pathological cardiac hypertrophy with increased interstitial 
fibrosis, this was prevented by maternal exercise intervention 
• Male offspring of obese dams had accompanying hypertension and in vivo cardiac 
dysfunction.  
• The observed hypertrophy was not a consequence of offspring hypertension, as the 
offspring of obese-exercised dams had hypertension without markers of cardiac 
hypertrophy. 
• Despite the haemodynamic stress of elevated SBP, the offspring of obese-exercised 
dams displayed normalised parameters of cardiac function. This could have been 
achieved through a compensatory sympathetic-activated increase in inotropy 
(contractility).  
• The discordance in the outcomes corrected by the exercise intervention suggests that 
the programming of cardiac dysfunction and hypertension occurs via divergent 
pathways. 
• Maternal hyperinsulinemia is not required to programme offspring hypertension but 
could be involved in the mechanism of cardiac hypertrophy and dysfunction. 
• Maternal hyperleptinemia that is not corrected by maternal exercise could instead 
programme offspring hypertension. 
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5. Cardiovascular phenotype in young adult 
female offspring 
5.1 Introduction 
5.1.1 Cardiovascular health of women 
Traditionally, cardiovascular studies have been carried out in males. However striking gender 
differences exist in cardiovascular health which might mean findings established in males 
may not be applicable to females. CVDs are still the leading cause of death in women despite 
the dramatic decline in CVD mortality over the past three decades (Wilmot et al., 2015). 
Recent data suggest stagnation in the improvements in incidence and mortality of CVD 
among younger women (<55 years) (Mozaffarian et al., 2015). This finding demonstrates a 
need for a necessary change from studying CVD from a male only perspective. One study 
suggested that out of the patients presenting in hospital with myocardial infarction, women 
were more likely to present without chest pain and have a higher mortality then men in the 
same age group (Canto et al., 2012).  Presenting with atypical symptoms and the under-
estimation of ischaemic heart disease risk can lead to a general under-diagnosis and under-
treatment in women (Brewer, Svatikova and Mulvagh, 2015). Obesity tends to have a deeper 
impact on the risk of CVD in women. For example, the Framingham Heart Study showed that 
obesity increased the risk of CVD by 64% in women, compared to 46% in men (Sharma and 
Gulati, 2013). Hypertension prevalence is also higher in women (> 60 years old) then in men 
(Garcia et al., 2016). 
5.1.2 Cardioprotective effects in females 
Some clinical studies have already revealed sex differences in CVD outcomes. Women that 
experience heart failure (HF) survive better than men and it also manifests at an older age and 
with less ischaemic aetiology (Levy et al., 2002). Heart failure with preserved ejection 
fraction (HFpEF) is more common women than men (Duca et al.. 2018), this is one class of 
heart failure that has diastolic dysfunction and increased LV stiffness but with preserved left 
ventricular ejection fraction. Women with isolated systolic hypertension have increased wall 
thickness but with smaller chambers (concentric hypertrophy), whereas men are more likely 
to have LV dilatation without increased wall thickness (eccentric hypertrophy) (Krumholz, 
Larson and Levy, 1993). 
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Pre-menopausal females tend to have better cardiovascular outcomes then age-matched males 
(Luczak and Leinwand, 2009). After menopause this effect is largely lost and therefore the 
ovarian reserve hormone estrogen was suggested to be cardioprotective (Kim and Levin, 
2006). Incidence of hypertrophy rapidly increases in post-menopausal women (Agabiti-Rosei 
and Muiesan, 2002) and this has been shown to be reversed by hormone replacement therapy 
(Miya et al., 2003). This suggests estrogen could have anti-hypertrophic action and could 
prevent the upregulation of hypertrophic genes.  
There are wide-ranging effects of estrogen on cardiac physiology, for example, the 
modulation of vascular tone, arterial resistance, arterial dilation, and blood flow. Also, effects 
include lowering BP, preventing the damage of arteries and the heart to various forms of 
injury, decreasing vascular inflammation, and atherosclerosis and preventing cardiac 
hypertrophy (Reviewed in: Kim and Levin, 2006). The mechanism by which estrogen 
mediates its cardioprotective effects is not fully known, however, it is known that estrogen 
activates NO production, alters Ca2+ flux and promotes cardiomyocyte survival through the 
PI3K-Akt pathway (Luczak and Leinwand, 2009).  
5.1.3 Sex differences in developmental programming 
As described in the previous section, there is a difference in the aetiology of cardiovascular 
disease between the sexes and this may be related to sex differences in myocardial function. 
Recent studies, however, have also demonstrated an intrinsic sex dichotomy in developmental 
programming through differential responses to adverse intrauterine environments. This could 
mean that male and female fetuses adapt differently to developmental stressors or that the sex 
hormones have an influence on the progression of developmentally programmed disease 
states.  
Human studies have shown that there are sex differences in the way birthweight affects 
cardiovascular physiology; a smaller size at birth was associated with higher systemic 
vascular resistance in boys following stress whereas girls had increased sympathetic 
activation both at rest and during stress (Jones et al., 2008). Autonomic cardiovascular control 
was altered between the sexes such that women, but not men, who were small at birth 
demonstrated increased BP variability and reduced baroreflex sensitivity (Jones et al., 2007).  
The Dutch Hunger Winter famine study (Section 1.4.1) showed offspring with phenotypes 
that depended on both sex and timing of exposure. Only females demonstrated increased BMI, 
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waist circumference and adiposity when exposed to famine in utero, and this was later shown 
to be accompanied by a disrupted lipid profile (Ravelli et al., 1999; Lumey et al., 2009). 
Developmental programming by a diabetic mother has a stronger impact on glucose 
homeostasis and BP in the female offspring, suggesting an increased sensitivity to changes in 
glucose availability during early life, when compared to males (Krishnaveni et al., 2010). The 
effect of maternal pre-pregnancy BMI on offspring weight, height and BMI growth patterns 
from 0 to 7 years of age was stronger in females than males (Oostvogels et al., 2017). Sex-
specific responses to developmental programming stimuli have also been reported in a wide 
range of animal models including rodent and large animal models (reviewed in: Aiken & 
Ozanne 2013). These studies highlight the importance of including both sexes in 
programming studies as there is a need to understand how changes in the early life 
environment impact differently on long-term health outcomes of male and female individuals.  
Male and females undergo development at different rates, in utero the male grows faster and 
therefore experience a greater exposure to the insult, and this has been suggested for one of 
the reasons that males appear to be more deeply impacted (Aiken and Ozanne, 2013). There 
are several mechanisms mediating sexual dimorphic programming, including epigenetics, sex 
differences in the anatomy and growth of the placenta, the protective effects of estrogen, and 
finally the difference in the circulating levels and sensitivity to metabolic hormones (Dearden, 
Bouret and Ozanne, 2018).  
5.1.4 Aims of chapter 
The first aim of this chapter was to investigate the effect of maternal obesity on the female 
offspring’s cardiovascular health. Once this was established, the second aim was to determine 
the impact on cardiovascular function of the maternal exercise intervention. Comparing the 
results with Chapter 4, will highlight sex differences in the effects of maternal obesity on the 
cardiovascular health of the offspring.  
5.1.5 Disclaimer 
The detection of mites in the animal facility meant all experiments and breeding had to be 
halted for six weeks to allow for effective treatment. The chosen treatment was permethrin 
based and concerns were raised about its impact on breeding and feeding behaviours (Bloom, 
Staatz and Dieringer, 1983; Zhang et al., 2007). This had the unfortunate consequence that no 
animal experiments could take place between July 2017 and January 2018; this included the 
treatment and quarantine period plus the time for the offspring to be generated again using our 
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diet-induced obesity model. The timing of this resulted in the data for the intervention group 
being incomplete. Therefore, although sufficient numbers of animals for all physiological 
measurements were successfully generated and experiments carried out, this down time meant 
there was not sufficient time to generate enough animals to carry out molecular and 
stereological analyses. Therefore this analysis was performed only in the control and obese 
offspring groups using existing banked fixed and frozen tissue. Hearts from the physiological 
experiments could not be used for molecular analysis due to the exposure to isoflurane after 
echocardiographic study.  
 
5.2 Methods 
5.2.1 Cardiomyocyte cell size analysis: WGA and HALOTM 
This method has been further optimized since it was carried out in Chapter 4, as the 
department purchased new equipment and software for this type of analysis. This enabled 
imaging of the whole heart and not just the LV. Perfusion-fixed hearts from eight week old 
offspring were processed and sectioned at 3 µm. Two mid-cardiac sections from each heart 
were selected for staining using a method as previously described (Blackmore et al., 2014). 
Six hearts (from six independent litters) were analysed per experimental group. Wheat germ 
agglutinin [TexasRed-X conjugate, (Molecular Probes, Life Technologies, USA)] was used to 
stain cardiomyocyte cell borders. The staining protocol is the same as has been described in 
section 4.2.2. The slides were imaged using an automated method with the Slide Scanner 
Axio Scan Z1 (Zeiss, Germany). Effort was taken to ensure a high quality of staining and 
imaging to allow for accurate analysis, therefore when this was considered suboptimal, the 
staining was repeated.  
Images were analysed using the muscle fiber module of the HALOTM analysis software 
(Indica labs). An algorithm was used to detect cell borders and automatically circumscribe the 
cells. Minimum and maximum fiber area, a measure of roundness and maximum 
segmentation length were fixed to ensure the cell areas were measured similarly. The 
ventricle was manually annotated and then the analysis was performed within the annotated 
area (Figure 5.1). This enabled comprehensive analysis of all cells in each ventricle that lie in 
cross section, unlike analysis performed in section 4.2.2 where 10 random images were taken 
of the LV. Two mid-cardiac sections were analysed per animal.  
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FIGURE 5.1: Representative images of HALOTM WGA analysis. A) Annotations drawn 
around ventricles in separate analysis layers. B) Image showing WGA-stained 
cardiomyocytes with areas that are excluded from analysis (yellow dotted line) C) HALOTM 
analysis of circumscribing cell borders. 
 
5.2.2 Ventricular and lumen dimensions in mid-cardiac sections  
Images of the mid-cardiac section that were stained and imaged for cell size/area analysis (see 
section 5.2.1) were analysed for ventricular widths and areas. The experimental group was 
blinded to the analyser. A previously published stereological method was utilised (Blackmore 
et al., 2014). Images were exported as TIFF format ensuring that a scale bar was added. 
Images were then analysed using FIJI software. Horizontal lines with equal spacing was 
superimposed onto the image to enable the unbiased assessment of ventricle wall widths. 
Where the superimposed line intersected with the edge of the ventricle wall a line to measure 
the width was drawn. An average (mean) was used of least 10 measurements taken down the 
length of the both ventricle walls (Figure 5.2A).  
Ventricle area was assessed by superimposing crosses onto the image where the area of the 
cross was known. The plugin (available on FIJI) called Cell counter was used to count the 
number of crosses falling on the LV, left lumen (LL), right ventricle (RV), right lumen (RL) 
and IVS (Figure 5.2B). This was analysed over two mid-cardiac sections and the average was 
calculated.  
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The Cavalieri principle was then used to calculate area of ventricles:  
𝐴𝑟𝑒𝑎 (𝑚𝑚2) = 𝐴(𝑝) × ∑ 𝑝,  A(p) = known area/point. Σp = Sum of each point counted.  
Total LV area was considered to be the sum of the LV and the IVS area. 
FIGURE 5.2: Representative images from FIJI analysis. This highlights the method used 
to determine ventricle width and area measurements. A) Wall width was measured where 
superimposed line intersects edge of wall to the neighbouring superimposed line. B) Ventricle 
areas were analysed by counting number of crosses that fall on the ventricles, lumens and IVS.  
 
5.2.3 PCR: primer sequences 
Gene expression was measured in ventricular heart tissue. The PCR protocol including how 
primers were designed is described in Section 2.6. The primer sequences used in this Chapter 
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TABLE 5.1: Primer sequences for PCR. A geomean of 3 housekeepers (in bold) was used 
to normalize the gene expression data in this chapter, Tbp- TATA-binding protein, Rpl4- 
Ribosomal protein L4 and Eef1e1- Eukaryotic translation elongation factor 1 epsilon 1. 
 Forward primer (5’-3’) Reverse primer (5’-3’) 
Tbp TATGACCCCTATCACTCCTG TTCTTCACTCTTGGCTCCTGT 
Rpl4 GCCGCTGGTGGTTGAAGATAA CGTCGGTTTCTCATTTTGCCC 
Eef1e1 TCCAGTAAAGAAGACACCCAGA GACAAAACCAGCGAGACACA 
Fetal genes see Section 4.2.3 
Antioxidant defence genes see Section 4.2.3 
SERCA2 CTCCATCTGCTTGTCCAT GCGGTTACTCCAGTATTG 
 
5.2.4 PicroSirius red stain: Fibrosis analysis 
The full protocol is described in Section 4.2.4. 
5.2.5 Non-invasive blood pressure measurement 
Full detailed methodology can be found in Section 2.4. 
5.2.6 Echocardiography: Aortic width analysis  
Full methodology is described in Section 2.5 
5.2.7 Western blotting  
The method for western blot is described in Section 2.8 and details of antibodies (including 
dilutions) are the same as those shown in Section 4.2.7. Coomassie stained gel to ensure even 
protein loading shown in Figure 5.3.  
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FIGURE 5.3: Coomassie stain of loaded gel to ensure even protein loading. Control n= 9 
and Obese n= 8. 
 
5.2.8 Statistical analysis 
When analysis was performed between two groups (offspring of control dams vs. offspring of 
obese dams) an unpaired parametric t-test was utilised. One-way ANOVA with Bonferroni 
post-hoc test was performed when three groups were compared.  TD-NMR measurements 
were analysed by two-way ANOVA with Bonferroni post-hoc test. The hierarchical linear 
model used to assess cardiomyocyte cell area was described in Section 4.2.8; the ventricles 
were considered in separate models. Cardiomyocyte area frequency distributions were plotted 
in R statistical software package version 2.14.1 (R Foundation for Statistical Computing, 
Austria) due to large number of data values. All data is presented as mean ± SEM.  
 
5.3 Results  
5.3.1 Body composition and organ weights 
Longitudinal assessment of bodyweight and body composition were carried out, and a two-
way ANOVA used to assess statistical significance as due to missing data a correction for 
repeated measures could not be carried out. Age had a significant effect on bodyweight, fat 
mass and lean mass, which all increased with age (Figure 5.4A-C). There was no significant 
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effect of maternal diet on bodyweight in the female offspring (Figure 5.4A). There was a 
significant effect of maternal diet on female offspring fat mass, with the ANOVA analysis 
suggesting that maternal obesity led to increased adiposity (Figure 5.4B). Lastly there was an 
effect of maternal diet on lean mass with female offspring of obesogenic diet-fed dams 
showing decreased lean mass compared to control (Figure 5.4C).  
FIGURE 5.4: Longitudinal assessment of body composition. Body composition measured 
by TD-NMR from four weeks of age to eight weeks of age in female offspring. TD-NMR 
measurements were carried out at the same time of the day each week (Morning) to account 
for different feeding behaviours in light/dark cycle. Control n= 8 and Obese n= 8. Two way 
ANOVA; A*** effect of age p< 0.001, M** effect of maternal diet p< 0.01.  
 
 
Body composition assessed at eight weeks of age was plotted individually and there was no 
difference in bodyweight, fat mass or lean mass between groups (Table 5.2). Female offspring 
were fasted for 16 hours (overnight) prior to post mortem at eight weeks of age. There were 
no differences in the fasted bodyweight or in the bodyweight lost during the fast (Table 5.2). 
There were no differences in fat depot weights in the offspring of obese dams. There were 
also no differences in other organ weights measured in Table 5.2 between offspring of control 
and obese dams.  
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TABLE 5.2: Body composition and organ weights in eight week old female offspring. 
TD-NMR measured body composition in the fed state. Data is presented mean ± SEM. 
Females were fasted for 16 hour before post mortem where organs were dissected and the wet 
tissue weight was recorded. P values calculated from unpaired t-test. 
Body composition + organ weights (g) Control n Obese n p value 
Fed bodyweight 19.76 ± 0.43 8 19.06 ± 0.27 8 0.196 
Fat mass 1.96 ±  0.11 8 2.20  ± 0.15 8 0.228 
Lean mass 12.85 ± 0.38 8 11.74 ± 0.61 8 0.150 
Fasted bodyweight 17.97 ± 0.49 6 17.22 ± 0.53 6 0.320 
Bodyweight lost with fast 2.17 ±  0.22 6 1.75 ± 0.17 6 0.167 
Gonadal fat 0.165 ± 0.023 6 0.191 ± 0.027 6 0.491 
Retroperitoneal fat 0.041 ± 0.009 6 0.033 ± 0.008 6 0.589 
Liver 0.86 ± 0.03 6 0.85 ± 0.04 6 0.949 
Kidney; left  0.121 0.002 6 0.120 ± 0.005 6 0.784 
Kidney; right 0.110 ± 0.003 6 0.113 ± 0.005 6 0.631 
Pancreas 0.098 ± 0.006 6 0.104 ± 0.008 6 0.584 
Spleen 0.064 ± 0.004 6 0.06 ± 0.004 6 0.465 
 
5.3.2 Serological analysis 
There were no significant differences in fasting plasma glucose from tail blood before the post 
mortem (Figure 5.5A). Female offspring of obese dams showed increased free fatty acids 
(FFAs) compared to control (Figure 5.5C) but there were no further differences in the 
measured metabolites (Figure 5.5B+D). There were also no differences between groups in 
serum leptin or insulin when ELISA was performed (Figure 5.5E+F). 
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FIGURE 5.5: Serological analysis in 16 hour fasted serum. Methods for serum analysis is 
described in Section 2.3. Control n= 8 and Obese n= 8. Except for cholesterol (2 outliers were 
detected by Grubbs test) Control n= 7 and Obese n= 7. FFAs (1 outlier detected) Control n= 
7 and Obese n= 8. Unpaired t-test; ** p< 0.01. 
 
5.3.3 Cardiac phenotype 
Increased heart weight 
At eight weeks of age, female offspring of obese dams had increased heart weight, when 
expressed as absolute weight (Figure 5.6A) and when expressed relative to bodyweight 
(Figure 5.6B). Heart weight was normalized to the fasting bodyweight measured immediately 
before post mortem and the fasted bodyweight was not different between groups (Table 5.2).  
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FIGURE 5.6: Heart weights at post mortem. Heart weight of female offspring was 
measured by weighing wet tissue weight at post mortem post 16 hour fast. Heart weight was 
also expressed relative to bodyweight. Control n= 8 and Obese n= 7. Unpaired t-test; * p< 
0.05 and ** p< 0.01. 
 
Right ventricular hypertrophy 
Cardiomyocyte cell area was assessed in mid-cardiac sections of perfusion fixed hearts. Both 
ventricles were assessed and increased mean cardiomyocyte cell size was observed in the RV, 
but not the LV, of the offspring of obese dams (Figure 5.7A+B). The frequency distribution 
of cardiomyocyte cell area has a rightward shift suggesting female offspring of obese dams 
had more cells of larger area in their RV (Figure 5.7D). A hierarchical linear model was 
employed to stringently assess the cardiomyocyte cell area of each ventricle separately. For 
the LV there was no significant effect of maternal diet on cell size (p= 0.13) but for the RV, 
there was a significant effect (p< 0.05).  
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FIGURE 5.7: Cardiomyocyte cell size analysis. Average cardiomyocyte cell area across A) 
LV and B) RV. Two mid-cardiac sections analysed per heart and n= 6 hearts analysed per 
group. One-way ANOVA with Bonferroni post-hoc test; * p< 0.05. Frequency distribution of 
cardiomyocyte cell area in C) LV and D) RV.  
 
Full comprehensive stereological analysis across the whole heart was not possible (due to 
time constraints). To complement and support the cell area data, analyses of ventricular wall 
and lumen dimensions was therefore performed on the same mid-cardiac sections as the cell 
area analysis. The wall thickness/width of the LV was not altered in the female offspring by 
maternal obesity and the wall: lumen ratio was similarly unaltered (Figure 5.8A+B). A 
significant increase in RV wall width in the female offspring of obese dams was seen (Figure 
5.8C). There was no statistical difference in the RV wall: lumen ratio (Figure 5.8D). The LV: 
RV wall width ratio was decreased as a result of the increase in RV wall width (Figure 5.8E).  
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FIGURE 5.8: Mid-cardiac ventricle wall width analysis. Two mid-cardiac sections were 
analysed for ventricular wall widths. A) LVPW, B) LV wall: lumen widths, C) RV wall width, 
D) RV wall: lumen widths and E) LV: RV width ratio. Control n= 6 and Obese n= 6. 
Unpaired t-test; * p< 0.05 and ** p< 0.01.  
 
LV area was not altered in the hearts of the female offspring after exposure to maternal 
obesity (Figure 5.9A+B). RV area was increased in the female offspring of obese dams 
(Figure 5.9C), and the RV area relative to total heart weight was also increased (Figure 5.9D). 
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This caused a reduction in the LV: RV area ratio (Figure 5.9E). Total heart area of the mid-
cardiac section was also increased in female offspring of obese dams (Figure 5.9F). 
 
FIGURE 5.9: Mid-cardiac ventricular and total heart area analysis. A) LV area, B) LV 
area relative to total heart area (%), C) RV area, D) RV area relative to total heart area (%), E) 
LV: RV area ratio and F) Total heart area of mid-cardiac section. Control n= 6 and Obese n= 
6. Unpaired t-test; * p< 0.05 and ** p< 0.01. 
 
 
Alongside the heart weight, cell size and mid-cardiac data, the mRNA expression of 
pathological cardiac hypertrophy markers was measured in ventricular tissues. The expression 
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of Nppa and Myh7 were increased compared to offspring of control dams (Figure 5.10A+E). 
The expression of Myh6 was unaltered between groups (Figure 5.10D), however the increased 
expression of Myh7 in the offspring of obese dams did not significantly alter the Myh7:Myh6 




FIGURE 5.10: Markers of pathological cardiac hypertrophy. Gene expression of key fetal 
genes in the ventricular tissue of female offspring. Normalised to the geometric mean of three 
housekeepers: TBP- TATA-binding protein, Rpl4- Ribosomal protein L4 and Eef1e1- 
Eukaryotic translation elongation factor 1 epsilon 1. Control n= 7 and Obese n= 7. Unpaired t-




Mid-cardiac sections were stained with PicroSirius red to allow for the assessment of cardiac 
fibrosis (method described in Section 4.2.4). Representative images are shown in Figure 
5.11A and analysis showed that there were no differences in % area of fibrosis between 
groups (Figure 5.11C). There were also no differences in the mRNA expression of antioxidant 
defence genes (Figure 5.11D).  
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FIGURE 5.11: Assessment of cardiac fibrosis and oxidative stress. Method is detailed in 
Section 4.2.4. A) Representative images of PicroSirius red stained heart sections. B) Images 
were converted into RGB stack in ImageJ to allow for analysis. C) % area of fibrosis (% area 
of red stain) was assessed in three groups. Control n= 4 and Obese n= 4. Heart sections for 
staining provided by Dr Sarah Carr. D) Expression of antioxidant defence genes: Cat- 
Catalase, Sod2- Superoxide dismutase 2, Gpx3- Glutathione peroxidase and Nrf2- Nuclear 
factor erythroid 2–related factor 2. Expression normalized by geometric mean of Tbp- TATA-
binding protein, Rpl4- Ribosomal protein L4 and Eef1e1- Eukaryotic translation elongation 
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Contractile machinery protein expression 
The expression of key contractile machinery proteins was assessed and showed no significant 
differences in any of them between the female offspring of obese and control dams. However, 
the expression of phosphorylated troponin I and the phos:total troponin I ratio appeared 
reduced in the offspring of obese dams (Figure 5.12B+C). The protein expression of SERCA2 
was not statistically different (Figure 5.12E) however when this was assessed at the mRNA 
level this was significantly reduced in the offspring of obese dams (Figure 5.12F).  
FIGURE 5.12: Expression of key contractile machinery proteins. A)-E) Expression level 
assessed by western blotting. F) mRNA expression by PCR of Serca2 gene. Control n= 8 and 
Obese n= 7. Unpaired t-test; * p< 0.05.  
 
Offspring blood pressure 
Female offspring of obese dams showed elevated SBP and this was not prevented by the 
exercise intervention (Figure 5.13A). The increased SBP was not accompanied by any 
changes in pulse rate (Figure 5.13B). 
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FIGURE 5.13: Female offspring SBP and pulse rate. A) BP measurements were carried 
out just prior to the start of the dark (active) cycle, at the same time (1600) across three 
consecutive days. Measurements were taken on the 3rd day when variation between 
measurements was lowest. This is fully described in Section 2.4. B) Pulse rate (bpm). Control 
n= 16, Obese n= 14 and Ob-Ex n= 10. One-way ANOVA with Bonferroni post-hoc test; * p< 
0.05 and ** p< 0.01.  
 
In vivo cardiac function 
Unlike the male offspring (see Section 4.3.3), female offspring of obese dams did not have 
impaired cardiac function as measured by in vivo echocardiography of the LV (Table 5.3). 
However in the female offspring of obese-exercised dams there were strikingly similar 
differences to the male offspring from the intervention group. Offspring of obese-exercised 
dams had increased LVPW at systole compared to offspring of control dams (p< 0.01). This 
caused an increased wall: lumen ratio at systole in these offspring (p< 0.01) (Table 5.3). The 
width at systole of the IVS and LVID were not affected. LV tracing measurements showed an 
increased ejection fraction and fractional shortening in female offspring born to obese-
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TABLE 5.3: In vivo cardiac function parameters. Data is presented mean ± SEM. P values 
calculated by one-way ANOVA. Letters represent differences between specified groups by 
Bonferroni post-hoc test (p< 0.05): b Control vs. Ob-Ex. Control n= 9, Obese n= 7 and Ob-Ex 
n= 7. For LVPW and wall: lumen ratio measurements; 1 outlier detected in control group. 
† LV= Left ventricle, IVS= Interventricular septum, LVID= LV internal diameter and 
LVPW= LV posterior wall. 
 
M mode dimensions Control Obese Ob-Ex p value 
IVS; diastole (mm) 0.807 ± 0.028 0.886 ± 0.087 0.779 ± 0.043 0.396 
LVID; diastole  (mm) 3.56 ± 0.08 3.56 ± 0.07 3.52 ± 0.08 0.945 
LVPW; diastole (mm) 0.75 ± 0.045 0.763 ± 0.063 0.81 ± 0.025 0.649 
Wall:Lumen ratio; diastole 0.221 ± 0.013 0.215 ± 0.018 0.233 ± 0.010 0.510 
IVS; systole (mm) 1.35 ± 0.05 1.42 ± 0.08 1.29 ± 0.04 0.308 
LVID; systole (mm) 2.26 ± 0.09 2.18 ± 0.07 2.08 ± 0.09 0.321 
LVPW; systole (mm) 1.03 ± 0.04 1.15 ± 0.10 1.35 ± 0.04b 0.005 
Wall:Lumen ratio; systole 0.457 ± 0.026 0.534 ± 0.050 0.661 ± 0.041b 0.005 
LV mass (mg) 92.3 ± 5.4 102.9 ± 8.3 95.4 ± 5.5 0.496 
LV tracing measurements     
End diastolic diameter (mm) 3.60 ± 0.08 3.62 ± 0.06 3.54 ± 0.09 0.790 
End diastolic volume (μl) 54.84 ± 2.98 54.52 ± 2.11 52.72 ± 3.19 0.871 
End systolic diameter (mm) 2.24 ± 0.07 2.18 ± 0.05 2.04 ± 0.10 0.211 
End systolic volume (μl) 17.15 ± 1.36 15.9 ± 0.87 13.82 ± 1.63 0.227 
Stroke volume (μl) 37.71 ± 1.80 38.68 ± 1.63 38.9 ± 1.70 0.870 
Heart rate (bpm) 471 ± 17 457 ± 10 460 ± 8 0.718 
Cardiac output (ml/min) 17.86 ± 1.28 17.83 ± 0.66 17.92 ± 0.97 0.998 
Ejection fraction (%) 69.02 ± 1.20 71.54 ± 0.97 74.33 ± 1.67b 0.027 
Fractional shortening (%) 38.02 ± 0.92 40.00 ± 0.81 42.53  ± 1.43b 0.022 
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5.4 Discussion  
The aim of this chapter was to firstly determine the impact of maternal obesity exposure on 
the cardiovascular health of the female offspring and secondly to provide preliminary data 
into the impact of maternal exercise intervention on female offspring in vivo cardiovascular 
function. The findings revealed that, like male offspring, female offspring of obese dams had 
increased heart weight both in absolute terms and when expressed relative to bodyweight. 
However, unlike the male offspring where there was hypertrophy of the LV, the female 
offspring of obese dams had markers for RV hypertrophy and not LV hypertrophy. In keeping 
with the hypertensive phenotype of the male offspring of obese dams, the female offspring 
also had elevated SBP without any change in pulse rate and this was not corrected by the 
maternal exercise intervention. Consistent with a lack of LV cardiac hypertrophy, there were 
no changes in cardiac function when systolic in vivo function was assessed in the LV. The 
exercise intervention in the obese dam caused increased contractility in the hearts of the 
female offspring demonstrated by increased systolic wall: lumen, ejection fraction and 
fractional shortening.  
5.4.1 Offspring body composition and serum analysis 
An overall effect on bodyweight suggests a small reduction in bodyweight in the offspring of 
obese dams however when bodyweight was plotted individually at eight weeks of age there 
was no significant difference. Lactation data shown in Section 3.3.3 shows maternal obesity 
caused decreased bodyweight shortly after birth and an accelerated growth rate through the 
lactation period. This was not significantly altered with the exercise intervention. As it was 
not possible to separate by sex, both sexes were included in this analysis, sex differences in 
the growth profile of the pups after birth could have been concealed. An altered growth 
profile was continued post weaning with a suggestion that growth was reduced once females 
were weaned onto the postnatal control RM1 diet. Food intake measurements were not 
possible as for accurate data the same number of animals is required in every cage and in this 
experiment the numbers per cage varied between two and three.  
As in male offspring, fat mass was increased in female offspring of obese dams with the fat 
mass diverging from seven weeks of age. Offspring of control dams did not appear to gain fat 
mass past this age but the offspring of obese dams continued to gain. This difference in fat 
mass was not present in eight week old animals after an overnight fast. Lean mass was 
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decreased by maternal diet with offspring of obese dams having reduced lean mass compared 
to offspring of control dams which was consistent with the reduction in bodyweight.  
Plasma FFA levels were increased in the offspring of obese dams. FFAs are usually elevated 
in obesity, the increased adipose tissue mass releases more FFAs and also the clearance of 
FFAs could be reduced (Bjorntorp, Bergman and Varnauskas, 1969). Interestingly, elevated 
plasma FFAs has been associated with insulin resistance by inhibiting insulin stimulated 
glucose uptake (Boden et al., 1994). Whole body insulin resistance did not appear to be 
present in the female offspring at this age as the serum fasting insulin was not increased; 
however there could be a selective insulin resistance in adipocytes and this should be assessed 
in the future. Furthermore this could suggest these offspring could be at increased risk of 
developing insulin resistance in later life. 
The absence of hyperinsulinemia in the females is unexpected, since the male offspring of 
obese dams were hyperinsulinemic at the same age and females tend to be inherently more 
insulin resistant and have higher circulating insulin levels from birth (Murphy et al., 2004; 
Manios et al., 2014). A study utilising the same diet-induced model did not demonstrate 
hyperinsulinemia until three months of age that progressed to a diabetic phenotype at six 
months of age that suggested β-cell exhaustion (Samuelsson et al., 2008). It is also important 
to note that the oestrous cycle of the female offspring was not monitored during the current 
study and this may have affected the results, as sex hormones are known to affect insulin 
sensitivity and glucose tolerance (Bailey and Matty, 1972).  
5.4.2 Maternal obesity programmed RV but not LV hypertrophy in female offspring 
As part of this project, the method for assessing cardiomyocyte cell area was optimised to 
become automated using new equipment and software purchased by the department during 
the course of the PhD. This has benefits in that this will reduce bias and also speed up the 
process of analysis. With the new method it was possible to image the entire WGA stained 
section enabling analysis to be performed in both ventricles, which was not possible at the 
time of doing the analysis on the male offspring. The relatively low analysis burden of 
utilising the HALOTM software greatly improved the efficiency of this analysis. This was 
critical in identifying the crucial finding that the RV and not the LV was involved in the 
cardiac hypertrophy in females. Cardiomyocyte cell area demonstrated significant differences 
but only in the RV and not the LV.  
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An interim analysis of mid-cardiac wall widths and ventricle area was performed on the same 
sections used for the cardiomyocyte cell analysis. The limitation of this analysis is that this 
was not carried out over 10 representative and equally spaced heart sections across the whole 
heart. Therefore, volume calculations could not be carried out and a comprehensive analysis 
was not possible. Hopefully, however, it provides a valid snapshot of morphology changes in 
the mid-cardiac section of the hearts. It is not currently known if these changes are present 
when the whole heart is considered and should form part of the future work for this project.  
Consistent with the increased heart weight recorded at post mortem, stereological analysis 
also revealed an increase in total area of the heart section. The effect on cardiomyocyte size in 
the RV was reinforced by the differences shown in the RV stereological measurements. 
Increased RV wall width and total RV area (includes wall and lumen) were demonstrated in 
the mid-cardiac sections from the offspring of obese dams. The RV area was also increased 
when expressed relative to the total area of that section suggesting a disproportionate increase 
in area of this ventricle. The increased RV wall width suggests the increased area could be 
due to RV wall thickening, without a corresponding change in the lumen. The reduction in the 
LV: RV area ratio demonstrated a shift in the relative size contribution between the ventricles; 
where the RV was larger in the female offspring of obese dams. The RV morphological 
changes occurred without any significant changes in the corresponding LV measurements. 
This asymmetric growth in the RV could lead to LV dysfunction due to the mechanical 
interaction between the ventricles (Slinker, Chagas and Glantz, 1987), in fact deficits in 
diastolic function have been demonstrated previously in a rodent model of RV hypertrophy 
(Lamberts et al., 2007). The presence of LV contractile dysfunction was not supported in the 
LV systolic cardiac measurements.  
Previous work in the laboratory has assessed the time course of cardiac hypertrophy in the 
male offspring. Hypertrophy was present from three weeks of age and an accelerated cardiac 
growth profile was present in the male offspring of obese dams. Interestingly biventricular 
cardiac growth was present up until five weeks of age before the LV growth dominated 
(Blackmore et al., 2014). At 12 weeks of age, the LV hypertrophy resolves suggesting a 
plateau in cardiac growth between 8-12 weeks of age in the male offspring of obese dams. 
This might suggest a different cardiac growth profile in the females and therefore LV 
hypertrophy may develop as the animal ages. The male offspring of obese dams appear to 
display hypertrophy at a more advanced stage then the female offspring. It would be 
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interesting to assess cardiac hypertrophy at younger and older ages in the females to establish 
a time course of cardiac growth.  
These structural changes were accompanied by increased expression of Nppa and Myh7, two 
fetal genes known to be re-expressed in pathological, but not physiological, cardiac 
hypertrophy (Nakamura and Sadoshima, 2018). This expression was measured in whole 
ventricular tissue and has not been analysed in each ventricle separately. This re-expression 
was probably driven by changes in the RV and the expression profile may have been more 
dramatic if the RV was assessed alone. Rockman and colleagues demonstrated increased 
Nppa in a pulmonary aorta banded model of RV hypertrophy (Rockman et al., 1994). The re-
expression of these genes is also present in the RV of a mouse model of right sided 
hypertrophy (Bartelds et al., 2011). 
The cardiac hypertrophy was not accompanied by cardiac fibrosis or deficits in oxidative 
stress response and this might suggest this hypertrophy may not be truly pathogenic in nature. 
The fibrosis, however, was analysed across the whole heart section with 10 random grids 
selected for quantification, therefore each ventricle was not analysed separately. This may 
have revealed differences in fibrosis isolated to the RV. RV maladaptive remodelling is 
associated with cardiac fibrosis and failure of antioxidant defence, this was not present in the 
female offspring when expression was assessed in both ventricles suggesting that there has 
not been progression to this stage of disease. However, if expression was just assessed in the 
RV, significant differences in key oxidative stress markers may be present. 
5.4.3 Possible mechanisms for RV hypertrophy 
Thickening of the left and right ventricle is commonly associated with systemic and 
pulmonary hypertension, respectively. However, evidence from human studies provides 
evidence that remodelling of the RV wall may also occur indirectly as a consequence of 
systemic hypertension. Patients with essential hypertension had a RV wall two-fold thicker 
than their normotensive counterparts (Nunez et al., 1987).  In a more recent study, 1 in 5 
hypertensive patients developed biventricular cardiac hypertrophy (Cuspidi et al., 2014). 
Systemic hypertension has been shown to be associated with elevated pulmonary arterial 
pressures (Oliveri et al., 1978). RV hypertrophy in systemic hypertension has been attributed 
to LV diastolic dysfunction acting via pulmonary venous hypertension and increased RV end-
diastolic pressure (Akintunde et al., 2010; Cuspidi et al., 2014). RV hypertrophy could be a 
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consequence of pulmonary vascular resistance which in turn causes RV pressure overload 
(Asosingh and Erzurum, 2018). Notably, babies born to obese women are at an increased risk 
of respiratory complications at birth and in childhood (Hernandez-Diaz et al., 2007; Lock et 
al., 2013). In a rodent model of calorie restriction during gestation combined with hypoxic 
stress later in life, offspring developed pulmonary hypertension and RV cardiac hypertrophy. 
Programming of this adverse phenotype in offspring was associated with epigenetic 
mechanisms through alterations in lung DNA methylation (Rexhaj and Bloch, 2011). The 
future work should assess the cause of the RV hypertrophy. Right ventricular systolic pressure 
as a proxy for the pulmonary artery pressure can be measured by right heart catheterisation.  
The fat mass of the female offspring of obese dams starts to diverge from seven weeks of age 
and may indicate that these animals have a predisposition to becoming obese in the future. 
Obesity, in the absence of traditional cardiovascular risk factors has been linked to RV 
hypertrophy. It has been shown that, with increasing BMI, women have proportionally greater 
RV hypertrophy independently of LV hypertrophy (Rider et al., 2014). This can be explained 
either by the fact that cytokines, adipokines and growth factors have a greater impact on the 
RV in females then in males or that sex hormones are somehow responsible. Furthering the 
hypothesis that sex has an effect on RV remodelling is a study that has demonstrated a 
stronger influence of metabolic syndrome on RV remodelling in females then in males (Tadic, 
Ivanovic and Grozdic, 2011).  
In Chapter 4, a possible mechanism for the observed LV cardiac hypertrophy was suggested 
to be hyperinsulinemia which is present in the mother and also present in the male offspring 
of obese dams at eight weeks of age. In contrast the female offspring of obese dams are not 
hyperinsulinemic at this age but will still have been exposed to maternal hyperinsulinemia 
during the fetal and neonatal period (Section 3.3.4). It will be important in future studies to 
assess insulin at different time points, insulin levels could have been high in females before 
birth and during lactation period. The initial insult may not need to be maintained to see an 
impact on heart growth. Equally, another explanation is that the suggested mechanism may be 
critical in driving the LV sided hypertrophy and a different mechanism is involved in the RV 
hypertrophy. As the female ages, hyperinsulinemia might develop and the LV hypertrophy 
could develop later than in the male offspring.  
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5.4.4 Elevated SBP and its impact on cardiac parameters 
SBP was elevated in the female offspring of obese dams and may share a common 
programming mechanism as the same was observed in the male offspring (see Section 4.3.3). 
Again, the exercise intervention did not modify this offspring outcome reinforcing the 
suggestion that this pathway involves a programming factor in the mother that is not 
modifiable by the exercise intervention (discussed in Section 4.4.4).  
Data from the male offspring suggested a disparity in the development of LV hypertrophy and 
hypertension as offspring of obese-exercised dams did not have both outcomes despite the 
effects of them being linked. Females born to obese dams also show hypertensive hearts that 
did not have hypertrophy in the LV. The reason for this is unclear, although hypertension will 
inevitably contribute to LV hypertrophy it is unlikely to be causative in these offspring. A 
study of patients with hypertension observed that more female patients had hypertension 
without LV hypertrophy then those who were hypertensive with accompanying LV 
hypertrophy; the same effect was not seen in the males (Jakovljevic et al., 2010). This could 
suggest that hypertensive females are more protected from LV hypertrophy.  
5.4.5 Protective effect on cardiac function in female offspring 
Unlike the male offspring, LV hypertrophy and systolic dysfunction were not present in the 
female offspring, this shows a sex difference in the offspring’s cardiovascular response to 
maternal obesity. There was no cardiac dysfunction despite increased afterload from elevated 
SBP; this indicates a gender difference in the response of the heart to a sustained elevated 
level of myocardial stress. Women often display preserved systolic function in situations 
where males have shown systolic dysfunction (Hayward, Kalnins and Kelly, 2001) and this 
could be the reason that no cardiac dysfunction was detected in the female offspring of obese 
dams. In a transverse aortic constriction model, female rats developed increased SBP but did 
not progress to heart failure unlike males who developed ventricular dilatation, increased wall 
stress and dysfunction (Douglas et al., 1998).  
The most highly discussed mediator of sex differences in cardiac physiology is estrogen. 
Estrogen has been shown to have anti-hypertrophic properties. In both volume and pressure 
overload models, ovariectomized females developed significantly more cardiac hypertrophy 
than intact females (Brower, Gardner and Janicki, 2003; Bhuiyan, Shioda and Fukunaga, 
2007). In vitro experiments in neonatal rat ventricular cardiomyocytes have shown that 
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estrogen increases the expression of Nppa which antagonises the development of LV 
hypertrophy (Babiker et al., 2004).  
With the echocardiographic method used in this thesis, the diastolic measurements could not 
easily be made and this remains a limitation of this study. Future work should assess the LV 
diastolic function as RV hypertrophy has been associated with LV diastolic dysfunction 
(Akintunde et al., 2010; Rider et al., 2014). It is more technically difficult to assess the RV 
function by echocardiography but for future studies an importance should be placed on 
achieving this. As RV hypertrophy is an independent risk factor for heart failure and 
cardiovascular mortality (Haddad et al., 2008) it is important to get a full assessment of 
cardiac function in the animals.  
5.4.6 Effect of maternal exercise on offspring cardiac function 
Maternal obesity has no effect on cardiac function in female offspring at eight weeks of age 
but there is a disparity in how the hearts of the female offspring with elevated SBP were 
behaving, depending on if the obese mother was exercised during pregnancy. When maternal 
obesity was combined with maternal exercise intervention during pregnancy, an increased 
heart contractility was seen compared to offspring of control dams, as shown by increased 
systolic wall: lumen ratio, ejection fraction and fractional shortening. The cardiac contractility 
was even greater than offspring of control dams and was despite the hemodynamic stress of 
the elevated SBP that was also present in these females. This might be a direct compensatory 
response to elevated SBP. The offspring of obese-exercised dams appear to have been far 
more effective at responding to an increased afterload and this was true for both sexes, but 
unlike the males the increased afterload in the offspring of obese dams did not cause cardiac 
dysfunction. The increase in inotropy demonstrated in female offspring of obese-exercised 
dams could be sympathetic activated, and this should be explored in the female offspring.  
Exercise during pregnancy has been shown to elicit a training response in the fetal heart by 
lowering fetal HR and increasing HR variability (May et al., 2012); these changes have then 
been shown to be carried on into the infant period (May et al., 2010). These cardiac 
adaptations are seen in adults as a response to exercise and are associated with a lowering of 
CVD risk (Shephard and Balady, 1999). It would be very insightful to determine if maternal 
exercise during pregnancy could confer increased cardiac contractility in offspring hearts 
when elevated SBP is not also present. This would determine if this was a directly 
programmed mechanism in these hearts or a compensatory response to maintain cardiac 
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output. This could perhaps be elucidated by carrying out a fourth experimental group where 
control dams are exercised. 
5.6.7 Conclusions 
Maternal obesity had both similar and diverse effects on the cardiovascular outcomes of the 
female offspring when compared to the male offspring. Offspring hypertension was 
programmed in the offspring of obese dams irrespective of sex. However sex differences were 
present in the programmed effects on cardiac hypertrophy and function. In the female 
offspring of obese dams there was no effect on the LV however there was an impact on the 
RV. RV hypertrophy was demonstrated by increased RV wall width and area, increased 
cardiomyocyte cell area and re-expression of fetal genes. Further work is needed to determine 
if this hypertrophy is truly pathological in nature by evaluating RV function. This work 
highlights the importance of carrying out studies in both sexes as the developmental 
programming effects are very different.  
The maternal exercise intervention did not prevent the programmed offspring hypertension 
and produced a similar response compared to the male offspring through increased cardiac 
contractility. The exercise in the obese dam during pregnancy programmed a response that 
has similarities to the normal cardiac response to exercise, despite the offspring never having 
exercised themselves.  
5.6.8 Summary of key findings 
Results of this chapter have shown: 
• The female offspring of obese dams at eight weeks of age were smaller (reduced 
bodyweight and lean mass) but had increased fat mass. 
• Maternal obesity caused RV hypertrophy in the female offspring demonstrated 
through increased RV wall width and area, increased cardiomyocyte area and re-
expression of fetal genes. This hypertrophy was not accompanied by changes in 
cardiac fibrosis and oxidative stress. 
• The female offspring of obese dams were hypertensive but unlike the male offspring 
this was not associated with any systolic cardiac dysfunction in the LV. 
• Maternal exercise intervention caused increased cardiac contractility in the female 
offspring despite the elevated SBP; these results mirrored those in the male offspring.  
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6. Immediate consequences of an obese 
pregnancy on the fetal heart 
6.1 Introduction 
6.1.1 In utero cardiac development 
The heart is the first organ to form and function in the developing fetus. In the mouse, the 
heart begins as a single beating heart tube at E8.0 but then develops into a four-chambered 
heart with functioning valves and a separate outflow tract. Primitive circulation is set up from 
E8.5 and ventricular morphogenesis occurs between E11-E16 (Savolainen, Foley and Elmore, 
2009). Cardiac morphogenesis and the formation of the four chambered heart in mice is 
comparable to that of humans, however in mice the developmental events happen over a 
shorter gestational window (Wessels and Sedmera, 2003). In the human, first heart 
contractions happen at around three weeks after conception, with completion of ventricular 
septation at around nine weeks Systematic comparative analysis of mouse and human fetal 
cardiovascular development has been carried out and demonstrated that the cardiac 
developmental sequences are comparable, with only minor differences in atrial and venous 
morphology. These differences include the mouse fetal heart having a thicker and more 
muscular atrioventricular septum, and larger, more prominent atrial appendages (Krishnan et 
al., 2014). 
Fetal circulation is distinct from the system in the adult, this is true in both mouse and human 
development (Figure 6.1). Oxygenated blood from the placenta enters the right atrium and is 
shunted to the left atrium through an inter atria channel, called the foramen ovale, and then 
into the LV. Blood is pumped out through the aorta into the body, where the now 
deoxygenated blood is returned through the superior vena cava to the right atrium and then on 
to the RV. The blood is pumped out of the pulmonary artery, however since the lungs are not 
yet fully functional, high pulmonary resistance forces the majority of the blood into the 
descending aorta through a shunt called the ductus arteriosus (Savolainen, Foley and Elmore, 
2009). Both ventricles eject blood in parallel into the systemic circulation; the LV directs the 
most oxygenated blood towards the heart and brain, and the RV ejects the less oxygenated 
blood to the lower body and placenta (Rizzo, Arduini and Romanini, 1992). Separation of the 
pulmonary and systemic circulation does not happen until after birth, when there is a 
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transition from fetal dependence on the placenta for oxygenated blood to self-oxygenation by 
the lungs. This important developmental event is achieved through the closure of the foramen 
ovale and the ductus arteriosus (Savolainen, Foley and Elmore, 2009). 
 
FIGURE 6.1: Differences in the anatomy and function of the human fetal heart. 
Modified with the permission [CC BY-SA] of Bruce Blaus, Blausen.com. Medical gallery of 
Blausen Medical 2014. 
 
Proliferation of cardiomyocytes is critical in supporting the increasing hemodynamic load 
during embryonic development. Cardiomyocyte proliferation must be regulated for normal 
morphogenesis to occur and will determine appropriate heart size. Apoptosis is equally 
important for developmental remodelling of the heart and has been shown to be critical in the 
development of the embryonic outflow tract, cardiac valves, and coronary vasculature (Fisher, 
Langille and Srivastava, 2000). The number of viable cardiomyocytes dictates cardiac 
function and is determined in early life, with negligible increases after that. In general, cell 
proliferation and hypertrophy allows cardiac growth before and after birth respectively in the 
human heart. In the rodent heart, the transition of proliferative and hyperplastic growth of 
mononucleated cells to hypertrophic growth of binucleated cells, and terminal differentiation 
of cardiomyocytes, takes place within the first two week after birth (Clubb and Bishop, 1984; 
Soonpaa et al., 1996).  
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Regulation of cardiomyocyte endowment in fetal life is critically important for the future 
cardiovascular health of that individual. Due to the inability in later life for cardiomyocytes to 
proliferate, the number of cardiomyocytes at birth will be similar to the number available for 
life (Thornburg et al., 2011). Cardiomyocyte proliferation is under the regulation of mediators 
such as insulin-like growth factor (Sundgren, Giraud, Schultz, et al., 2003), angiotensin II 
(Sundgren, Giraud, Stork, et al., 2003), and corticosterone (Giraud et al., 2006), as well as 
mechanical stimuli such as arterial pressure load (Giraud et al., 2005). Suppressors of 
cardiomyocyte proliferation include triiodothyronine (Chattergoon, Giraud and Thornburg, 
2007), atrial natriuretic peptide (O’Tierney, Chattergoon, et al., 2010), and reduced cardiac 
systolic load (O’Tierney, Anderson, et al., 2010). Poorly controlled cardiomyocyte 
development will most likely lead to cardiac dysfunction, for example in growth-restricted 
animal models, a reduced number of cardiomyocytes might leave the heart vulnerable in 
conditions of high workload (Porrello, Widdop and Delbridge, 2008) 
6.1.2 Intrauterine exposures that impact on fetal development 
Hypoxia 
Hypoxia is a major fetal stressor and can occur in pre-eclampsia, placental insufficiency, and 
nicotine exposure during pregnancy (Paradis, Gay and Zhang, 2014). Restricted oxygen 
supply is necessary for normal intrauterine organ development, however excessive or severe 
hypoxia is damaging (Tong et al., 2011). The fetus can initially adapt to hypoxia by 
increasing the blood supply to the brain, heart and upper body, while decreasing perfusion to 
the lower body. This redistribution in blood flow has consequences in the heart; cerebral 
vasodilation leads to decreased LV afterload and the opposing systemic vasoconstriction 
increases RV afterload (Al-Ghazali et al., 1989). In rodents, the heart is particularly 
vulnerable to stressors such as hypoxia, during late fetal development and early postnatal life 
when it undergoes rapid growth and maturation (Louey and Thornburg, 2005).  
Hypoxia exposure during pregnancy in a rat causes increased heart to bodyweight ratio in the 
fetus and this is accompanied by decreased LV wall thickness (Tong et al., 2011). Hypoxia 
inhibits proliferation of fetal rat cardiomyocytes (Tong et al., 2013) and increases the cell size 
and percentage of binucleated cardiomyocytes in fetal rat hearts (Bae et al., 2003). Fetal 
hypoxia causes a premature exit of the cell cycle, and if this deficit in proliferation leads to 
fewer but larger cardiomyocytes then this will predispose the individual to cardiac 
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hypertrophy. Cardiac remodelling was seen in both fetal and neonatal rat hearts when exposed 
to hypoxia during pregnancy (Tong et al., 2011). 
Glucocorticoids 
Glucocorticoids are a class of hormone that are essential for normal lung and cardiovascular 
system development and in particular maturation. Glucocorticoids are administered to preterm 
babies to promote lung development, but although there is short-term benefits for immediate 
survival, there are also possible long-term side effects (Bolt et al., 2001). Fetal sheep infused 
with cortisol have increased proliferation of cardiomyocyte without an increase in size. There 
were no differences in the percentage of binucleated cells, therefore the 
differentiation/maturation of the cardiomyocytes was unaffected and instead there was 
hyperplastic growth (Giraud et al., 2006). A fetal rat low-dose dexamethasone model also 
showed increased proliferation and a delay in heart maturation (Torres et al., 1997).  
IUGR 
IUGR occurs in a range of conditions (e.g. inadequate nutrition, placental insufficiency and 
hypoxia) and is defined as inadequate growth. A sheep model of placental insufficiency using 
umbilicoplacental embolization showed reduced heart and bodyweight with no difference in 
heart to bodyweight ratio. Proliferation and maturation of the cardiomyocytes was suppressed; 
alongside the finding that the smaller hearts did not have reductions in cardiomyocyte size, 
thus suggesting a deficit in working cardiomyocytes (Louey et al., 2007). 
Maternal protein restriction in rats also resulted in pups of lower birthweight and reduced 
heart size. The number and size of cardiomyocytes were reduced in one day old pups without 
any changes in the fraction of binucleated cells (Corstius et al., 2005). The burden of 
mechanical stresses and contractile force generation was consequently shared between fewer 
cardiomyocytes, therefore as a compensatory mechanism to normalize wall stress there was 
hypertrophy of the chamber wall accompanied by cardiomyocyte enlargement (Roberts, Frias 
and Grove, 2015). 
Maternal obesity  
Maternal obesity has previously been associated with an increased risk of congenital heart 
malformations in humans (Mikhail, Walker and Mittendorf, 2002; Mills et al., 2010). 
Assessment of fetal anatomy, in particular identifying fetal heart abnormalities, is far more 
limited in obese women due to poor ultrasound visualisation, and this can have adverse 
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consequences (Hendler et al., 2005). The missed diagnosis of congenital heart problems 
greatly increases the risk of death, as proper and timely treatment cannot be administered 
(Chang, Gurvitz and Rodriguez, 2008).  
A study of pregnant women was undertaken to assess the effect of maternal obesity on fetal 
cardiac function through fetal echocardiography. The obese pregnant women had increased 
SBP and resting HR. At 14 weeks of gestation, fetal echocardiography demonstrated 
decreased global strain rate of the left and right ventricle in fetal hearts, which is a measure of 
reduced systolic function (Ingul et al., 2016).  
An overfeeding sheep model of maternal obesity caused increased bodyweight and LV weight. 
Cardiomyocytes had increased length, and decreased peak shortening and sarcomere length. 
Ca2+ homeostasis, which is critical for normal cardiac contraction, was disrupted and showed 
increased resting and peak Ca2+ in both LV and RV cardiomyocytes (Wang et al., 2018).  
6.1.3 Aims of chapter 
The primary aim of the chapter was to assess the immediate consequences of maternal diet-
induced obesity on the morphology of the fetal heart in both sexes. The impact of the 
maternal exercise intervention in the obese dam was also to be assessed. The second aim was 
to assess if oxidative stress is present in the fetal heart of obese dams.  
 
6.2 Methods 
6.2.1 E19 tissue collection 
On embryonic day 19, dams were killed by rising CO2 concentration and fetuses were 
dissected. Fetuses were sexed by visual inspection for testes, and individual bodyweights 
were recorded. Hearts were collected and snap frozen for MDA assay. Torsos (male and 
female) were immersion-fixed in formalin for stereological analysis. This was performed by 
Dr Denise Fernandez-Twinn and Dr Heather Blackmore.  
6.2.2 Stereological assessment of E19 heart 
Immersion-fixed whole E19 torsos were processed and the heart was exhaustively sectioned 
in the coronal plane at 10 µm. Due to the small size of the E19 heart (especially following 
processing) it was not possible to manually align the isolated heart before embedding, 
therefore whole torsos were aligned and fixed. The fetal torsos themselves aligned the heart, 
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and this allowed for a more successful embedding and serial sectioning process. Slides were 
chosen for staining using a systematic method, a total of 10 equally spaced sections 
throughout the heart were required for analysis. Firstly, the number of sections taken for each 
torso’s heart was counted. The number of sections required between each stained section was 
calculated by dividing the total number of sections by 10. For example, for a heart cut into 
150 sections, a stained section at every 15th interval was analysed. The chosen heart sections 
were stained with haematoxylin and eosin, and imaged on the Slide Scanner Axio Scan Z1 
(Zeiss, Germany) using a 20x objective. A previously published stereological method was 
utilised (Blackmore et al., 2014). Images were exported in TIFF format ensuring that a scale 
bar was added. Images were then analysed using FIJI software. Ventricle area was assessed 
by superimposing crosses onto the image where the area of the cross was known (previously 
described in Section 5.2.2). The plugin (available on FIJI) called Cell counter was used to 
count the number of crosses falling on the LV, LL, RV, RL and IVS. This was analysed over 
10 sections across the whole heart. The Cavalieri principle was then used to calculate area and 
volume of ventricles and lumens:  
𝐴𝑟𝑒𝑎 (𝑚𝑚2) = 𝐴(𝑝) × ∑ 𝑝,    A(p) = known area /point. Σp = Sum of each point counted.  
𝑉𝑜𝑙𝑢𝑚𝑒 (𝑚𝑚3) = 𝐴𝑟𝑒𝑎 (𝑚𝑚2) × 𝑡ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠 𝑜𝑓 𝑠𝑒𝑐𝑡𝑖𝑜𝑛 (𝑚𝑚) × 𝑡𝑜𝑡𝑎𝑙 𝑛𝑜. 𝑜𝑓 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑠 
Total LV area was considered to be the sum of the LVPW and the IVS area.  
6.2.3 Lipid peroxidation MDA assay 
Malondialdehyde (MDA) is an end product of lipid peroxidation and is therefore a good 
measure of oxidative stress. MDA was measured in E19 heart tissue through the use of a lipid 
peroxidation fluorometric assay kit (Abcam, UK). The protocol was adapted to account for 
the low tissue weight. The tissue was homogenised by hand using the lysis buffer provided 
and a micropestle (Sigma-Aldrich, USA). The MDA present in the prepared lysates reacted 
with thiobarbituric acid and formed an adduct that was then measured fluorometrically at an 
excitation/emission wavelength of 532/553 nm. The level of MDA (nmol/well) was calculated 
through the use of a standard curve of known MDA concentrations. This was then normalised 
per mg of heart tissue.   
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6.3 Results 
6.3.1 Fetal bodyweight at E19 
Fetal weights were measured at the point of post mortem. There was no effect of sex on fetal 
weight however there was a significant effect of maternal lifestyle. Maternal obesity 
decreased fetal weight in both sexes and this was not corrected by the maternal exercise 
intervention (Figure 6.2).  
 
FIGURE 6.2: Fetal weights at E19. Male: Control n= 5, Obese n= 6 and Ob-Ex n= 4. 
Female: Control n= 5, Obese n= 6 and Ob-Ex n= 3. Two-way ANOVA with Bonferroni post-
hoc test; ** p< 0.01. 
 
6.3.2 Fetal heart alignment 
Unfortunately, there were natural differences in the heart alignments between the individual 
fetal torsos which reflects biological heterogeneity in how the heart lies in the chest cavity. 
This was a major limitation encountered in this study which was not anticipated when 
designing the experiments. In the males, roughly one third of all analysed fetal hearts were at 
a different alignment, with the apex of the heart pointing upwards towards the sternum as 
opposed to lying flatter in the chest cavity. This was not confined to one experimental group, 
appearing equally between all maternal groups. This meant the heart appeared ‘twisted’ with 
the RV not being well represented in the first few (of the 10) sections but becomes dominant 
in the later sections. Figure 6.3 illustrates representative mid-cardiac sections showing the two 
alignments.  
The alignment of the heart within the chest cavity also appeared to be influenced by sex. In 
the females, all of those analysed appeared to have the ‘twisted’ heart alignment. In support of 
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this, when performing echocardiography analysis in the female offspring at 8 weeks of age 
(for Chapter 5), it was noted that the transducer had to be positioned differently compared to 
the males to achieve the parasternal axis view needed for analysis. Due to these sex 
differences it was not possible to directly compare stereological differences between the sexes 
at E19.  
Ventricular wall width analysis of the mid-cardiac section was not carried out, as this is 
highly dependent on correct alignment and the results would not be meaningful. Additionally, 
as shown in Figure 6.3, the RV wall is under-represented in the mid-cardiac section of the 
‘twisted’ alignment. Unless identified as a Grubbs statistical outlier (p< 0.05), all hearts were 
included in the area/volume analysis, as this was considered most stringent and least likely to 
add bias. Those with the ‘twisted’ alignment are shown as red data points in the scatter plots 
of this results section. Despite the different heart alignments, total heart and ventricular 
area/volumes appear fairly similar within groups. The alignment had most impact on the 
lumen measurements. 
FIGURE 6.3: Representative images showing the two cardiac alignments. Images show 
mid-cardiac sections of haematoxylin and eosin stained torsos. A) Standard alignment B) 
‘twisted’ alignment where heart points up towards sternum.  
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6.3.3 E19 total heart area and volume 
Males 
Absolute total area was not altered between groups in the male fetal hearts, and similarly heart 
volume was also unaltered (Figure 6.4A+B). When expressed relative to fetal weight, heart 
area continued to be unchanged (Figure 6.4C), however heart volume expressed relative to 
fetal weight was increased in the fetuses of obesogenic diet-fed dams (Figure 6.4D). The 
relative contributions to heart volume of the two ventricles was unaltered between groups as 
shown by the calculated LV: RV volume ratio (Control, 1.80 ± 0.05; Obese, 2.07 ± 0.11; Ob-
Ex, 1.88 ± 0.05; p= 0.074). 
 
FIGURE 6.4: Total area and volume of male fetal heart. A) Total heart area B) Total heart 
volume C) Total heart area relative to fetal weight and D) Total heart volume relative to fetal 
weight. Red data points are those analysed hearts with ‘twisted’ alignment. Control n= 5, 
Obese n= 6 and Ob-Ex n= 4. One-way ANOVA with Bonferroni post-hoc test; * p< 0.05 and 
** p< 0.01.  
 
Females 
In the female hearts, area was increased in the fetuses of obese-exercised dams compared to 
fetuses in the non-exercised obese dams (Figure 6.5A). This did not result in any changes in 
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the volume of the female hearts between groups (Figure 6.5B). There was a significant 
difference in the heart area relative to fetal weight in the fetuses of obese-exercised dams 
compared to both the other groups (Figure 6.5C). Again, heart volume was not altered even 
with normalisation to fetal weight (Figure 6.5D). An unchanged LV: RV volume ratio 
demonstrated no differences in the relative volume of the two ventricles (Control, 1.29 ± 0.03; 
Obese, 1.27 ± 0.04; Ob-Ex 1.21 ± 0.10; p= 0.550). 
 
FIGURE 6.5: Total area and volume of female fetal heart. A) Total heart area B) Total 
heart volume C) Total heart area relative to fetal weight and D) Total heart volume relative to 
fetal weight. Red data points are those analysed hearts with ‘twisted’ alignment. Control n= 5, 
Obese n= 6 and Ob-Ex n= 3. One-way ANOVA with Bonferroni post-hoc test; * p< 0.05 and 
** p< 0.01.  
 
6.3.4 Area and volume: left side of the heart 
Males 
LV Area was decreased in the hearts of male fetuses of obese and obese-exercised dams 
(Figure 6.6A). There was no significant difference in LV volume (Figure 6.6B) or LV volume  
relative to fetal weight (Figure 6.6C). There was a significant increase in LL area in male 
fetuses of obese dams and the increase in fetuses of obese-exercised dams was not significant 
(Figure 6.6D).  LL volume was increased in the male fetuses of both obese dams and obese-
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exercised dams (Figure 6.6E). LL volume expressed relative to fetal weight was increased in 
male fetuses of obese dams but the increase in the obese-exercised dams was not significant 
(Figure 6.6F). The LV: LL volume ratio in the male fetal hearts showed significant 
differences (Control, 25.37 ± 5.57; Obese, 5.94 ± 1.15; Ob-Ex, 7.32 ± 2.94; p= 0.004); with 
post-hoc testing revealing a significant decrease in fetuses of obese and obese-exercised dams 
compared to fetuses of control dams. 
 
FIGURE 6.6: Area and volume of LV and LL in male E19 hearts. A) Total LV area B) 
Total LV volume C) Total LV volume relative to fetal weight D) LL area E) LL volume and 
F) LL volume relative to fetal weight. Red data points are those analysed hearts with ‘twisted’ 
alignment. Control n= 5, Obese n= 6 and Ob-Ex n= 4. One-way ANOVA with Bonferroni 
post-hoc test; * p< 0.05 and M: overall effect of maternal lifestyle.  
 
Females 
There was a decrease in the LV area and volume in female fetuses of obese dams (Figure 
6.7A+B). There was no significant reduction in LV volume in the female fetuses of obese-
exercised dams (Figure 6.7B). These differences were not present if LV volume was 
expressed relative to fetal weight (Figure 6.7C). There were no significant differences in the 
area or volume of the LL in the female fetal heart (Figure 6.7D-F). The LV: LL volume ratio 
in the females showed no significant differences between groups (Control, 11.52 ± 3.70; 
Obese, 8.59 ± 2.85; Ob-Ex, 4.92 ± 1.27; p= 0.450).  
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FIGURE 6.7: Area and volume of LV and LL in female E19 hearts. A) Total LV area B) 
Total LV volume C) Total LV volume relative to fetal weight D) LL area E) LL volume and 
F) LL volume relative to fetal weight. Red data points are those analysed hearts with ‘twisted’ 
alignment. Control n= 5, Obese n= 6 and Ob-Ex n= 3. One-way ANOVA with Bonferroni 
post-hoc test; ** p< 0.01.  
 
6.3.5 Area and volume: right side of the heart  
Males 
In the male E19 fetal hearts, RV area and volume were decreased in the groups from 
obesogenic diet-fed dams when expressed as absolute values (Figure 6.8A+B); however, 
when expressed relative to fetal weight the difference was not present (Figure 6.8C). RL area 
and volume was increased in the hearts of fetuses of obese and obese-exercised dams (Figure 
6.8D+E). Unlike the RV, the difference in RL volume as a consequence of maternal obesity 
was maintained when normalised to fetal weight (Figure 6.8F). The RV: RL volume ratio 
revealed statistical differences (Control, 14.17 ± 3.489; Obese, 2.59 ± 2.59; Ob-Ex 4.151 ± 
1.974; p= 0.006); with post-hoc testing revealing a significant decrease in fetuses of obese (p< 
0.01) and obese-exercised (p< 0.05) dams compared to fetuses of control dams. 
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FIGURE 6.8: Area and volume of RV and RL in male E19 hearts. A) RV area B) RV 
volume C) RV volume relative to fetal weight D) RL area E) RL volume and F) RL volume 
relative to fetal weight. Red data points are those analysed hearts with ‘twisted’ alignment. 
Control n= 5, Obese n= 6 and Ob-Ex n= 4. One-way ANOVA with Bonferroni post-hoc test; 
* p< 0.05, ** p< 0.01.  
 
Females 
In the female hearts, RV area and volume were decreased in the fetuses of obese dams 
compared to fetuses of control dams (Figure 6.9A+B). This difference was absent when 
expressed relative to fetal weight (Figure 6.9C). There were no differences in RL 
measurements between the groups (Figure 6.9D-F). The RV: RL volume ratio was unchanged 
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FIGURE 6.9: Area and volume of RV and RL in female E19 hearts. A) RV area B) RV 
volume C) RV volume relative to fetal weight D) RL area E) RL volume and F) RL volume 
relative to fetal weight. Red data points are those analysed hearts with ‘twisted’ alignment. 
Control n= 5, Obese n= 6 and Ob-Ex n= 3. One-way ANOVA with Bonferroni post-hoc test; 
* p< 0.05.  
 
6.3.6 Lipid peroxidation-MDA assay  
Whole E19 hearts were assessed for the level of lipid peroxidation (MDA). There were no 
measured differences in the level of MDA in the male fetal hearts (Figure 6.10A). However, 
no significant increase in MDA level in the female fetal hearts of obese dams compared to 
control, however an increase was prevented by maternal exercise (Figure 6.10B).   
FIGURE 6.10: MDA assay in male and female E19 hearts. MDA normalised to mg of 
heart tissue in A) male and B) female fetal hearts. Male: Control n= 5, Obese n= 4 and Ob-Ex 
n= 4. Female: Control n= 5, Obese n= 5 and Ob-Ex n= 4. One-way ANOVA with Bonferroni 
post-hoc test; * p< 0.05.  
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6.4 Discussion 
This chapter aimed to perform stereological analysis of the hearts from fetuses of obese dams, 
to assess if cardiac morphology was directly altered by an obesogenic environment during 
development. This was undertaken to identify possible causes for the poor cardiovascular 
health of offspring of obese dams in adulthood. A further aim was to establish if a maternal 
exercise intervention had any impact on fetal heart morphology. The findings revealed that 
the male fetal hearts were more affected then the female hearts. Male and female fetuses of 
obese dams were smaller at E19, suggesting that they were growth restricted, and this was not 
corrected by maternal exercise intervention. When a correction for the smaller fetal weight of 
the obese dams was added, it showed that the heart volume was increased in the males and 
this was caused by an increase in the volume of both lumens. This was not present in the 
female fetuses.  
The second aim was to assess if oxidative stress could be a mediator for the changes in the 
fetal heart and to do this lipid peroxidation (MDA) was assessed in whole fetal hearts. As 
opposed to the cardiac stereology analysis, there was no significant increase in the amount of 
MDA in both the male and female fetal hearts of obese dams. The changes in cardiac 
structure could not be prevented by the maternal exercise intervention however the MDA 
level was normalised to control levels in the female fetal hearts of obese-exercised dams.  
6.4.1 Altered cardiac morphology in male fetuses after exposure to maternal obesity 
Despite the smaller fetal weight caused by maternal obesity, the heart area and volume were 
unchanged between groups. It was therefore important to correct for the difference in body 
size by normalising the stereological measurements by fetal weight. This adjustment revealed 
increased heart volume in the male fetuses of obese and obese-exercised dams. During normal 
fetal life, the heart should increase in size and chamber volume in proportion to body growth 
(Louey and Thornburg, 2005). Therefore, the heart size in the males was disproportionate to 
the fetal size indicating increased and possibly aberrant cardiac growth. A previous study has 
shown that expression of the gene Nppa, which is mainly associated with cardiac hypertrophy, 
was increased in the fetal hearts of obese dams generated in the same model (Loche 2018, 
personal communication). Nppa has been shown to suppress cardiomyocyte proliferation in 
the fetal sheep heart and it is hypothesised that it controls normal heart growth, in particular 
preventing cardiac overgrowth. Mice lacking NPRA have larger hearts at birth when 
compared to the wild-type controls (Knowles et al., 2001). Activation of Nppa in the fetal 
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heart occurs in response to increased stretch, much like the adult heart (Jaekle et al., 1995). In 
the fetuses of obese dams, increased expression of Nppa could be compensatory in an attempt 
to normalise cardiac growth in response to myocardial stretch.  
The increase in heart volume in male offspring was driven by greater lumenal volume in both 
the left and right ventricles. The decreased ratios of LV: LL and RV: RL observed in the 
maternal obesity exposed-fetuses demonstrated an increased lumenal volume that was not 
proportional to ventricle wall volume. This indicated chamber dilatation without any change 
in ventricle wall measurements. These changes are associated with a type of cardiac 
hypertrophy that is known as eccentric hypertrophy (Müller and Dhalla, 2013). It has been 
suggested that eccentric hypertrophy can occur as a result of a reduced cardiomyocyte number, 
a study using forensic autopsy reports showed that hearts with eccentric hypertrophy were 
more likely to have fewer cardiomyocytes (Tracy, 2013). It will be important in the future to 
1) assess cardiomyocyte proliferation through either Ki-67 or BrdU analysis, 2) quantify 
cardiomyocyte number, and 3) calculate the mononucleated/binucleated ratio. This would 
help define if morphological differences are due to changes in the regulation of 
cardiomyocyte development. There may also be rationale for analysing cardiomyocyte cell 
size, as both cardiomyocyte length and width are increased in eccentric hypertrophy (Heineke 
and Molkentin, 2006).  
Volume overload is the primary cause of eccentric hypertrophy, and the molecular basis for 
this type of hypertrophy differs from concentric hypertrophy, which is more likely to be 
caused by pressure overload. Concentric hypertrophy is the enlargement and thickening of 
ventricular walls (Müller and Dhalla, 2013) and this more closely matches the type of 
hypertrophy seen in the LV from male offspring of obese dams at eight weeks of age, for 
which wall widths were increased (Fernandez-Twinn et al., 2012).  Volume overload 
induced-eccentric hypertrophy in the adult heart can have causes that are either physiological 
(e.g. pregnancy and endurance aerobic training) or pathological (e.g. chronic kidney disease, 
valve regurgitation and anemia) (Heineke and Molkentin, 2006; Müller and Dhalla, 2013). 
Further work is needed to investigate possible causes of the hypertrophy in the fetal heart. It 
remains to be ascertained whether the hypertrophy is pathogenic in nature, and in forthcoming 
studies it will be important to assess this, as pathological eccentric hypertrophy will very 
likely cause cardiac dysfunction (Heineke and Molkentin, 2006). It would be useful, therefore, 
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in future studies to perform fetal Doppler echocardiography to assess fetal cardiac function, 
though this may be technically challenging in the mouse.  
Anemia is one mechanism for generating volume overload that can occur in the fetus. 
Possible causes of the anemia are red blood cell destruction as well as poor production. 
Maternal obesity has been shown to have a negative influence on the iron status of both the 
mother and the infant (Jones et al., 2016). Fetal anemia results in a diminished oxygen 
carrying capacity to the developing tissues. The heart adapts to attempt to maintain sufficient 
oxygenation by increasing cardiac output through increases in venous return (preload) and 
ventricular filling pressures (Davey, Szwast and Rychik, 2012). There are also positive 
inotropic and chronotropic effects and this causes increased fetal HR. These necessary 
hemodynamic changes lead to enhanced myocardial stretching and cardiac 
enlargement/hypertrophy (Metivier et al., 2000). Fetal anemia is a possible mechanism in the 
resulting cardiac remodelling seen in the fetuses of obese dams. Preliminary data measuring 
haematocrits in E19 fetal blood indicates a possible decrease in the maternal obesity exposed 
groups, with no protective effect of the exercise intervention (Fernandez-Twinn 2018, 
personal communication).  
Another possible cause for fetal cardiac remodelling could lie in changes to the placental and 
fetal circulation. Chronic hypoxia in pregnant guinea pigs increased uterine resistance and 
pulsatility index, causing IUGR in the developing fetus. Hypoxia had no impact on umbilical 
artery Doppler indices, meaning that afterload experienced by the hearts was not altered. 
Diastolic filling was enhanced, indicating an increased preload mediated by increased venous 
return (Turan, Aberdeen and Thompson, 2017). Volume overload and increased filling 
pressures will lead to increased stretching in the heart, and this will trigger a hypertrophic 
response increasing contractile force to counter balance increased wall stretch (Mihl, Dassen 
and Kuipers, 2008). In the mouse model used in this thesis, placental hypoxia is thought to be 
present in obese dams and to be ameliorated by the exercise intervention (Fernandez-Twinn et 
al., 2017). The cardiac morphological changes did not mirror the positive findings in the 
intervention group, therefore hypoxia alone may not be the driving mechanism in the 
observed cardiac remodelling. Hypoxia, however, is not the only cause for variations in 
uterine and umbilical blood flow, it can be negatively impacted by placental insufficiency 
(Papageorghiou and Roberts, 2005) and hypertensive disorders during pregnancy (Lee et al., 
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2016). It would therefore be valuable to assess umbilical and uterine artery Doppler flow 
measurements in future studies.  
6.4.2 Female fetal hearts were protected from exposure to maternal obesity  
Unlike the male fetuses, all measurements of total heart area and volume were unaltered in the 
female fetuses of obese dams. In keeping with this, there were no changes in the ventricular or 
lumenal stereological measurements that were not in proportion to the smaller fetal size. 
Differences in the female fetuses of obese-exercised dams will be discussed in Section 6.4.3. 
Direct comparison between the sexes was not possible due to the different heart alignments 
seen between the sexes. Limitations exist within this study that might mean that true 
differences are being missed. The variability within the groups is greater in the female than in 
the male stereological data. It is, as yet, unclear why this is true. A source of the variability 
could be a due to the alignment of the heart, with all females appearing to have a different 
alignment to the males. Ideally, a more stringent criteria for an acceptable alignment for 
analysis should be used, however in the present study the number of available samples did not 
allow for this.  
Chapter 5 of this thesis demonstrated that female adult offspring showed an arguably milder 
cardiac phenotype with a less significant degree of hypertrophy that is confined to the RV and 
no obvious LV systolic dysfunction. Data from this chapter, could suggest that even before 
birth, males are far more susceptible to the damaging effects of maternal obesity on their 
cardiovascular health. In Section 5.1.2, the cardioprotective properties of estrogen were 
discussed, and although this factor will have influence in an adult mouse, it is unlikely to be 
responsible for the differences seen at this fetal stage as they are not sexually mature. 
Therefore, in this instance it is perhaps more accurate to conclude that adaptations to adverse 
intrauterine exposures are different between the sexes.  
6.4.3 Effect of maternal exercise intervention during an obese pregnancy on the fetal 
heart 
The exercise intervention did not prevent the reduced fetal weight seen in maternal obesity-
exposed fetuses. This was supported by neonatal offspring data (discussed in Section 3.4.2) 
where maternal exercise intervention did not cause any additional changes in pup weight at 
PND2. Stereological parameters in the male fetuses of obese-exercised dams were similar to 
those of the male fetuses of obese dams who were not exercised. This suggests the maternal 
exercise intervention could not have any impact on male fetal cardiac structure. This is 
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interesting as in the adult male the intervention has a striking protective effect on heart 
morphology and function. It is unclear how and why, despite showing similar findings in the 
fetal heart, the male offspring of obese dams go on to develop significant LV hypertrophy and 
systolic dysfunction whereas the male offspring of obese-exercised dams do not. This would 
be an interesting question to address in future work.  
The data in the female fetus appears more puzzling; total heart area was increased in fetuses 
of obese-exercised dams. This was not accompanied by changes in total heart volume or even 
in ventricular or lumenal area measurements. The lack of significant differences in these 
parameters may be due to a lack of power in that group, as unfortunately only a sample size of 
three was possible. It is, therefore, an unclear finding that would need further investigation. 
6.4.4 Oxidative stress as a mediator for poor cardiovascular health  
Placental hypoxia is present in the obese dams during pregnancy (Fernandez-Twinn et al., 
2017) but it has not yet been determined if this insult will be transferred to the fetus. Previous 
work has assessed the level of expression of antioxidant defence genes in the fetal heart; data 
is shown in Appendix AP3. Catalase and superoxide dismutase 2 are two of the critical 
enzymes in the antioxidant defence network against oxidative stress damage mediated by 
reactive oxygen species (ROS) (Birben et al., 2012). Both were increased in male and female 
fetal hearts of obese and obese-exercised dams. Nuclear factor erythroid 2–related factor 2 is 
a transcription factor that is a major regulator of antioxidant defence (Ma, 2013), and was 
similarly increased in hearts of male and female fetuses of obesogenic diet-fed dams. 
Glutathione peroxidase 3, like catalase, acts in the defence against ROS by eliminating 
hydrogen peroxide (Birben et al., 2012), and this was elevated with maternal obesity in a sex-
dependent manner, where just the males showed an elevated expression. Previous studies 
have also shown a lower expression of glutathione peroxidase in female animals (Kander, Cui 
and Liu, 2017). 
Despite the elevated expression of antioxidant defence genes in male and female fetal hearts 
of obese dams (Appendix AP3), lipid peroxidation was not significantly elevated in the fetal 
hearts of obese dams. Secondly, in the female fetuses, maternal exercise appears to be 
protective against lipid peroxidation in these hearts. This suggests that although antioxidant 
defence has been triggered, these defensive systems have not been overcome, therefore 
oxidative stress was not yet present if the obese dam was exercised during pregnancy or if the 
fetus was male. However, there are other consequences of oxidative stress (e.g. DNA 
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damage) and these need to be assessed to determine if male fetuses and fetuses of obese-
exercised dams are fully protected against oxidative stress. 
The lipid peroxidation findings do not mirror the changes in the fetal heart structure. Despite 
significant cardiac morphological changes in the male fetuses of obesogenic diet-fed dams, no 
changes in lipid peroxidation between male groups were seen. On the other hand, the 
expression profile of antioxidant defence genes was in agreement with cardiac changes in the 
male fetus indicating it was a potential mediator. The female fetal hearts of obese dams had 
no significant increase in lipid peroxidation (MDA) level, and in contrast to the males this 
was accompanied with no cardiac morphological changes. All measured antioxidant defence 
genes, except glutathione peroxidase 3, were also upregulated in the female fetal hearts 
despite no cardiac changes. Many studies have shown that females have an apparent lower 
susceptibility to oxidative stress damage (Marotti et al., 2010; Kander, Cui and Liu, 2017), 
and although the MDA data did not fully show this, it still may explain the prevention of the 
cardiac remodelling.  
6.4.5 Conclusions 
Maternal obesity caused cardiac remodelling in the E19 heart in a sex-dependent manner. The 
sex of the fetus determined how the fetus adapted to the developmental stressor of an 
obesogenic environment. These differences could explain why the cardiovascular phenotype 
in the adult offspring is so different between the sexes. The maternal exercise intervention 
was not successful at preventing the cardiac structural changes, therefore the mechanism by 
which the maternal exercise intervention prevents cardiac dysfunction in the male adult 
offspring is unknown.  
6.4.6 Summary of key findings 
Results from this chapter has shown that: 
• Fetuses of obesogenic diet-fed dams were smaller at E19 and may be growth 
restricted. 
• Hearts from male fetuses of obesogenic diet-fed dams displayed signs of chamber 
dilatation and possible eccentric hypertrophy. 
• Female fetal heart morphology appeared to be protected from the adverse exposure of 
maternal obesity.  
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• Maternal exercise did not appear to protect the male fetal hearts from altered 
stereological measurements and further work is needed to determine the full effect on 
female fetal hearts. 
• Lipid peroxidation was not significantly increased in the fetal hearts of obese dams 
despite elevated oxidative stress markers. 
• The maternal exercise intervention reduced lipid peroxidation in female fetal hearts 
when compared to the female fetuses of non-exercised obese dams, even though the 
intervention did not alter oxidative stress markers.  
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7. General Discussion 
This growing field of DOHaD research has transformed our understanding of health and 
disease by demonstrating the power of nutrition in influencing health across generations. The 
health legacy of an individual can be pre-determined before birth and in the earliest days of 
life by the intrauterine and neonatal environment. The growing prevalence of maternal obesity 
in today’s world is of huge concern, in particular with respect to the impact of the so-called 
‘programmed’ disease on the next generation. Strategies aiming to break the cycle and abate 
the burden of cardiometabolic disease need to be developed. In-depth studies need to be 
carried out to identify translatable interventions, in order to incorporate evidence-based 
interventions into clinical practise. 
This thesis sought to test the effectiveness of a maternal exercise intervention in preventing 
the unwanted cardiovascular changes that have previously been shown to arise in the male 
offspring born to obese dams. In undertaking this study it was important to define the in utero 
environment in the obese dams, and how this was altered by the intervention, in order to be 
able to identify drivers of programming mechanisms. There is a lack of studies that 
investigate cardiovascular outcomes in the female offspring of obese dams. Therefore, this 
thesis also aimed to fill the current knowledge gap about this often under-represented sex in 
programming studies. The final aim of this thesis was to identify the immediate consequences 
of maternal obesity on the fetal heart, and also determine the influence of the maternal 
exercise intervention. Defining these changes would improve understanding of how and why 
the poor cardiovascular health in the offspring occurs, as well as trying to address the sex 
differences in these cardiovascular phenotypes. The findings in the offspring are summarised 
in Figure 7.1. 
7.1 Sex differences in the response to exposure to maternal obesity 
When this thesis investigated the cardiovascular health of both male and female offspring, it 
became clear that significant sex differences existed in the programming by maternal obesity. 
The differences it highlighted will be explored in the following section. Male fetuses of obese 
dams had enlarged heart to body ratios, which was caused by increases in both lumenal 
volumes after adjustment for the smaller bodyweights of these growth-restricted fetuses. 
Despite the female fetuses of an obese pregnancy also being growth restricted, they were 
protected against cardiac remodelling during heart development. This highlights a difference 
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between the sexes in their response and ability to adapt to an adverse intrauterine obesogenic 
environment.  
Cardiac hypertrophy in the offspring of obese dams appears to affect different ventricles 
depending on sex; the LV hypertrophy was present in the male offspring while only the RV 
was impacted in the female offspring. The cause of hypertrophy in each ventricle may be 
distinct and the mechanisms should be explored in further work. Nevertheless, it has not yet 
been determined if the male offspring also had RV hypertrophy and this remains an important 
question to address. Data from this thesis indicates that RV hypertrophy is expected to be 
present in the males as the fetal heart analysis showed that the right side of the heart was 
equally as affected as the left side. Secondly, the offspring were hypertensive and this could 
be further complicated by pulmonary hypertension (as discussed in Section 5.4.3), which will 
inevitably impact the RV. Using the automated cell area method developed during this PhD, 
this analysis can now be carried out with relative ease. 
LV hypertrophy appeared to be associated with LV systolic dysfunction and fibrosis since 
these outcomes always occurred together. Unlike the male offspring, the female offspring 
appear protected from LV dysfunction, despite haemodynamic stress acting on their hearts 
caused by hypertension, and indications of an adverse expression profile of myofilament 
contractile proteins. Nonetheless, cardiac function does need to be assessed in the RV of the 
female hearts because it is this side of the heart that has been affected by the hypertrophy. The 
RV remodelling in the female hearts did not cause cardiac fibrosis unlike the cardiac 
remodelling seen in the male offspring, possibly indicating it is not as severe. The female 
offspring appear protected from the most adverse cardiovascular outcomes programmed by 
maternal obesity. This divergence in outcomes between male and female offspring is 
observed in young adult life. A suboptimal early-life environment increases propensity for 
age-associated disease (Tarry-Adkins and Ozanne, 2017), and programmed phenotypes 
typically worsen or become more pronounced with age, consequently it will be important to 
establish if females remain protected in later life.  







FIGURE 7.1: Summary of the cardiovascular findings in the offspring of obese dams. 
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7.2 Similar effects of exercise intervention on the offspring hearts 
Despite different cardiovascular phenotypes that occurred between sexes in response to 
maternal obesity, the maternal exercise intervention altered cardiac function in both sexes. 
The effects of the exercise intervention are visualised in Figure 7.1 through the use of a star 
symbol. The exercise intervention in the obese dams increased offspring cardiac contractility, 
which in the males was possibly mediated by sympathetic activated inotropy. Previous studies 
using Langendorff data has shown that male offspring of non-exercised obese dams had 
sympathetic dominance accompanying ex vivo cardiac dysfunction. To explore the hypothesis 
of sympathetic activated increases in inotropy, future work could use a Langendorff isolated 
heart perfusion set up to assess the responsiveness of the offspring hearts to sympathetic 
(isoprenaline) and parasympathetic (carbachol) agonists. In the males, this increased 
contractility only acted to prevent the maternal obesity-induced cardiac dysfunction, as they 
had to overcome a deficit in cardiac function that was present in the offspring of non-
exercised obese dams. This deficit in cardiac function shown in the male offspring of obese 
dams was likely a result of the altered hemodynamic load caused by increased SBP. In the 
females, this increased contractility resulted in systolic function parameters that were 
increased even when compared to the offspring of control dams.  
A short exercise intervention undertaken during an obese pregnancy in males was able to 
impact the cardiac health of the offspring in early adulthood, despite there being no protective 
effect seen in fetal life. This presents strong evidence for the importance of intervention 
studies undertaking long-term follow up in the offspring, in order to be able to fully assess the 
potential value of the intervention. It could suggest that even the most disappointing study, 
showing no positive outcomes of the intervention on the fetus or neonate, could still be 
advantageous to those offspring in adulthood. This finding is particularly relevant to human 
studies where primary fetal outcomes are often not met. 
 
7.3 Unanswered questions and future directions 
7.3.1 What causes the cardiac remodelling in the fetal heart? 
An eccentric hypertrophy-like phenotype was seen in the male fetal hearts of obese dams, 
with chamber dilatation in both ventricles. The mechanism underlying the fetal cardiac 
changes cannot involve factors that were corrected by the maternal exercise intervention. 
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Modifications in cardiomyocyte proliferation or differentiation, that will respectively alter the 
number and maturation of the cardiomyocytes, could be a possible cause. Further histological 
and immunohistochemical analyses should be carried out in the fetal heart to answer this 
question. Another mechanism to investigate is fetal anemia, a cause of fetal heart failure that 
results in adaptive cardiac remodelling, leading to the abnormal enlargement of the heart 
(Davey, Szwast and Rychik, 2012). In order to assess fetal anemia, fetal blood haematocrits 
should be measured at the point of post mortem. It is also not yet clear how the female fetal 
hearts can be protected from the cardiac remodelling caused by these potential mechanisms. It 
is also important to establish if this cardiac remodelling is accompanied by cardiac 
dysfunction, and this can be assessed by fetal Doppler echocardiography. The reliance of the 
fetal heart on the maternal circulation means that changes in umbilical and uterine pulsatility 
indices, often caused by placental insufficiency, are further possible causes of fetal cardiac 
remodelling.  
7.3.2 Why do the cardiac changes that occur in fetal life develop into the different 
cardiovascular phenotypes in the adult? 
Male fetuses of obese dams had fetal cardiac remodelling, which the maternal exercise 
intervention did not appear to prevent, and yet these fetuses will grow up and have very 
different cardiovascular phenotypes in early adulthood. Male fetuses of obese dams become 
adults who have LV hypertrophy, cardiac fibrosis, and systolic dysfunction. On the other hand, 
the offspring from the intervention group were protected against these cardiac changes, 
despite sharing the same fetal heart changes. The maternal exercise intervention ends on E17 
of pregnancy, which is before the fetal heart analysis was undertaken, so the intervention 
period is short and yet it appears to still be able to influence the offspring many weeks later. 
Epigenetic mechanisms that allow the intervention offspring to avoid these unfavourable 
changes should be explored.   
The neonatal period is an important developmental window in the mouse and therefore 
programming of adverse offspring outcomes can still occur during this time. The intervention 
did not continue after birth and was solely carried out during pregnancy. The positive effects 
of the exercise intervention in the dam is likely to be transient, it is currently unknown if the 
exercise intervention during pregnancy can still benefit the offspring during this period. This 
remains an important question to answer. 
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7.3.3 What mechanisms underlie the programmed sex differences in the offspring?  
In both fetal and young adult life, the female offspring of obese dams appear to be protected 
from the worst of the adverse programming effects. They did not have fetal cardiac 
remodelling and the cardiovascular phenotype at eight weeks of age was also, arguably, 
milder. The females had RV, and not LV, hypertrophy that was not complicated by fibrosis 
and there was no LV systolic dysfunction. A limitation of this thesis was that the experiments 
in the male and female offspring were undertaken at different stages of the PhD, and therefore 
direct comparisons were not fully possible. In future studies, male and female littermates 
should be compared and this will allow statistics to analyse for true sex differences, while 
controlling for other confounding factors. Possible mechanisms that can mediate these sex 
differences should be explored; including epigenetics, difference in circulating levels and 
sensitivity to metabolic hormones, and finally the cardioprotective effects of estrogen 
(Dearden, Bouret and Ozanne, 2018). This is a challenging question to fully answer. To assess 
the role of estrogen on the cardiovascular outcomes in the adult mouse, it would be possible 
to perform an ovariectomy on the female offspring to remove the influence of estrogen.  
7.3.4 What programming mechanisms are involved in the development of offspring 
hypertension? 
Maternal obesity, in our model, programmed hypertension in the offspring. Due to significant 
sex differences, this cardiovascular outcome was the only measure that was present in both 
sexes. The intervention undertaken in this PhD did not prevent offspring hypertension, 
therefore the mechanism involved could not have been corrected by the exercise intervention. 
Furthermore, in the males, the programming pathway that mediates offspring hypertension 
must be divergent to the pathway controlling cardiac hypertrophy and dysfunction. Exercise 
did not lower body fat mass in the dam and, in keeping with this, they remained 
hyperleptinemic. Leptin has been shown to be involved in the programming of hypertension 
in the offspring (Samuelsson et al., 2010, 2016). The postnatal leptin surge should be tracked 
in the neonates, to establish if the exaggerated surge that is seen with maternal obesity 
continues to be exaggerated after the maternal exercise intervention. It is important to identify 
the mechanism involved in order to be able to develop a new intervention that can target this 
particular programmed effect. 
To be able to fully target the cardiovascular health of the offspring exposed to maternal 
obesity, another intervention needs to be combined with the exercise intervention. 
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Behavioural interventions, used in the UPBEAT study, combine exercise with a dietary 
intervention that recommended a low glycemic index (GI) diet (Poston et al., 2015). Another 
potential intervention is metformin administration during pregnancy; a previous study 
suggests it could be a good candidate since prenatal metformin in high fructose diet-fed dams 
prevented hypertension in HFD diet-fed offspring (Tain et al., 2018). Finally, antioxidants 
could be employed alongside exercise to address the oxidative stress that may be a potential 
programming factor in the dam.  
7.4 Concluding remarks 
The deleterious influence of an obesogenic environment on the offspring’s cardiovascular 
health is evident before birth. Maternal obesity disrupted heart development of male, but not 
female, fetuses. A maternal exercise intervention during pregnancy could not prevent this 
disadvantageous change. In young adulthood, male offspring developed more significant 
deficits in their cardiovascular health. Female offspring had more favourable maternal 
obesity-programmed cardiovascular outcomes, as they demonstrated a greater ability to adapt 
to a harmful in utero environment. The exercise intervention during pregnancy in the obese 
dams did prevent, to a certain degree, this detrimental progression to poor cardiovascular 
health. There is a need for combination interventions to fully target the offspring’s poor 
cardiovascular health. In developmental programming, it is no longer appropriate to base the 
success of an intervention study on short-term outcomes. This thesis provides evidence for an 
intervention that can have long-term beneficial effects despite initially showing some shortfall 
in preventing disadvantageous short-term outcomes.  
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AP1 Cardiac calculations used in Vevo770 software 
𝐸𝑆𝑉 (𝜇𝑙) = (
7
(2.4 + 𝐿𝑉𝐼𝐷; 𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑒)
) × 𝐿𝑉𝐼𝐷; 𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑒3 
 
𝐸𝐷𝑉 (µ𝑙) = (
7
(2.4 + 𝐿𝑉𝐼𝐷; 𝑠𝑦𝑠𝑡𝑜𝑙𝑒)
) × 𝐿𝑉𝐼𝐷; 𝑠𝑦𝑠𝑡𝑜𝑙𝑒3 
 
𝑠𝑡𝑟𝑜𝑘𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑆𝑉)(µ𝑙) = 𝐸𝑛𝑑 𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐 𝑣𝑜𝑙𝑢𝑚𝑒 (𝐸𝐷𝑉) − 𝐸𝑛𝑑 𝑠𝑦𝑠𝑡𝑜𝑙𝑖𝑐 𝑣𝑜𝑙𝑢𝑚𝑒 (ESV) 
 





𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑠ℎ𝑜𝑟𝑡𝑒𝑛𝑖𝑛𝑔 (%) =




𝐶𝑎𝑟𝑑𝑖𝑎𝑐 𝑜𝑢𝑡𝑝𝑢𝑡 (µ𝑙/𝑚𝑖𝑛) = 𝑆𝑉 ×   𝐻𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒 
 
𝐿𝑉 𝑚𝑎𝑠𝑠 (𝑚𝑔) = 1.053
× ((𝐿𝑉𝐼𝐷; 𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑒 + 𝐿𝑉𝑃𝑊; 𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑒 + 𝐼𝑉𝑆; 𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑒)3 − 𝐿𝑉𝐼𝐷; 𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑒3) 
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AP2 Post weaning dam GTT with three groups (Control, Obese and Ob-Ex) 
FIGURE 1: Maternal GTT at weaning (Control, Obese and Ob-Ex). Data kindly 
provided by Dr Laura Kusinski and Dr Lisa Nicholas. Control n= 15, Obese n= 10 and Ob-Ex 
n= 5. 
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AP3 E19 oxidative stress genes in E19 heart  
 
FIGURE 2: Expression of antioxidant defence genes in E19 hearts. mRNA gene 
expression was assessed in the heart tissue of male and female foetuses of control, obese and 
obese-exercised dams. Data kindly provided by Dr Daniela de Barros Mucci. Cat- Catalase, 
Sod2- Superoxide dismutase 2, Nrf2- Nuclear factor erythroid 2–related factor 2 and Gpx3- 
Glutathione peroxidase. Expression normalised to Rpl6- Ribosomal protein L6 and Sdha- 
Succinate dehydrogenase complex, subunit A. Male E19: Control n= 8, Obese n= 8 and Ob-
Ex n= 7. Female E19: Control n= 7, Obese n= 7 and Ob-Ex n= 7. One-way ANOVA with 
Tukey post-hoc test, * p< 0.05, ** p< 0.01, *** p< 0.001 and **** p< 0.0001. 
 
 
 
 
